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Summary
Ataxia-Telangiectasia Mutated (ATM) is an apical signalling kinase that responds to DNA double
strand breaks (DSBs). DSBs are the most dangerous form of DNA damage. Therefore cells have
evolved multiple pathways to repair such lesions and signal the damage to the cell to organise
the DNA damage response (DDR). DSBs are sensed by the Mre11-Rad50-Nbs1 (MRN) complex,
which initiates repair via homologous recombination (HR). At the beginning of this process, MRN
activates the ATM kinase, which phosphorylates hundreds of substrates, including other DNA
repair factors and kinases to orchestrate a cell-wide DNA damage response.
ATM belongs to the family of PI3-kinase like kinases (PIKKs). It has a very large HEAT-repeat
domain, which plays a role in interacting with other proteins, and a highly conserved kinase domain,
showing more homology to PI3-lipid kinases than protein kinases. ATM is normally present in the
nucleus as an autoinhibited dimer, but rapidly becomes active upon DNA damage. As a part of its
activation mechanism ATM is postulated to monomerise and become autophosphorylated.
In order to understand the molecular mechanism of ATM activation better, the aim of this work was
to solve the structure of ctTel1, a fungal ATM ortholog from the mould Chaetomium thermophilum,
using cryo-electron microscopy (cryo-EM). Due the large size of the protein (650 kDa as a dimer)
recombinant expression was not possible. Therefore ctTel1 was purified from endogenous sources.
The other aim was to characterise its interaction with MRN and DNA, for which a truncated ctTel1
construct was used which could be obtained in large quantities.
Using the truncated construct, the interactions between ATM and Nbs1, and the MRN complex,
were characterised using pull-downs, analytical gel filtration and fluorescence anisotropy, showing
that it forms a stable complex. Furthermore we found that truncated ctTel1 has DNA binding
properties, preferring blunt-ended double stranded DNA and displaying a length-dependency.
Using cryo-EM we determined the first complete and the highest resolution structure of any ATM
kinase to date, with the kinase domain at 2.8 Å and an overall structure including the HEAT repeat
domain at 3.7 Å. This allowed for the building of a complete atomic model, except for a number
of flexible loops. The structure reveals a hydrophobic dimer interface, suggesting monomerisation
is unlikely to be an aspect of the activation mechanism.
In the active site of the kinase the loops required for catalysis are structured, coordinating ATPγS
and a Mg2+ ion. This suggests that ATM is in a catalytic proficient state. However, access to the
active site is physically blocked by the PIKK regulatory domain (PRD) a regulatory helix. The PRD
thus functions as a pseudosubstrate, suggesting that part of the activation mechanism entails its
removal in response to allosteric binding of activators. Cancer mutations and ataxia-telangiectasia
(A-T) mutations were mapped onto the structure, revealing the elements which are important
for the activation. Taken together, the ctTel1 structure reveals the autoinhibitory circuitry and




1.1 DNA damage and repair
All information that is needed for the development and function of any living organism is encoded
in deoxyribonucleic acid (DNA). Therefore it is of high importance that this genomic information
is maintained. The DNA molecule is vulnerable to insults coming from both external sources and
internal sources. Due to its function in storing information, errors in the DNA will last much longer
than other biomolecules, which only have short life spans in the cell, and could even be transferred
to daughter cells. Furthermore, DNA damage can interfere with transcription and replication.
Unsurprisingly, DNA damage underlies many diseases, most famously cancer, and also ageing. To
maintain genomic integrity, cells in all domains of life have developed mechanisms to repair DNA
damage.1
1.1.1 Origins and forms of DNA damage
As there are many different types of DNA damage, different mechanisms have evolved to resolve
the different types of lesions that can occur. This DNA damage response (DDR) consists out of
multiple highly coordinated steps, which start with sensing of the DNA damage, followed by damage
signalling and ends with the coordinated repair of the lesion.2
Many factors, whether physical or chemical, can lead to chemical modifications and structural
changes in the DNA. These can be extrinsic, such as radiation or toxins in fumes, or intrinsic, such
as reactive oxygens species (ROS) which occur as by-products of cellular metabolism. Cells can
also introduce DNA damage in a programmed manner in order to increase genetic diversity, for
example in meiosis.
1
DNA damage can occur spontaneously within the chemical environment of the cell. ROS that
are generated during cellular respiration can lead to multiple forms of DNA damage, such as base
modifications, single strand breaks, double strand breaks and protein-DNA linkages.3,4 Abasic sites
in the DNA can occur due to spontaneous hydrolysis of the bases.5 Another common endogenous
source of DNA damage is replication, in which DNA polymerases misincorporate nucleotides, or
incorporate chemically altered precursors.2,6
Exogenous sources of DNA damage, such as physical stress, ionizing radiation (IR), ultra-violet
(UV) light and toxic chemicals, for example found in smoke, can also lead to a wide variety of
lesions.7 DNA damaging chemicals can lead to single strand breaks, double strand breaks and even
lead to covalent linkages of protein to the DNA. UV light often induces pyrimidine dimers, in which
two bases are covalently linked. IR can induce damage in a multitude of direct and indirect ways,
either by generating ROS or by directly causing breaks in the DNA.8
1.1.2 Repair pathways
To repair this wide variety of different lesions that arise, cells evolve a multitude of different DNA
repair pathways.
Minor modifications in the DNA that do not distort the structure of the DNA or base pairing,
for example alkylations and certain photoproducts induced by UV-light, can be repaired by Dir-
ect DNA-lesion reversal. This is typically mediated by only one enzyme, directly removing the
modification without further alterations/cutting in the DNA.8
During replication, erroneous base pairing mismatches can occur. Although mismatches do not
affect any processes occurring on the DNA, they can lead to permanent mutations as the sequence
is altered. Such lesions, and also other insertions and deletions occurring during replication are
resolved via mismatch repair (MMR).8,9
The insertion of an abnormal DNA base or a simple base adduct is typically resolved by Base
Excision Repair (BER) and single-strand break repair (SSBR). The damaged base is removed in a
coordinated process of different enzymes that recognize the damaged base, mediate its excision, fill
the gap and ligate the break.8,10
More complex forms of DNA damage, such as inter- and intra-strand crosslinks which induces dis-
tortions in the DNA helix are repaired by Nucleotide Excision Repair (NER). Once a distortion in
the DNA is sensed, duplex melting is induced and up to 30 bases are excised around the lesion.
The resulting gap is filled in by polymerase I and then ligated. NER is divided in two sub-pathways
depending on the lesion recognition: Transcription coupled repair (TRC) if occurring cotransla-
tionally, where the DNA damage is sensed by RNA Polymerase II, and global-genome NER.8,11
Furthermore, inter-strand DNA crosslinks can also be repair via the Fanconi Anaemia (FANC)
pathway.12
2
Translesion DNA synthesis (TLS) is rather a damage-tolerance mechanism than a direct DNA
repair mechanism. This process takes place if certain lesions persist and block genome duplication.
To avoid stalled replication forks, which are highly detrimental to a cell, specialised polymerases
can skip over the damage to give the cell more time to repair the lesion.13
For double strand break (DSB) repair, multiple pathways are available depending on the cell cycle:
homologous recombination (HR) which depends on the presence of a sister chromatid as a template,
and non-homologous end joining (NHEJ) which involves the direct ligation of DNA ends. These
pathways will be discussed in more detail below, as the proteins that signal these forms of damage
are the focus of this thesis.8
1.1.3 DNA double strand breaks
DSBs involve breaks closely located to each other in the sugar-phosphate backbone of both strands
of the DNA chain. DSBs are considered to be the most dangerous form of DNA damage. If left
unrepaired, DSBs can lead to chromosomal rearrangements, aneuploidy and cell death. One DSBs
is sufficient to induce apoptosis. Due to their deleterious nature, DSBs are often at the root of the
development of cancer and other diseases.1
DSBs can arise spontaneously both due to various extra- or intracellular factors. Additionally,
numerous physiological processes involve DSB formation in a tightly programmed manner, as will
be discussed in more detail below.
1.1.3.1 Physiological DSBs
In a physiological context, cells generate DSBs as intermediates in the recombination and rearrange-
ment of genetic material within or between chromosomes.
In sexually reproducing organisms, DSBs are generated at specific hotspots by SPOrulation 11
(Spo11), a topoisomerase II like protein, during meiotic prophase I. The break is repaired through
homologous recombination. Through the formation of cross-overs genetic material is exchanged
between the homologous chromosomes, leading to genetic diversification.14
Programmed DSBs and genetic diversification are also essential in V(D)J and class switch recom-
bination to generate immunoglobulins (Igs) and T-cell receptors (TCRs), which are expressed in
B- and T-cells. For the adaptive immune system, it is essential to recognise a wide range of an-
tigens, which requires high genetic diversity. This diversity is obtained by reshuffling of genetic
coding segments Variable (V), Diversity (D) and Joining (J) and a signal segment in developing
lymphocytes.15 Recombination is induced by the RAG recombinase, which creates programmed
DSBs. This leads to rearrangement of the coding segments, which are ligated via non-homologous
end-joining.16–18
3
DSBs are also introduced during mating-type switching in the yeast Saccharomyces cerevisiae. This
yeast can exist either in a diploid or a haploid form. In its haploid form, yeast have a primitive form
of sexual differentiation which is based on the allele present at the MAT locus. Haploid yeast cells
can only mate with a cell of an opposite cell type to produce a diploid cell. During mating-type
switching, a site-specific DSB is introduced at the MAT locus by the HO-endonuclease, which is
resected and repaired via homologous recombination. This way, the mating gene type is exchanged
for a silenced copy of the other MAT allele.19
1.1.3.2 Endogenous DSBs
While programmed DSBs are essential for meiosis and adaptive immunity, DSBs occur more fre-
quently by accident during other cellular processes, especially during DNA replication.20. The
progression of replication can be hindered by many different obstacles in and on the DNA, such
as lesions, secondary structure formation in the DNA and other DNA-bound proteins. The replic-
ative stress can lead to replication fork stalling and collapse. This in turn may lead to incomplete
replication and exposed DNA ends, triggering a DSB repair response, typically via HR, as there is
a sister chromatid available as a template.21–24
Cellular processes such as respiration can lead to the formation of ROS which can directly induce
many different types of DNA damage, including DSBs. Additionally, ROS-induced single-strand
breaks (SSBs) and crosslinks can also lead to replication fork collapse as described above, hereby
indirectly inducing DSBs as well.25
1.1.3.3 Exogenous DSBs
DSBs can be caused by extracellular sources, such as IR, UV light and numerous genotoxic agents.
IR includes high energy radiation such as cosmic radiation, gamma rays and x-rays. IR can damage
the DNA directly or indirectly through the formation of ROS. In both cases, SSBs are created
which can lead to DSBs either through replication fork collapse as described above, or when two
SSBs are formed in close proximity.26,27
UV light can induce covalent dimerization between neighbouring pyrimidines, which are normally
repaired through NER. If this pathway fails, it can lead to replication stress and DSB formation
as described before.8,28–30
A vast array of DNA damaging chemicals, or clastogens, have been reported, which induce differ-
ent forms of DNA damage. Some can induce breaks in the DNA directly, whereas other chemicals
induce damage that leads to replication fork collapse. Topoisomerase inhibitors, such as camp-
tothecin, block the ligation step performed by topoisomerase after it cleaves a DNA strand. This
way topoisomerase is covalently trapped on the DNA, which can lead to SSBs and DSBs.31
4
Nonribosomal peptides such as bleomycin directly induce breaks in the DNA. The exact mechanism
has not been elucidated, but appears to be a process which depends on oxygen and metal ions for
catalysis.32,33
Many other chemicals induce other types of DNA damage which can lead to DSB generation through
replication fork collapse. DNA alkylating agents, such as methyl methanesulfonate (MMS), and
crosslinking agents like cisplatin directly modify the DNA and cause replication stress.34 Chemicals
including, N-nitrosamines, polycyclic aromatic hydrocarbons, and aldehydes which are ubiquitous
in our environment and are for example found in processed food and smoke, also can lead to the
formation of bulky adducts on the DNA and inter-strand crosslinks, causing replication stress and
DNA damage as described above.2,12
While exposure to these physical and chemical sources is harmful for the cell, ionizing radiation and
clastogens can be used in a positive manner in the form of radiation therapy and chemotherapeutics
in cancer therapy to kill fast growing cells by damaging their genome.33,35
1.2 DSB repair pathways
As DSBs are highly detrimental, cells in all kingdoms of life have evolved dedicated repair pathways,
which consists out of proteins which sense the DSB, repair the lesion and signal the damage to the
cell.
DSBs are repaired via two pathways, namely canonical non-homologous end joining (c-NHEJ), in
which the DNA ends are directly ligated, and HR, which depends on resection and a sister chromatid
as a template for repair. A third pathway, alternative non-homologous end joining (alt-NHEJ) has
characteristics of the two other pathways, involving microhomology with a template close to the
site of the lesion, and a limited amount of resection, prior to ligation of the ends (Figure 1.1).36,37
Reflecting the physiological functions of DSBs and the danger occurring when such lesions are
not repaired, mutations in any component of these repair pathways are typically associated with
diseases leading to sterility, immune deficiency, neurodegeneration, congenital anomalies and other
developmental disorders and cancer. Some repair proteins are essential, leading to embryonic leth-
ality in the case of mutations.38
The double-strand break repair mechanisms described here are specific for eukaryotes.
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1.2.1 Homologous recombination
HR consists out of a related set of mechanisms to repair the different types of DSBs. Which pathway
is chosen depends on the cell type, the phase of cell cycle, and the organism, although the main
players in the process highly conserved throughout evolution.39–41
Typically, HR depends on the presence of a non-damaged homologous DNA fragments and therefore
occurs primarily in Synthesis phase (S phase), when a sister chromatid is available as a template.
Due to the use of a template, HR is suggested to be less mutagenic than NHEJ, in which the ends
are directly ligated.42
When a DSB occurs, it is sensed by the meiotic recombination 11 - radiation sensitive 50 - Nijme-
gen breakage syndrome 1 (Mre11-Rad50-Nbs1 or MRN) complex.43 MRN subsequently recruits
Ataxia-Telangiectasia mutated (ATM), a signalling kinase to the lesion, where it becomes activ-
ated and phosphorylates many substrates to orchestrate the DNA damage response and halt the
cell cycle.44–46 MRN also initiates resection at the site of the lesion and catalysis together with
with CtBP-interacting protein (CtIP, Sae2 in yeast) the removal of an oligonucleotide from each 5′
end to create a clean template for further resection.47 Another function of CtIP is the recruitment
of breast cancer 1(BRCA1), which stimulates HR further.48
The initial short processing is followed by extensive resection in 5′-3′ direction. This resection
is either performed by the exonuclease exonuclease 1 (Exo1), or by the DNA replication ATP-
dependent helicase/nuclease 2 (Dna2) together with the helicases Bloom syndrom protein (BLM)
or Werner syndrome ATP-dependent helicase (WRN). This generates a long 3′-overhang which is
immediately coated by replication protein A (RPA).41,49 The coating by RPA leads to removal
from secondary structure from the DNA. Furthermore RPA-ssDNA activates the kinase Ataxia tel-
angiectasia and Rad3 related (ATR) which similarly to ATM regulates the DNA damage response.
RPA is replaced by Rad51, a process which is mediated by multiple proteins, including BRCA2,
which function it is to stabilise the Rad51-ssDNA nucleofilament.50,51
The Rad51 nucleofilament then searches for a homologous DNA sequence and subsequently invades
the homologous DNA segment, displacing the complementary DNA and forming a displacement
loop (D-loop).52 Rad51 subsequently dissociates from the DNA, exposing a single stranded 3′-
prime end for DNA synthesis mediated by polymerase η. This process is followed by ligation by
DNA ligase ι, yielding a Holliday junction or, if the D-loop undergoes a second-end invasion, a
double Holliday junction.39,53,54
Such Holliday junctions can be resolved in different ways, resulting either in cross-over or non-cross-
over products.55 Most D-loops are disrupted and then repaired by synthesis-dependent strand an-
nealing (SDSA). If the D-loop undergoes second-end capture, the resulting double Holliday junction
is resolved by the action of topoisomerases, which can lead to crossover or non-crossover events.54
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Figure 1.1: DSB repair by non-homologous end joining and by homologous recombination.
Depending on the stage of the cell cycle and the nature of the DSB, broken ends are either sensed by
Ku or by the MRN complex. In NHEJ, Ku recruits the catalytic subunit of DNA-dependent protein
kinase (DNA-PKcs) to form DNA-PK. This is followed by minimal processing by Artemis and other
factors. The DSBs are ligated by X-ray repair cross-complementing protein 4 (XRCC4), Ligase IV and
XRCC4-like factor (XLF). HR consists out of more steps, starting with long-range resection stimulated
by MRN and CtIP. The resulting ssDNA is coated by RPA, which is replaced by Rad51 in later steps.
Rad51 mediates homology search in a sister chromatid. This way the sister chromatid functions as a
template for DNA synthesis to repair the lesion. The resulting Holliday junctions is resolved through
multiple mechanism.
1.2.2 Non-homologous end-joining
NHEJ is mainly favoured in the Gap 1 phase (G1 phase) and early S phase when no sister chromatid
available. Essentially, in NHEJ the DNA ends are directly ligated, which is considered a more error
prone process than HR, due to the absence of a template, and because frequently a few base pairs
are deleted in the process. This may lead to the loss of genetic information, although other sources
claim that NHEJ is in fact a reliable DNA repair mechanism.42,56
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In the first step, the DNA break is recognised by Ku70/80, a dimeric ring-shaped complex which has
a very high affinity for DNA ends.57 Binding of Ku protects the ends from premature processing by
other enzymes, and mediates the recruitment other NHEJ factors, most importantly DNA-PKcs
(catalytic subunit), a large kinase. DNA-PKcs is recruited to the break via the C-terminus of
Ku80.58–60 Together with the Ku-dimer it forms DNA-PK (DNA dependent protein kinase). Once
bound to the DNA ends, DNA-PK autophosphorylates and undergoes conformational changes,
which leads to the exposure of the DNA ends.42,61–64
Due to the great variety of ends that can occur in a DSB, additional steps are required to generate
blunt ended DNA required for ligation. This can be done by minimal resection and gap filling.
Resection is performed by the nuclease Artemis, which is recruited by DNA-PK and leaves either
a blunt end or a short 3′ overhang.65,66 Blunt overhangs can also be obtained by filling in the gap
to limit sequence loss, which is catalysed by polymerase µ and λ or by terminal deoxynucleotidyl
transferase (Tdt). An additional step in end-processing is the addition of a 5′ phosphate group by
polynucleotide kinase (PNK) to enable ligation.59,67–70
The gap between the broken ends is bridged by XLF (XRCC4-like factor), which links DNA ligase
IV-XRCC4 complex to DNA-PK and stimulates its activity, which leads to the final ligation of the
broken ends.71–73
An alternative pathway in NHEJ is alt-NHEJ or microhomology mediated end joining (MMEJ),
which is used when there are short stretches of homologous DNA available close to the lesion. This
pathway is considered to be highly error-prone and seems to be used mainly during Ig heavy chain
class switching in B cells.74–76
1.2.3 Repair pathway choice
Throughout the years many aspects the mechanisms of double-strand break repair have become
elucidated, but it is still not fully understood why cells choose one pathway over the other. Several
factors that are known to play a role in the decision are the nature and the origin of the double-
strand break, the cell type and the stage of the cell cycle. HR is for example only possible in the
S phase, when there is a sister chromatid available, whereas NHEJ is favoured in the (G1 phase)
phase.39 The type of end found in a DSB seems to be indeed a major determinant, with ”dirty”
ends, for example ends with protein blocks, often required resection, whereas clean ends can be
ligated more easily via NHEJ.77 Furthermore, the choice of pathway can also be determined by
relative abundance of repair factors, posttranslational modifications and the accessibility of the
chromatin.78 Furthermore, there seem to be differences between organisms as well. NHEJ appears
to be the preferred DSB repair pathway in mammals, whereas in yeast HR is more common. Why
this difference exists is not understood, but may be related to the complexity of the genomes.79
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The choice between the pathways furthermore appears to involve an intricate interplay between
53BP1-Rif1 and BRCA1-CtIP. NHEJ is stimulated by 53BP1-Rif1, which associates with a double
strand break and promotes activity by the NHEJ machinery during (G1 phase) phase. Further-
more p53-binding protein 1 and Replication Timing Regulatory Factor 1 (53BP1-Rif1) inhibits
resection.80–82 During the S-phase and G2 phase, this complex is inhibited by BRCA1-CtIP, which
thereby stimulates HR and enables long range resection.42,48
Long range resection by Exo1 and Dna2 requires remodelling of the chromatin around the lesion to
enable access to the DNA. This reorganisation, catalysed by chromatin remodellers such as INOsitol
requiring 80 (Ino80), is possible due to inhibition of 53BP1 by BRCA1.48,83,84
The preference for a pathway also depends on the phase of the cell cycle. Cyclin dependent kinases
(CDKs) have been found to directly modify proteins involved in either HR or NHEJ, thereby
tuning their activities and enabling recruitment of other repair factors.85–87 CDK dependent phos-
phorylation of Nbs1 plays a role in colocalization of BRCA1 with MRN, thereby stimulating HR
as described above. CDK also phosphorylates Exo1, directly stimulation its nuclease activity.87
The cell cycle is furthermore also directly affected by the recruitment and activation of ATM by
MRN. ATM phosphorylates many substrates, such as histone H2AX, 53BP1 and effector kinases
such as CHK1, thereby directly influencing both the phase of the cell cycle and also the repair
pathway choice.35,44
Although how cells choose the repair pathway is not entirely clear, it is evident that this involves
a high degree of crosstalk between different kinases and other proteins that not only directly affect
the cell cycle, but are also affected themselves by the phase of the cell cycle.
1.3 DNA damage signalling in DSB repair: the MRN-ATM axis
The repair processes described above are events that require to be regulated carefully. When a
lesion is sensed by the MRN complex, it recruits the ATM kinase to the damage site, where it is
activated and orchestrates the DNA damage response. In this section more details about the MRN
complex and the ATM kinase are discussed.
1.3.1 MRN complex: structure and functions
1.3.1.1 Structure
The MRN complex is one of the central complexes in DNA double strand break repair, in par-
ticularly in HR, which it initiates upon sensing DNA ends, although MRN also appears to play
roles in NHEJ.43 MRN also performs the first steps towards repair of the lesion and is believed to
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tether the DNA ends. Furthermore, MRN signals DNA damage by recruiting the ATM kinase to
the lesion through interactions with the very C-terminus of Nbs1 (X-ray sensitive 2 (Xrs2) in S.
cerevisiae).60,88 In this course of this process, ATM becomes active and signals damage to the cell
to orchestrate the DNA damage response and halt the cell cycle.89
Mre11 and Rad50 are conserved in all kingdoms of life, whereas Nbs1 is only found in eukaryotes.
MR forms the core of the complex, consisting of a heterotetramer made up out of two Mre11 and
two Rad50 molecules. Either one or two copies of Nbs1 are associated with MR.90,91
Mre11 interacts with Rad50 and Nbs1, forming the core of the MRN complex. Mre11 is a phos-
phoesterase which has both endo- and exonuclease activity. The activity requires the presence of
two Mn2+ ions.92,93 Mre11 interacts with the Rad50 coiled-coils via a helix-loop-helix motif at
its C-terminus.94,95 In crystal structures of Mre11 orthologs from eukaryotes, further stabilisation
is obtained via a latching loop. This loop becomes ordered upon Nbs1 binding. Nbs1 interacts
with Mre11 via its flexible C-terminal tail, binding across the Mre11 dimer and breaking its sym-
metry.90,96,97
Rad50 belongs to the Structural Maintenance of Chromosome (SMC) family of ATP Binding Cas-
sette (ABC) ATPases superfamily, a family which also includes the SMC proteins found in cohesin
and condensin. As is characteristic for SMC proteins, Rad50 contains long, rod-like coiled-coils,
which connect the N-terminal half of its nucleotide binding domain (NBD) to its C-terminal half.
Binding of ATP leads to tight complex of the NBD domains.92,93,98
Depending on the domain of life, the length of the coiled-coil varies from 15-60 nm and may be
correlated with the complexity of the organisation of the genome.91 At the apical end of the coiled-
coil is a Zn2+-hook which is coordinated by a conserved CxxC motif. It is believed to play a role
in the intermolecular interactions with other MRN complexes.99–101 Mutations in this Zn2+ hook,
as well as deletions of the Zn2+ hook impair Rad50 function, and abolish repair and signalling
functions associated with the globular domain, despite the relatively large distance. Deletion of the
coiled-coils has the same effect, suggesting that the MRN complex is controlled allosterically.101,102
Nbs1 only exists in eukaryotes and has no enzymatic activities, but is important for recruitment
of other DNA repair factors, functioning primarily as a binding scaffold. Nbs1 has a structured
N-terminus, and a long unstructured C-terminus. The N-terminus contains a Fork-head associated
(FHA) domain and two BRCA1 carboxy-terminal (BRCT) in tandem, which play a role in the
recruitment of nuclease CtIP, helicase BLM, BRCA1, and checkpoint protein Mediator Of DNA
Damage Checkpoint 1 (MDC1), which are all proteins that stimulate HR .83,103–106 The unstruc-
tured C-terminal domain contains a conserved Mre11 binding motif.90,107 The very C-terminus
contains a conserved motif that mediates binding to ATM.60,88
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1.3.1.2 Functions in vitro
Although the MRN complex has been studied for many years, many open questions remain con-
cerning its biochemical activities, which seem to differ between bacteria, archaea and eukaryotes.
Mre11 displays both exonuclease and endonuclease activity. The requirement for ATP in these
processes is unclear, as it appears to be required for exonuclease activity in bacteria and archaea,
but not in eukaryotes. The ATP hydrolysis rate of Rad50 is rather slow, turning over 0.1 ATP
molecule per minute, meaning that Rad50 maintains a relatively long ATP-bound state, although
this hydrolysis rate can be stimulated by double stranded DNA. The ATP bound state appears
to be important to maintain an DNA end-tethered state, and is required for damage signalling
through ATM.108–112
ATP binding was found in some crystal structures to induce a conformational change forming a
DNA binding groove between the coiled-coils of Rad50. Curiously, this would block the nuclease
site of Mre11. The drawback of these studies was that the coiled-coils were removed to enable
crystallisation.94,113–116 A more recent structure of intact E. coli MR (SbcCD) shows that Mre11
undergoes a massive conformational change upon DNA binding and ATP hydrolysis, giving the
DNA access to the nuclease while the Rad50 coiled-coil forms a rigid rod.117 Combined with
mutational studies of the Zn2+ hook and the coiled-coils, this suggests a high degree of allosteric
regulation within the MRN complex.
Nbs1, which is only present in eukaryotes, regulates the activities of the MR complex, by stimulating
DNA binding and processing. For DNA damage signalling it recruits ATM with a conserved C-
terminal domain. Interestingly, some studies have shown that ATM can also directly bind to MR
in the absence of Nbs1, with ATM activation depending on Rad50.111,112
Taken together, the MRN complex is very flexible and is subject to a high degree of allosteric
control, which allows the complex to respond adequately to many different types of DSBs. The
ATP-bound state of Rad50 and its coiled-coils are important for functions in the globular domain
of MRN, including the activation of the ATM kinase.
1.3.1.3 Functions in vivo
As described above, the main role of MRN is in double strand break repair, mainly through initiating
and mediating HR. MRN is also playing a role in NHEJ, although the interplay with the Ku-dimer,
which binds to the end first as part of the first step of NHEJ, remains to be elucidated.118,119
Indeed, MRN has been shown to be able to cleave Ku-bound ends, possibly due to its endonuclease
activity, suggesting there are more factors, dependent on the nature of the break and the cell cycle,
that regulate the pathway choice.120,121
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Resection, which is characteristic for HR, depends largely on CtIP, which is recruited by Nbs1.
Depending on the organism, CtIP/Sae2 was shown to directly stimulate the endonuclease activities
of Mre11, whereas in higher eukaryotes BRCA1 recruitment via CtIP seems to be more important
to promote long range resection.48,122–124
Apart from its role in DNA repair, MRN has been found to play a role in the maintenance of
telomeres, the capping structures at the ends of eukaryotic chromosomes. They consist out of a
repetitive sequence and a single stranded tail, which forms a T-loop. This structure is stabilised by
shelterin, which protects the ends from degradation by protein repair machinery. In yeast, MRN as-
sociates with the telomeres and recruits the telomerase Cdc13-Stn1-Ten1 (CST) complex. Whether
MRN actually processes telomeric DNA, or whether it works only as a scaffold for telomerase is
not well understood.125 In higher eukaryotes, MRN associates with shelterin and plays a role in
generating the single stranded DNA that is part of the telomere cap. MRN also activates ATM to
orchestrate a DNA damage response to broken or otherwise dysfunctional telomeres.42,89,126,127
MRN also plays a role in the repair of programmed DSBs that are induced in meiosis by Spo11.
DSBs generated this way have topoisomerases trapped covalently on the DNA. These fusions are
removed by MRN and another set of factors which are specific for meiosis.14
During replication topoisomerases can also get covalently attached to the DNA, which can lead
to replication fork stalling. Several HR factors stabilise these forks to avoid their degradation,
which would lead to further genome instability. MRN induced signalling via ATR-ATRIP leads to
phosphorylation events that in turn lead to restart of the replication fork.128–130
Apart from its direct role in DNA repair and the initiation of resection, MRN furthermore induces
the orchestration of a cell-wide DNA damage response through its activation of the ATM kinase,
which plays an apical role in the phosphorylation cascade that organises the response. As the ATM
kinase is the main topic of this thesis, this will be discussed in detail below.
1.4 Signalling in DSB repair: ATM kinase
1.4.1 Discovery of ATM and its role in DNA repair
The ATM kinase was originally identified by genetic mutations in the rare autosomal recessive
disorder ataxia-telangiectasia (A-T) which is characterised by neurodegeneration leading to ataxia,
dilation of the blood vessel (telangiectasia) and genomic instability.131 Their genomic instability
leads to immunodefiency, radiosensitivity and a high susceptibility to malignancies.89,132
The mutations occurred in a very large gene, encoding a gigantic 350 kDa protein (700 kDa as a
dimer), which was identified as a kinase that displays homology to the phosphatidylinositol-3 (PI3)
12
family of lipid kinases, which phosphorylate phosphatidylinositol to generate phospholipid second
messengers. However, ATM does not phosphorylate lipids, but targets proteins.131
The functional relationship between MRN and ATM was discovered when patients with a syndrome
similar to A-T, called A-T Like Disorder (ATLD), were identified to have mutations in Mre11. Cells
with this mutated Mre11 showed indeed much lower ATM activation, demonstrating that the MRN
complex is needed for ATM activation.133–135
This led to the establishment of ATM as an apical DNA damage signalling kinase, mainly phos-
phorylating proteins that play a role in genome maintenance and the regulating of the cell cycle.
In the light of these findings is not surprising that ATM is frequently mutated in many forms of
cancer.136 Phosphorylations are among the most common post-translational modifications (PTM)
in signalling and can have a variety of effects on the target protein. Typically, phosphorylation
leads to modulation of substrate activity, protein stability, interactions with other proteins and
localisation. A cascade of phosphorylation events therefore can have a wide range of effects on the
cell .45 ATM is a prime example, as (auto)phosphorylation leads to activation, recruitment of other
proteins to the lesion and stabilises interactions between DNA repair factors and modulators. This
way, ATM orchestrates the DNA damage response.
ATM was found to have an ortholog in lower eukaryotes such as S. cerevisiae as well, where
the protein was named telomere length regulation protein 1 (Tel1), reflecting its role in telomere
maintenance. As in higher eukaryotes, Tel1 is activated by MRX, the fungal homolog of MRN, in
response to DSBs, showing that this mechanism is conserved amongst eukaryotes.137,138
1.4.2 The PIKK family of signalling kinases
ATM belongs to the family of PI3 like Protein Kinases (PIKKs) together with ATR (denoted Mec1
in S. cerevisiae), mammalian target of rapamycin (mTOR, TOR in yeast), DNA-PK (not found
in lower eukaryotes), Transformation/transcription domain-associated protein (TRRAP, Tra1 in
yeast) and Suppressor with morphogenetic effect on genitalia 1 (SMG1), which only exists in plants
and higher eukaryotes. All family members are very large kinases (300 to 500 kDa for monomers)
involved in homeostasis surveillance and stress signalling.89,139,140
ATR/Mec1 and DNA-PK are also involved in DNA damage signalling, which like ATM and MRN
associate with the lesions via DNA binding cofactors. All three are serine/threonine kinases, with a
preference for an S/TQ motif.42,89,141,142 The other PIKKs are involved in other pathways, such as
nutrient sensing and the regulation of metabolism. Regulation of metabolism and nutrient sensing
is orchestrated by mTOR. SMG1 controls nonsense-mediated RNA decay (NMD). TRAPP/Tra1
is the only pseudokinase amongst PIKKs and is part of multiple protein complexes playing a role
in the regulation of transcription.140
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Figure 1.2: The domain organisation of PIKKs. All PIKKs are enormous enzymes. The numbers
refer to the length of the amino acid chain in human PIKKs. The HEAT and FAT domains, which
form the largest part of the polypeptide chain length, are entirely α-helical. The kinase domain in some
PIKKs contains an FRB domain, which is a regulatory four-helical bundle. All PIKKs have a regulatory
PRD and FATC domain at their C-terminus.
All PIKKs share a similar domain architecture, consisting out of a number of conserved elements
(Figure 1.2). Apart from their kinase domain, which shows homology to PI3-kinases, they are
entirely α-helical, forming repeat elements. The N-terminal α-solenoid domain consisting out of
a 1000-3000 residues and consists mainly out of Huntingtin, elongation factor 3 (EF3), protein
phosphatase 2A (PP2A), and the yeast kinase TOR1 (HEAT) repeats.143 In terms of sequence,
the α-solenoid is not highly conserved. However, HEAT repeats are often implied to play a role in
interactions with other proteins and DNA, suggesting that the α-solenoid domain functions as an
interaction hub or a scaffold for other proteins.144 Such a function would reflect the apical roles
the kinases play in their pathways they regulate.140
The N-terminal α-solenoid is followed by a sequence-wise more conserved FRAP-ATM-TRRAP
(FAT) domain, which plays a role in regulating kinase activity. The FAT domain is followed by
a highly conserved kinase domain, which is only 5- 10 % of the overall peptide chain length. The
kinase domain contains numerous elements that are specific for PIKKs. At the C-terminus, there
is a PIKK Regulatory Domain (PRD) followed by a FATC (C-terminus of FAT) domain. Some
PIKKs, but not ATM and ATR, contain an FKBP12-Rapamycin binding (FRB) domain at the
beginning of the kinase domain.89,145,146
The PRD was discovered to be important for the regulation of kinase activity in ATR.147 Later
it was found to be present in all PIKKs, where it likely has a similar role. The FRB, which
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is missing in ATM and ATR, was originally identified in mTOR and is important for binding of
rapamycin.148 Together with the FAT domain, the kinase and its insertions form an integral domain
often denoted as FATKIN.140,146 The crystal structure of the mTOR FATKIN domain shows how
the FAT domain indeed wraps around the kinase, showing how the FAT domain could directly
regulate the kinase.149 In addition, many elements in the active site are highly conserved, such as
the catalytic loop, the activation loop and the P-loop which shields the active site. Furthermore,
the kinase domain contains an Lethal with Sec Thirteen (LST8) binding element (LBE), a helical
insert in the C-terminal domain, which binds to LST8 in mTOR, but may also have regulatory
roles in other PIKKs.146,149
1.4.3 PIKK family members
Of the PIKK family, ATR and DNA-PKcs are together with ATM involved in genome maintenance.
ATR (Mec1 in yeast) is in terms of sequence, and as later structural work showed, also in ar-
chitecture most similar to ATM, as it also forms a dimer. Unless DNA-PKcs and ATM, ATR is
essential in proliferating cells, where it is the apical kinase in response to DNA replication stress.
Comparable to ATM it also phosphorylates hundreds of substrates.44 ATR is activated in response
to more forms of DNA damage than than DSBs, which mainly active DNA-PK and ATM. ATR
forms a complex with ATRIP, which is recruited to RPA-ssDNA.150 Furthermore ATR is activated
by DNA topoisomerase 2-binding protein 1 (TopBP1).151 Another activator is ETAA1, which also
contains and ATR-activating domain like TopBP1. Both activators might be relevant for different
signalling pathways.42
DNA-PKcs is an enormous 460 kDa protein that also becomes activated in response to DSBs.152
Together with Ku70/Ku80, which recruits the kinase to the DSBs, it forms DNA-PK and mediates
and promotes the first steps in NHEJ, as has been described above. DNA-PK and NHEJ seem
to be of high importance especially during lymphocyte maturation and V(D)J and class-switch
maturation. Furthermore, mutations in DNA-PKcs are also associated with neurological defects,
suggesting that NHEJ is important for DSB repair in neuronal progenitor cells. DNA-PK was the
first PIKK of which a structure was solved, revealing that the HEAT repeat domain domain forms
an enormous α-solenoid cradle, on top of which the kinase domain is located.42,153
While the other PIKKs are not involved in DNA damage signalling, they play important roles in
other aspects of the maintenance of cellular homeostasis.
TOR (mTOR in mammals) controls cell growth by promoting anabolic processes and suppressing
catabolic processes. TOR was identified to be the protein to which the immunosuppressant rapa-
mycin is binding. Yeast has two variants of the TOR protein, whereas higher eukaryotes have one
mTOR protein, which is part of two different complexes, namely mTOR complex 1 (mTORC1)
and mTOR complex 2 (mTORC2), which regulate different cellular processes. Furthermore, many
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other proteins associate with these complexes to modulate their activity, such as the GTPase Rheb,
which activates mTORC1.148 The preferred phosphorylation motif is a hydrophobic or aromatic
residue followed by a serine or threonine.154 A crystal structure of the human mTOR FATKIN
domain provided the first high resolution insight into this class of kinases. It was revealed that
the regulatory FAT domain cradles the kinase domain, revealing a way of allosteric control of the
kinase. The active site itself was shown to be highly structured, reflecting an active state. The
kinase is rendered inactive nevertheless by elements such as the PRD, and the proximity of the
FRB, which block access to the active site.149
SMG1 is involved in NMD, a process in which transcripts with premature termination codons are
degraded. It is only found in higher eukaryotes and some plant species, but not in fungi. In contrast
to some other PIKKs, SMG1 phosphorylates only one substrate, UPF1, a conserved effector protein
which activates the NMD pathway. SMG1 forms a complex together with SMG8/9 which inhibit
its kinase activity.155
Tra1 (in yeast, TRAPP in higher eukaryotes) is the only pseudokinase of the PIKK family, as
it lacks the conserved catalytic DFG motif in its active site. Tra1 forms a scaffolding subunit in
two large complexes involved in the regulation of transcription. In yeast Tra1 is found in SAGA
(Spt-Ada-Gcn5-Acetyltransferase) and NuA4 (nucleosome-Acetyltransferase-of-histone-H4). Fur-
thermore Tra1 is also found in other chromatin-related complexes, such as the ASTRA complex
in yeast and its human ortholog TRAPP in complexes such as Tip60. Both Tra1 and TRAPP are
essential, reflecting the importance of the many complexes they are part of.140,156,157
1.4.4 Cellular function of ATM
ATM is recruited to the site of the DSB by the MRN complex.45,135 During this process, ATM
becomes activated and phosphorylates hundreds of proteins with an S/TQ motif, including MRN it-
self and many other DNA repair factors.44,46,141,142 ATM furthermore phosphorylates other kinases,
such as CHK1 and 2. This way ATM orchestrates the DDR, which has a wide range of effects on the
cell, such as cell cycle arrest, cell death, regulation of gene expression and protein degradation, as
well as more localised effects such as modulation of the chromatin, mainly through phosphorylation
of histone H2AX (which is denoted upon phosphorylation as γH2AX) flanking the DSB to enable
subsequent DNA repair (Figure 1.3).158,159
Despite its apical role in the damage response against DSBs, ATM is not essential, as cells in which is
knock-out are still viable. As there is a high degree of crosstalk between the DNA damage signaling
kinases, it is likely that ATR and DNA-PK can take over some of the signalling function of ATM.
Mutations in ATM, especially truncations, lead to more severe phenotypes than knockouts.42,89
Although ATM is mainly recruited and activated by MRN in the first steps of HR, ATM has
been found to be activated in NHEJ. In general, there is a significant degree of crosstalk between
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Figure 1.3: ATM activation and signalling. In its resting state, ATM is present in the nucleus
as an autoinhibited dimer. It is activated by the MRN complex upon the occurrence of a DSB. ATM
is autophosphorylated in this process and reported to monomerise. Activated ATM phosphorylates
hundreds of substrates, of which only a few are depicted here. Most importantly, the formation of
γH2AX leads to reorganisation of the chromatin and recruitment of more repair factors. ATM can also
phosphorylate p53, leading to apoptosis, CHK1 and CHK2, which control cell cycle checkpoints. ATM-
dependent phosphorylation of PBAF leads to transcriptional silencing by inhibiting Pol II. Furthermore,
many factors, including ATM targets, regulate ATM activity, either through stimulating ATM more to
amplify the signal, or by tempering its activity, e.g. through phosphatase activity. These concerted
activities lead to a robust DNA damage response.
the different pathways and the signalling kinases. About 80 % of lesions repaired by NHEJ are
independent of ATM, but a subset of lesions, mainly located in heterochromatin and with blocked
ends, depends on ATM, ATR and DNA-PK. The mechanism may be that ATM, activated by
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MRN, activates DNA-PK in these situations.160–162 Another role of ATM in NHEJ could be DSB-
end bridging.42,163 ATM indeed phosphorylates many proteins that are involved in NHEJ, such as
Artemis, PKN and DNA-PKcs itself.45
The main role of ATM, however, is in stimulating HR upon recruitment by MRN. An important step
in this process is ATM-dependent phosphorylation of Nbs1, which recruits CtIP, which then initiates
long-range resection. ATM-mediated phosphorylation of CtIP is also implied to play a role in
removing Ku from single stranded DSBs to allow HR in the case of replication fork collapse.42,164,165
Despite its stimulatory role in HR, ATM is not essential for HR progression. ATR may take over
part of the DNA damage signalling during resection when the single stranded DNA is coated by
RPA.42.
One of the key targets of ATM phosphorylation is histone H2AX. The resulting γH2AX is the
foundation for a further chromatin-based signalling cascade. This mark is primarily read by MDC1,
which is further stabilized on the chromatin by ATM. Further phosphorylation of MDC1 leads to
further retention of MRN on the chromatin via Nbs1. This in turn could lead to more ATM
recruitment, further γH2AX formation, and subsequently more recruitment of MDC1, initiating an
amplification loop to robustly signal DSBs.42,158,159
Another effect of ATM-dependent phosphorylation of MDC1 is the recruitment of the Ring Finger
Protein 8 (RNF8) ubiquitin ligase, which leads to recruitment of 53BP1. As described above, this
protein stimulates NHEJ.78 Curiously, ATM also phosphorylates BRCA1 in response to DSBs,
which antagonizes 53BP1, leading to HR. The choice for HR or NHEJ seems to depend on many
factors, including the stage of the cell cycle, but the role of ATM herein is poorly understood.42
ATM-dependent phosphorylation of H2AX also leads to transcriptional silencing, ensuring that the
transcription machinery does not collide with the DNA repair machinery. ATR and DNA-PKcs can
also phosphorylate H2AX, but the exact effect of this depends on the cellular context. ATM appears
to be mainly responsible for nucleolar DNA silencing.166 Another way in which ATM induces
transcriptional silencing is by phosphorylating the Polybromo-associated BAF complex (PBAF)
SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeler, which leads to silencing of
RNA polymerase II.42,167 Furthermore, γH2AX has also been suggested to promote DNA repair
by concentrating DNA repairs factor via phase separation.168,169
In order to ensure that the cell does not divide as long as damage is present, CHK1 and CHK2 are
also phosphorylated by ATM, leading to cell cycle arrest until the lesion is repaired. If the damage
is too severe for repair, ATM-dependent phosphorylation of p53 can lead to apoptosis.45
In addition to its role in DNA repair, ATM plays a role in the maintenance of telomeres, which
also depends on activation by MRN, as has been described in previous sections. ATM and ATR
both become activated when telomeres become too short, which leads to cell-cycle arrest and
senescence.42
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ATM also has been found to have roles in responding to transcriptional stress and regulating RNA
metabolism. For example, the spliceosome has been found to be both a target and an effector for
ATM in response to the formation of R-loops, although many details remain elusive.42,170
Some studies suggest that ATM can also be directly activated through oxidation by ROS, a mech-
anism which would not require MRN nor DNA.89,171 ATM can indeed be stimulated in vivo by
the addition of hydrogen peroxide. It is suggested that this ROS pathway is mainly relevant in
neurons, in which ATM is more frequently located in the cytoplasm than in other cell types. This
phenomenon might provide an explanation for the neurodegeneration observed in A-T.89 Many
questions remain to be answered, however, as ROS can also induce DSBs, which in turn are known
to activate ATM.
ATM located in the cytoplasm has furthermore been reported to play a role in innate immunity in
the detection of viral DNAs via MRN.172 The presence of viral genomes have indeed been found
to trigger a DDR too. As a self-defence mechanism, certain viruses have been described to encode
proteins that inhibit ATM, enabling them to multiply in the their host cell.173–175
ATM thus appears to be involved in many aspects of cell physiology, but its main role is in the
response to DNA damage. There is a significant degree of crosstalk between the different DSB repair
pathways and the other kinases, ATR and DNA-PKcs, that mediate these. In addition, ATM may
play a role in completely different pathways too, such as innate immunity and the response to ROS,
although many aspects of the role of ATM there remain to be investigated.
1.4.5 ATM activation
As ATM activation has large consequences for the cell, ATM is normally residing in the nucleus in
an autoinhibited dimeric state. Autoinhibition is also a hallmark of the related PI3-kinases, which
are typically bound to regulatory subunits. These interact with the kinase domain and active site
via multiple interfaces, thereby physically blocking access to the active sites. This way, these lipid
kinases remain inactive, until the blockage is lifted by an activating factor.89 Earlier structures
of PIKKs reveal similar mechanisms for autoinhibition, suggesting that ATM is probably also
redundantly autoinhibited, requiring several strong cue to induce an active conformation.89,149,176
MRN activates ATM by recruiting the kinase through the C-terminus of Nbs1.60,88 Mre11 and
Rad50 have also been shown to interact directly with ATM and can activate ATM independently
of Nbs1. Several studies have shown that MR in the ATP bound state can activate ATM, not
through ATP-hydrolysis. As Rad50 hydrolyses ATP slowly, it has a longer ATP-bound state which
could activate ATM.111,112,129,177,178 Some studies suggested that ATM can also be activated in the
absence of MRN and Ku.179 This would suggest that ATM may also be activated by other factors.
A plausible candidate would be DNA. Pull-down experiments with Xenopus laevis cell extracts
have shown that ATM in the absence of MRN can be activated by an excess of DNA ends.180,181
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ATM has been demonstrated to have DNA binding properties. It has a preference for long DNA
strands (1 kb or larger) with blunt end or short overhangs.111,112,182,183 Recent work on the activa-
tion of scTel1 showed that double stranded DNA and MRN synergistically activate ATM. ATM has
a preference for long nucleosome free DNA, which appears to be in agreement with earlier studies,
but there is no requirement for double stranded ends, suggesting that scTel1 binds to internal parts
of the DNA.111
In addition to its affinity for DNA, the chromatin context itself is also important for ATM activation.
Certain chromatin modifications indirectly stimulate ATM activation, leading to recruitment of
factors that modify ATM. One of these factors, Tip60, acetylates ATM at the Lys3016 in the C-
terminus, a modification which stimulates kinase activity. Furthermore, certain histone methylations
affect the level and duration of ATM activation, and can additionally also lead to the recruitment of
remodellers, which modify the chromatin in such a way that ATM can be fully activated. Binding
of MDC1 to γH2AX, a process which stimulates HR, indeed promotes persisting ATM activity as
DSB sites, as described above. This activation may be distinct from the initial activation of ATM
at the DSBs by MRN.89,184,185
Although more and more factors are found to activate ATM, it still poorly understood what changes
take place in ATM to turn it into an active conformation. Early on it was reported that autophos-
phorylation of Ser1981, which is located in the FAT domain, is essential for ATM activation. This
modification occurs in trans and leads to monomerisation.46 However, this mechanism is contro-
versial, as modification of the equivalent serine in mouse is not associated with activation.186,187
Also, the monomerization is unlikely in light with recent structural work, including the structure
described in this thesis, as the dimer interface is largely hydrophobic.188. Although an intermediate
resolution structure of an ATM monomer has been reported, it is not clear whether this represents
an activated state.189
1.4.6 Regulation of ATM activity
Although MRN activates ATM in the ATP-bound state, nuclease activity appears to require ATP
hydrolysis. This raises the question what DNA substrate is presented to ATM in vivo, because
the double-stranded DNA is resected. There seems to be a significant degree of cross-talk between
ATM, ATR and DNA-PK. Upon resection, the ssDNA is coated by RPA, which stimulates ATR
but not ATM. This may lead to changes in the signalling cascade, as ATR could take over from
ATM. DNA-PK has been reported to phosphorylate ATM, which leads to the downregulation of
its activity.42,190
MRN also becomes phosphorylated by ATM and other PIKKs, which has effects both on DNA
repair and ATM signaling. Phosphorylation of Mre11 has been associated with a reduction of
its affinity for DNA, also reducing further ATM recruitment to the DNA.191 Phosphorylation of
Rad50 and Nbs1 has been associated with checkpoint control through Smc1 and other factors.
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Mechanistically the effects of phosphorylation of MRN are poorly understood and require further
investigation.89
As (auto)phosphorylation is important for the regulation ATM activity, several phosphatases have
been described to modulate ATM activity, although full details remain unclear. The protein phos-
phatase PP2A constitutively associates with ATM, but the association is lost upon DNA damage.192
Similarly, PP1γ, which associates with ATM through Repo-Man, which is also lost upon DNA dam-
age, leading to an increase of autophosphorylation.193 Inhibiting both phosphatases indeed appears
to lead to a near-complete DNA damage response as ATM becomes hyperphosphorylated. Another
phosphatase, Wild-Type P53-Induced Phosphatase 1 (Wip1), regulates ATM activity after is in-
duced via p53-dependent expression occurring upon DNA damage, suggesting a way of reducing
the signalling cascade.89,194
Many other types of factors that modulate ATM activity have been described, and only a few will
be described here as examples. The protein ATM interacting factor (ATMIN) binds to ATM with
similar C-terminal motif as Nbs1, suggesting it might compete with Nbs1. ATMIN does not appear
to play a role in the DDR, however, but may be of importance in other pathways, such as the
cellular response against osmotic shock.89,195 In situations in which MRN levels in the cell are low,
other factors can compensate for the lack of MRN to activate ATM. ATM has indeed been reported
to be directly stimulated by 53BP1 and BRCA1 in vitro, although the stimulatory effect appears
to correlate with direct binding between MRN, ATM and both of these factors.196 In mammalian
cells, proteins of the homeodomain family of transcriptional regulators, NKX3.1 and homeobox B9,
which are both found to mutated in certain forms of cancer, can bind directly to ATM, stimulating
autophosphorylation and further phosphorylation of targets upon DNA damage.89,197,198
Some targets of ATM also directly stimulate ATM activity. For example, the apoptotic inhibitor
Aven, which plays a role in controlling Gap 2 (G2 phase)/Mitotic (M) checkpoint, is phosphorylated
by ATM, but also binds to ATM upon DNA damage and stimulates its activity.199. Ribosomal S6
kinase, which plays a role in controlling the same checkpoint, is also an ATM target and activ-
ates ATM further upon DNA damage. This provides a further way in which ATM is involved in
regulating the cell cycle.89,200
It is currently unclear how such a large number of proteins can bind to and modulate ATM, as
there is no common binding motif. The answer probably lies in the large size of the HEAT repeat
domain of ATM, which could accommodate many modulators. This is indeed the case for e.g. Tra1,
which functions as a hub within large complexes. As ATM activation has major consequences for
the cell, it is not surprising that many modulators regulate ATM activity to fine-tune the signalling
cascade.89
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1.4.7 Aim of the project
ATM is an apical signalling kinase in the response to DSBs. Its importance in genome maintenance
is reflected in the fact that it is frequently mutated in cancer, and also in the variety of severe
symptoms that characterise A-T. When ATM is activated by MRN, it phosphorylates hundreds
of substrates, including other kinases, leading to the recruitment of many DNA repair factors,
cell cycle arrest and even cell death, if the damage is beyond repair. Furthermore, emerging roles
of ATM in completely different areas have been identified, such as innate immunity and redox
signalling.
However, many key questions remain. Due to the large size of ATM, it is not possible to express
it recombinantly in quantities required for biochemistry and crystallography. Therefore, structural
data and insights in its in vitro biochemistry have remained elusive. It is for example not understood
how MRN activates ATM, and especially not what structural rearrangements need to take place
within ATM in order to turn it into an active conformation. Furthermore, the binding to MRN and
any potential DNA binding properties were not characterized in high detail.
The aims of this thesis, therefore, were to determine a structure of ctTel1, an ATM ortholog from
the thermophilic fungus Chaetomium thermophilum and to characterise its binding properties to
DNA and MRN, in order to gain more insight in its activation mechanism. C. thermophilum has
become popular amongst structural biologists in recent years as its proteins are more stable, making
them well suited for structural studies.
Although it was not possible to express full-length ctTel1 recombinantly, a truncated construct,
consisting of the HEAT-repeat domain, was identified which could be expressed in large quantities
in Escherichia coli. This construct was then used to probe the binding properties towards MRN and
DNA. Furthermore, nanobodies were raised against this protein, enabling the purification of the
full-length endogenous ctTel1 from C. thermophilum. Although the amounts were small, they proved
to be sufficient for high-resolution structure determination using cryo-EM. These two approaches





All chemicals used in this study were obtained from Carl Roth (Karlsruhe), Merck (Darmstadt) or
Sigma Aldrich (Deisenhofen) unless stated otherwise. Enzymes for molecular biology were purchased
from Fermentas (St. Leonrot) or New England Biolabs (Frankfurt). Desalted oligonucleotides for
molecular cloning and HPLC purified oligonucleotides for biochemical assays were obtained from
Metabion (Planegg). Media for insect cell culture was obtained from GIBCO/Invitrogen. Chroma-
tography columns and materials were obtained from GE Healthcare (Penzberg) unless indicated
otherwise.
Sterilised glassware and laboratory materials were used for all experiments.
2.1.1 Oligonucleotides
Table 2.1: DNA oligonucleotides used DNA binding assays. Bp: base pair, Fw: forward, rv:
reverse, 6-FAM: 6-carboxyfluorescein.
Oligo Sequence (5′-3′)
60 bp fw 6-FAM-AAGGGAACATCGGGTAGTTGAACAGCATAGGCCCGGTCTTGCCTTAACCTCTAATTCTCG
60 bp rv CGAGAATTAGAGGTTAAGGCAAGACCGGGCCTATGCTGTTCAACTACCCGATGTTCCCTT
30 bp fw 6-FAM-ACCGTAGGTTTACTGTCACGATATCAGTGC
30 bp rv GCACTGATATCGTGACAGTAAACCTACGGT
25 bp fw 6-FAM-GAGATCCGTATGCCTACTGACATTG
25 bp rv CAATGTCAGTAGGCATACGGATCTC
20 bp fw 6-FAM-CCTATATGAAGCTGAGTGCC
20 bp rv GGCACTCAGCTTCATATAGG
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Table 2.2: DNA oligonucleotides used for cloning. Fw: forward, rv: reverse, his: His6-tag, KD:
kinase dead, FLAG: triple FLAG-tag, ctTel1-#: number of the DNA fraction for Gibson assembly, G4S:
protein linker consisting out of four glycines and one serine.
Amplified gene Sequence (5′-3′ direction) Cloning method
ctTel1(1-1864)-his fw GCGGCCGCACTCGAGCACCAC Blunt end ligation
ctTel1(1-1864)-his rv GGCTCGGTCGGCAATCGAGGATTC Blunt end ligation
MBP-ctTel1(1-1864) fw AAGGAGATATACATAATGAAACATCACCATCACCATCACC InFusion
MBP-ctTel1(1-1864) rv TTGACCCGCGGCATAGCGCCCTGAAAATAAAGATTCTCG InFusion
FLAG-ctTel1(KD) for TTGACCCGCGGCATAGCGCCCTGAAAATAAAGATTCTCG QuikChange
FLAG-ctTel1(KD) rev CCAGCAGGATTTTGTGGCCGTGACGCGCACCCAGTCCCA QuikChange
FLAG-ctTel1-1 fw GCTGGGCGGCATACGCATAAAGAGCCTGCAGTCTCGACA Gibson Assembly
FLAG-ctTel1-1 rv ACGTCCAGCCAGTGTGCTCTGCTTCCAGATTTATCGTCG Gibson Assembly
FLAG-ctTel1-2 fw ACGACGATAAATCTGGAAGCAGAGCACACTGGCTGGAC Gibson Assembly
FLAG-ctTel1-2 rv TTGTCGAGACTGCAGGCTCTTTATGCGTATGCCGCCCAG Gibson Assembly
FLAG-ctTel1-3 fw GAGAATCCTCGATTGCGGACAGAGCACACTGGCTGGAC Gibson Assembly
FLAG-ctTel1-3 rv CCTGAGAGACCCGCTAGTTGGCTTCCAGATTTATCGTCGTCGT Gibson Assembly
FLAG-ctTel1-4 fw ACGACGATAAATCTGGAAGCCAACTAGCGGGTCTCTCAGGC Gibson Assembly
FLAG-ctTel1-4 rv ACGTCCAGCCAGTGTGCTCTGTCCGCAATCGAGGATTCTCC Gibson Assembly
FLAG-ctTel1-5 fw TCCCAGAGCCCATCATCAACCAACTAGCGGGTCTCTCAG Gibson Assembly
FLAG-ctTel1-5 rv TAACTCTTGACCCGCGGCATGCTTCCAGATTTATCGTCGTCGT Gibson Assembly
FLAG-ctTel1-6 fw ACGACGATAAATCTGGAAGCATGCCGCGGGTCAAGAG Gibson Assembly
FLAG-ctTel1-6 rv CCTGAGAGACCCGCTAGTTGGTTGATGATGGGCTCTGGGAT Gibson Assembly
Nanobody-G4S-FLAG fw ACAAGGATGACGATGACAAGGCGGCCGCACTCG Gibson Assembly
Nanobody-G4S-FLAG rv TGGTGCTCGAGTGCGGCCGCCTTGTCATCGTC Gibson Assembly
2.1.2 Plasmids
Table 2.3: Plasmids for recombinant protein expression in E. coli or in insect cells. Labels
and abbreviations as in table 2.1.
Construct Encoded Sequence Vector
ctTel1(1-1864)-his ctTel1 aa 1-1864 pET28
MBP-ctTel1(1-1864)-his ctTel1 aa 1-1864 pET28
FLAG-ctTel1 ctTel1 pACEbac
FLAG-ctTel1(KD) ctTel1 D2760A and N2765K pACEbac
D4-FLAG-his anti-ctTel1 nanobody D4 pMJS187
F7-FLAG-his anti-ctTel1 nanobody F7 pMJS187
D4-G4S-PreScission-G4S-FLAG-his anti-ctTel1 nanobody D4 pMJS187
F7-G4S-PreScission-G4S-FLAG-his anti-ctTel1 nanobody F7 pMJS187
24
2.1.3 Strains
Table 2.4: Strains used for molecular cloning, protein expression and pull-downs. E. coli
XL1Blue was used for molecular cloning, E. coli DH10 for the generation of bacmids for insect cell
expression and E. coli Rosetta for recombinant protein expression. C. thermophilum was used for endo-
genous ctTel1 pull-downs. Sf21 and High five insect cells were used for virus production and recombinant
protein expression, respectively.
Organism Strain Source
C. thermophilum var. DSM 1495 DSMZ and Prof. Dr. Hurt, University of Heidelberg
E. coli XL1Blue Strategene, Heidelberg
E. coli Rosetta(DE3) Novagen, Madison, USA
E. coli DH10 MultiBac Redbiotech, Schlieren, Switzerland
S. frugiperda Sf21 Invitrogen, Karlsruhe
T. ni HighFive Invitrogen, Karlsruhe
2.1.4 Antibodies
Table 2.5: Antibodies for Western blots. Labels and abbreviations as in table 2.1.
Antibody Primary or Secondary Origin Dilution Source
anti-ctTel1 Primary Mouse 1:500 Prof. Kremmer Lab, LMU Munich
anti-FLAG Primary Rabbit 1:1000 Sigma Aldrich, Munich
anti-mouse IgG2a-HRP Secondary Sheep 1:1000 GE Healthcare, Penzberg
anti-rabbit-IgG2 Secondary Goat 1:1000 Biorad, Munich
2.1.5 Common buffers, media and antibiotics
Escherichia coli cultures were grown in liquid Lysogeny Broth (LB) medium (1% (w/v) bacto-
tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl) or on LB agar plates (LB + 1.5% (w/v)
agar). Antibiotics were added to the following final concentrations: 100 µg/mL ampicillin, 50 µg/mL
kanamycin, 34 µg/mL chloramphenicol.
E. coli DH10 MultiBac cultures were grown in liquid LB medium or on LB plates containing 0.1 mM
IPTG, 50 µg/mL kanamycin, 10 µg/mL tetracycline, 10 µg/mL X-Gal and 7 µg/mL gentamycin.
Sf21 cells were cultured in Sf-900 III serum-free medium (GIBCO/Invitrogen, Karlsruhe) with
10 µg/mL gentamycin. HighFive cells were grown in ExpressFive serum-free medium (prepared
according to instruction from GIBCO/Invitrogen, Karlsruhe) with 10 µg/mL gentamycin.
C. thermophilum was cultured in liquid Chaetomium Culture Medium (CCM), composed of 3 g
sucrose, 0.5 g NaCl, 0.65 g K2HPO4 · 3 H2O, 0.5 g MgSO4 · 7 H2O, 0.01 g Fe(III)sulfate-hydrate,
5 g tryptone, 1 g peptone, 1 g yeast extract and 15 g potato dextrin per L, pH 7.0.
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Table 2.6: Common buffers.
Buffer Composition
4x Laemmli buffer 0.11 M TRIS pH 6.8, 16% (v/v) ethanol, 4% (w/v) SDS 5% (v/v)
β-mercaptoethanol, 0.05% bromophenol blue
Coomassie stain 50% (v/v) ethanol, 7% (v/v) acetic acid, 0.2% (w/v) Coomassie
Brilliant Blue R250
2x TG buffer 50 mM TRIS, 384 mM glycine, 20% (v/v) ethanol, 0.05% SDS
10x TBS 200 mM TRIS-HCl pH 7.4, 1.37 M NaCl, 26 mM KCl
1x TBST 1x TBS, 0.1% TWEEN-20
20x ECL 2 M TRIS pH 8.5
1x ECL (10 mL) 10 mL 20x ECL solution, 3 µL H2O2, 25 µL cumaric acid (90 mM),
50 µL luminol (250 mM)
2.1.6 Software and algorithms
Table 2.7: Software.
Software Source
COOT Emsley et al., 2010
CTFFind 4.1 Rohou and Grigorieff, 2015
EPU FEI
JalView Waterhouse et al., 2009
MAFFT Katoh et al., 2005
MotionCor2 Zheng et al., 2017
PHENIX Adams et al., 2010
Prism GraphPad
PyMOL Schrödinger LLC
Relion 3.0 Zivanov et al., 2018
Sequence Manipulation Suite Stothard, 2000
SnapGene GSL Biotech LLC
SWISS-MODEL server Waterhouse et al., 2018
UCSF Chimera Pettersen et al., 2004
UCSF ChimeraX Goddard et al., 2017
2.2 Methods
2.2.1 Molecular Biology Methods
2.2.1.1 Molecular cloning
Genes were amplified using the polymerase chain reaction technique (PCR) using a self-made
Phusion High-Fidelity PCR Master Mix (ThermoFisher Scientific). For a typical reaction 10-50 ng
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template DNA was used and 0.5 µM (final concentration) oligonucleotide primer, to a total volume
of 20 µL. The standard PCR protocol is shown in table 2.8.
Bands were separated using agarose gel electrophoresis and were visualised using UV light. Bands
of the correct size were cut out and purified using the NucleoSpin Gel and PCR Clean-up Kit
(Macherey-Nagel, Düren). PCR products and plasmid DNA were assembled using Gibson Assembly
(New England Biolabs) or via blunt end ligation according to the manufacturers instructions. For
blunt end ligation, the primers were phosphorylated using PNK prior to their use for PCR. The
reactions were transformed into chemically competent E. coli.
The TEV cleavage site from the original ctTel1(1-1864)-TEV-his construct was removed to clone
ctTel1(1-1864)-his using blunt end ligation. Nanobodies with a G4S-PreScission-G4S-FLAG-his tag
were cloned into a pMJS187 vector using Gibson assembly. The codon-optimised kinase domain and
the catalytically-dead mutant (GenScript, Hong Kong), with N-terminal FLAG-tags, and fragments
of ctTel1(1-1864)-his were cloned sequentially into a pACEbac vector using Gibson assembly in
order to obtain full-length FLAG-ctTel1.
The integrity of all constructs was confirmed by DNA sequencing (GATC/Eurofins, Ebersberg).
Table 2.8: PCR program used for molecular cloning. The annealing temperatures X depended
on the temperatures calculated in SnapGene. The extension time was adjusted according to the length
of the gene or vector.
Cycle step Temperature Time Cycles
Initial denaturation 98 °C 2 min 1x
Denaturation 98 °C 30 sec
Annealing X °C 30 sec 30x
Extension 72 °C 30 sec/kb
Final extension 72 °C 10 min 1x
Cooling 10 °C ∞
2.2.1.2 Site-directed mutagenesis
To generate kinase-dead full-length ctTel1, site-directed mutagenesis using QuikChange (Agilent,
Oberhaching) was performed using the Phusion kit. Primers for site-directed mutagenesis were
designed using SnapGene. A typical Quikchange reaction contained 100-200 ng of template and
25 nM (final concentration) of each DNA oligonucleotide. The standard QuikChange PCR program
is shown in table 2.9.
After DpnI digestion, 5 µL of the reaction was transformed into 50 µL chemically competent
XL1Blue E. coli cells. The presence of the desired point mutation and the integrity of the gene was
confirmed using DNA sequencing (GATC/Eurofins, Ebersberg).
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Table 2.9: PCR program used for site-directed mutagenesis. The annealing temperatures were
adjusted depending on the reaction. The extension time was adjusted according to the length of the
gene.
Cycle step Temperature Time Cycles
Initial denaturation 98 °C 30 sec 1x
Denaturation 98 °C 10 sec
Annealing 65 - 72 °C 30 sec 30x
Extension 72 °C 30 sec/kb
Final extension 72 °C 10 min 1x
Cooling 10 °C ∞
2.2.2 Microbiology methods: E. coli
2.2.2.1 Generation of competent E. coli
To prepare chemically competent cells, an overnight culture of E. coli was prepared and used to
inoculate 200 mL of LB medium with the appropriate antibiotics and grown until an OD600 of 0.3-
0.5. The cells were centrifuged at 3000g for 5 min at 4 °C and resuspended in chilled TSS buffer,
aliquoted in 100 µL, flash-frozen in liquid nitrogen and stored at -80 °C.
2.2.2.2 Transformation into E. coli
For transformation, 10-100 ng of plasmid DNA was added to 100 µL of competent E. coli and
incubated on ice for 30 min. The cells were heat shocked for 45 sec at 42 °C and incubated on ice
for 5 min. Then 900 µL of LB was added and the cells were incubated at 37 °C for 30-60 min.
Afterwards, the cells were centrifuged at 3000g for 5 min and 800 µL of the supernatant was
removed. The cells were then resuspended before plating out on LB agar plates supplemented with
the correct antibiotics.
E. coli DH10Multibac cells were thawed on ice and 1-2 µL of a few 100 ng of pACEbac vector
were added and incubated on ice for 15-30 min and heat shocked for 45 sec at 42 °C, and rested on
ice for 2 min. 900 µL LB was added and the cells were incubated at 37 °C overnight. The culture
was centrifuged at 3000 g for 5 min and plated onto LB agar bacmid plates supplemented with the
appropriate antibiotics, X-gal and IPTG. The plates were incubated for minimally 24 h until blue
and white colonies could be distinguished.
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2.2.2.3 Isolation of plasmid DNA
Single colonies were picked and used to inoculated 5 mL LB medium with the corresponding
antibiotic. Cells were shaken overnight at 37 °C 200 rpm and harvested by centrifugation 3000 g
for 5 min.
For cloning purposes and for expression in E. coli, plasmid DNA was isolated from a 5 mL overnight
E. coli XL1Blue culture using Nucleospin Plasmid EasyPure kit (Macherey-Nagel, Düren) follow-
ing the instructions of the manufacturer. Nucleic acid concentrations were determined using a
NanoDrop (NanoDropTM 1000 Spectrophotometer,ThermoScientific).
2.2.2.4 Purification of MultiBacmid
Several of the white colonies were restreaked to confirm they were the correct colonies. Then these
were used to seed LB cultures for a midiprep. For the isolation of bacmid DNA for virus generation
and protein expression in insect cells, the NucleoBond Xtra Midi prep (Macherey-Nagel, Düren)
was used according to the instructions.
2.2.3 Microbiology methods: C. thermophilum
Culturing of C. thermophilum was done according to instructions from the Hurt laboratory (Uni-
versity of Heidelberg).201
2.2.3.1 Culturing C. thermophilum on agar plates
C. thermophilum was either grown from freeze-dried mycelium, from dried spores and from fresh
mycelium. To start a new culture on plates, freeze-dried mycelium was cut into pieces and put onto
the agar plate and then hydrated with sterile CCM medium. Alternatively, dried spores were plated
out the same way. To plate out frozen spores, they were thawed and directly pipetted onto the agar
plate. To propagate plates with mycelia, pieces were cut out and used to inoculate fresh CCM agar
plates. In all cases, the plate was incubated at 55 °C in a sealed plastic bag supplemented with a
wet tissue to avoid dehydration. The plates were incubated until the plate was fully covered with
mycelium (48-72 h). Plates with mycelia were stored at room temperature until further use.
2.2.3.2 Culturing C. thermophilum in liquid medium
Two CCM agar plates with mycelium were cut into pieces and used to inoculate a preculture of
500 mL of liquid CCM medium in a 1 L baffled Erlenmeyer flask supplied with ampicillin and
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incubated in a rotary shaker at 90 rpm for 24 h at 55 °C. The preculture was transferred into a
kitchen blender and shredded until a blended mycelium broth was obtained. The broth was used to
inoculate 6 x 2 L CCM media in 5 L baffled Erlenmeyer flasks, which were grown overnight at 55 °C
at 90 rpm. After harvesting the mycelium (see below) the flasks were returned to the incubator to
obtain a second batch of mycelium.
2.2.3.3 Harvesting and lysis of mycelium
The cultures were strained through a metal sieve with a very fine pore size. The mycelium was
transferred to vacuum filter to remove residual medium. The mycelium was divided into smaller
pieces and flash frozen in liquid nitrogen. The frozen mycelia were stored at -80 °C until lysis.
The frozen mycelia were lysed by means of cryo-milling (SPEX 6970EFM). The milling cycle
consisted of 5 min of precooling, 3 min grinding at a rate of 9 and 3 min of cooling down. The lysed
mycelia were stored at -80 °C.
2.2.3.4 Generation of spores
C. thermophilum spores were generated by culturing mycelium on rice agar. 75 g rice was cooked
for 2 h in 1 L water. The obtained rice broth was filtered through a sieve to remove the rice seeds
and filled up to 1 L with water. 15 g of agar was added prior to autoclaving. 50 mL rice agar was
filled in sterile glass beakers. 2 mL of liquid mycelium culture (cultured as described above) was
added to the agar and incubated at 37 °C for minimally one week until black spores appeared on
the surface of the agar. The spores were harvested in 1 M sterile sorbitol solution by scraping of
the spores with a sterile inoculating loop. The spore slurry was filtered through a sterile gauze to
remove remaining agar or mycelium. The filtered spore solution was aliquoted and stored at -20 °C.
2.2.4 Insect cell methods
2.2.4.1 Production of baculovirus in Sf21 cells
For transfection, 200 µL medium was mixed with 3 µL FuGene transfection reagent (Promega,
Wallheim) and 1-2 µg bacmid and then incubated at room temperature for 45 min. Then 2 mL
of 0.4 x 106/mL Sf21 cells was incubated in a 6-well culture plate at 27.5 °C for 30 min. The
transfection mixture was added to the cells after these had attached to the bottom of the plate and
incubated for 72-84 h at 27.5 °C. The resulting supernatant contained the P0 virus.
A suspension of 10 mL 1 x 106/mL Sf21 cells was prepared in a 100 mL Erlenmeyer. To this, 1 mL
of the supernatant containing the P0 baculovirus was added. Cells were incubated for 3-4 days at
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27.5 °C and 95 rpm, until signs of transfection, such as changes in viability and morphology, could
be observed.
In case of succesful transfection, cells were pelleted (10 min 3000 g) and 0.5 mL of the supernatant
containing P1 virus was added to 50 mL Sf21 cells 0.4 x 106/mL in a 500 mL Erlenmeyer. This was
incubated for 72 h at 27.5 °C while shaking at 95 rpm. To obtain the P2 virus, cells were centrifuged
at 3000 g for 10 min and the virus-containing supernatant was filtered through a 0.22 µm filter and
stored at 4 °C.
2.2.5 Protein biochemistry methods
2.2.5.1 Protein expression in E. coli
For large scale protein expression, 100 mL overnight culture of LB medium with the right selection
antibiotics was prepared by streaking colonies of a plate with E. coli Rosetta (DE3). The culture was
grown overnight at 37 °C. A 3 L LB medium culture with the appropriate antibiotics was inoculated
1:100 with the overnight culture. Cells were grown until an OD600 = 0.6-0.8 and expression was
induced with 0.5 mM IPTG. The temperature was lowered to 18 °C and cells were grown overnight.
Cells were harvested the next day by centrifugation at 3000 g for 10 min and either frozen in liquid
nitrogen and stored until further use, or used immediately for purification.
2.2.5.2 Test expression ctTel1 in HighFive insect cells
For test expressions, 50 mL media with 1 x 106/mL in 250 mL flasks were used and baculovirus P2
titrated in different ratios. Cells were incubated at 27.5 °C shaking 95 rpm for 1-4 days and then
harvested. Every 24 h the cell count was monitored and a sample was harvested for analysis of the
expression levels of ctTel1.
2.2.5.3 Purification of ctTel1(1-1864)
Cells were resuspended in Lysis buffer (50 mM TRIS-HCl pH 8.0, 300 mM NaCl, 5 % (v/v) glycerol,
30 mM imidazole, 1 mM β-mercaptoethanol) supplemented with protease inhibitor tablets. Cells
were lysed by sonication on ice (Branson Sonifier 250). Lysate was cleared by centrifugation at
30.600 g 4 °C for 45 min (rotor SS34) and loaded onto an immobilised metal affinity chromatography
column (HisTrap), which was preequilibrated in Lysis buffer. After loading the column was washed
with lysis buffer. Protein was eluted using Elution buffer (50 mM TRIS-HCl pH 8.0, 50 mM NaCl,
5 % (v/v) glycerol, 500 mM imidazole, 1 mM β-mercaptoethanol). The purity of the fractions was
analysed using SDS-PAGE. The best samples were pooled and loaded on a HiTrap Q anion exchange
column which was preequilibrated in QA buffer (25 mM TRIS-HCl pH 8.0, 100 mM NaCl, 5 % (v/v)
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glycerol, 2 mM imidazole, 1 mM β-mercaptoethanol). The column was washed with three column
volumes of QA buffer prior to elution using a gradient over 5 column volumes with buffer QB (25
mM TRIS-HCl pH 8.0, 1 M NaCl, 5 % (v/v) glycerol, 2 mM imidazole, 1 mM β-mercaptoethanol).
The eluted fractions were analysed using SDS-PAGE gel. The purest fractions were pooled and spin-
concentrated. The protein was further purified using size exclusion chromatography with a HiLoad
Superdex 200 16/60 column, which was preequilibrated in SEC buffer (25 mM HEPES NaOH pH
8.0, 300 mM NaCl, 2 mM imidazole, 2 mM TCEP). The purest fractions were spin-concentrated
and either using directly or flash-frozen in liquid nitrogen and stored at -80 °C.
2.2.5.4 Purification of nanobodies against ctTel1
Nanobodies were generated against ctTel1(1-1864) by C. Linke-Winnebeck, in collaboration with
ChromoTek GmbH, Martinsried.
Nanobodies were expressed in E. coli Rosetta from a pMJS187 vector, which is optimised for ex-
pression of disulfide-containing proteins.202–204 The cell pellet was resuspended in Buffer A (50 mM
TRIS-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole) supplemented with protease inhibitor tablets.
Cells were lysed by sonication 15 min at 30 % output. The lysate was cleared by centrifugation
at 30.600 g 4 °C for 45 min. The supernatant was incubated for 30 min with Ni2+-NTA agarose
(IBA Life Sciences), preequilibrated in Buffer A. After incubation, the beads were transferred to
a gravity chromatography column (Biorad) and were washed with Buffer A. Protein was eluted
using Buffer B (50 mM TRIS-HCl pH 8.0, 300 mM NaCl, 500 mM imidazole). The lysate, super-
natant, wash fraction and the eluted fractions were analysed on an SDS-PAGE gel. The purest
fractions were pooled and dialysed overnight into Buffer C (25 mM TRIS-HCl pH 8.0, 150 mM
NaCl). The protein was then concentrated using an Amicon spinconcentrator with a 5 or 13 kDa
cut-off, depending on the exact construct. The concentrated protein was purified further using size
exclusion chromatography using a HiLoad 75 16/600 column. The eluted fractions were analysed
using SDS-PAGE and the purest fractions were pooled, concentrated, flash frozen in liquid nitrogen
and stored at -80 °C until further use.
2.2.5.5 Test expression of recombinant ctTel1
Codon-optimised FLAG-ctTel1 and FLAG-ctTel1(KD) were expressed in HighFive cells infected
with different baculovirus ratios. Cells were harvested after three days by centrifuging at 3000 g for
10 min. The cells were flash frozen in liquid nitrogen and then thawed on ice. Cells were resuspended
in Lysis buffer (50 mM HEPES NaOH pH 8.0, 250 mM NaCl, 10 % (v/v) glycerol, 0.1 % (w/v)
CHAPS) supplemented with protease inhibitor tablets. The cells were lysed on ice using a glass
homogenizer. Additionally, the cells were sonicated for 30 sec at 20 % output. The lysate was
cleared by centrifugation at 30.600 g 45 min at 4 °C. The supernatant was filtered with a 0.45 µm
syringe filter. The supernatant was incubated with 150 µL FLAG-beads (preequilibrated in Lysis
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buffer) for 60 min in the cold room under rotation. The beads were washed with Lysis buffer and
boiled. The fractions were analysed using SDS-PAGE.
2.2.5.6 Purification of endogenous ctTel1
Endogenous ctTel1 was purified from C. thermophilum var DSM1495 using a nanobody-mediated
pull-down. 100 g of C. thermophilum powder was resuspended in Resupension Buffer (25 mM
HEPES-NaOH pH 7.5, 150 mM NaCl, 5 % (v/v) glycerol, 0,1 % (w/v) CHAPS) supplemented
with protease inhibitor tablets. The lysate was cleared by centrifugation at 30.600 g for 45 min at
4 °C.
M2 FLAG affinity resin (150 µL, Sigma Aldrich) was preequilibrated in Resuspension Buffer and
incubated with a nanobody for 1 h at 10 °C on a rotating wheel. Excess nanobody was washed off
4 x 1 mL lysis buffer. Nanobody coated beads were incubated with the cleared lysate overnight at
10 °C under rotation in an insect cell harvesting vessel.
The beads were harvested by gentle centrifugation at 4 °C 5 min and washed using 4 times 15 mL
washing buffer (25 mM HEPES-NaOH pH 7.5, 150 mM NaCl). The nanobody-ctTel1 complex was
eluted by proteolytic cleavage using PreScission protease. ATPγS and MgCl2 were added to the
ctTel1 eluate to a final concentration of 0.1 mM and 1 mM, respectively.
Concentrations of endogenous ctTel1 were estimated on SDS-PAGE gel, by comparing the size of the
ctTel1 band to bands from a dilution series of a similarly-sized protein, of which the concentration
can be accurately determined.
2.2.5.7 Denaturing polyacrylamide gel electrophoresis (SDS-PAGE)
The purity of protein samples was assessed by means of denaturing polyacrylamide gel electro-
phoresis (sodium dodecyl sulfate polyacrylamide gel electrophoresis, SDS-PAGE) using 4-20 %
precast Bis-Tris Gels and RunBlue running buffer (Expedeon, Heidelberg).
Protein samples were mixed with 4x Laemmli buffer and denatured for 5 min at 95 °C. Cell lysate
samples were diluted further in water before adding Laemmli buffer. Proteins were separated by
running the gels at 120 V in 1x RunBlue SDS buffer. The gel was stained either by incubated
the gel for 30 min with Coomassie Brilliant Blue staining solution followed by destaining in hot
water, or by staining with InstantBlue and destaining with water. Alternatively, the gel was used
for Western blot.
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2.2.5.8 Western blot analysis
The sample of interest was separated by size using an SDS-PAGE gel run at 100 V and transferred
to a PVDF membrane using wet transfer with a Mini-Trans Blot electrophoretic transfer cell (Bio-
Rad). The PVDF membrane was active by soaking it for 5 min in 100 % (v/v) methanol. All other
components were pre-soaked in cold 2x TG buffer (50 mM TRIS, 384 mM glycine, 20 % (v/v)
methanol, 0,05 % (w/v) SDS) for 30 min. The gel was sandwiched with the PVDF membrane
between a foam pad and two Whatman papers on both sides and clamped tightly prior to transfer
to the blotting chamber. The transfer was run for 2 h at 250 mA in the cold room/write actual
temperature.
After the transfer, the membrane was blocked by incubation in 50 mL TBST + 5 % (w/v) milk
powder for 1 h at room temperature. The membrane was then incubated with the primary antibody
mAB anti-ctTel1 8D9 (Kremmer lab, work by C. Linke-Winnebeck) diluted 1:500 in TBST + 1 %
(w/v) milk powder overnight in the cold room on a rocker. The membrane was then washed using
4x 50 mL TBST for 15 min at room temperature. The membrane was then incubated with the
secondary antibody mouse anti rat Ig2a-HRP horse radish peroxidase conjugated diluted 1:1000 in 5
mL TBST + 1 % (w/v) milk powder for 1 h at room temperature. The membrane was then washed
4x for 15 min in TBST. To detect ctTel1, the membrane was incubated in 10 mL ECL solution for
1 minute. The chemiluminescence was directly measured using an AmershamTM Imager 600 (GE
Healthcare, Penzberg). Alternatively, an antibody against the FLAG-tag was used (see table 2.5).
2.2.6 Assays
2.2.6.1 Annealing of DNA
Oligonucleotides of various lengths were ordered commercially (20, 25, 30 and 60 bp). Labelled oli-
gonucleotides were mixed with a 1.1-fold molar excess of the unlabelled oligonucleotide in annealing
buffer (25 mM TRIS pH 7.5, 50 mM NaCl and 10 mM MgCl2). The mixture was incubated at 95
°C for 5 min in a thermocycler, and cooled down gradually to 20 °C at a cooling rate of 0.1 °C/sec.
2.2.6.2 Affinity measurement by fluorescence anisotropy with DNA
CtTel1(1-1864) was diluted in Assay Buffer (25 mM HEPES-NaOH pH 8.0, 100 mM NaCl and
5 mM β-mercaptoethanol) and mixed with an equal volume of 6-FAM 5′-labelled oligonucleotide
(5 nM final concentration). After incubation for 30 min at 25 °C, the fluorescence anisotropy was
measured at an excitation wavelength of 470 nm and an emission wavelength of 520 nm, using a
plate reader (Tecan). The results were analysed using Prism (GraphPad) and fit using an equation
assuming one specific binding site. Experiments were performed in triplicates.
34
2.2.6.3 Affinity measurement by fluorescence anisotropy with FAM-Nbs1 peptide
FAM-Nbs1 peptide (2643.9 Da, aa 939-954, Genscript, Hong Kong) was dissolved in Assay Buffer
(25 mM HEPES-NaOH pH 8.0, 100 mM NaCl and 5 mM β-mercaptoethanol) to a concentration of 1
mM. For the experiment, the peptide was diluted to a final concentration of 5 nM in Assay Buffer.
CtTel1(1-1864) was diluted stepwise from 5 µM to 0.08 µM and mixed 1:1 with the prediluted
peptide and incubated for 30 min at room temperature. The fluorescence anisotropy was measured
as described before. The experiment was performed in triplicates and the results were analysed
using GraphPad Prism and fit according an equation assuming one specific binding site.
2.2.6.4 Pull-down assays
Anti-MBP-nanobody beads (ChromoTek) were used for pull-down experiments, as ctMRN(ΔCC)
(work by Aaron Alt and Brigitte Kessler) has a tendency to stick to most other resins. Therefore,
a construct of ctTel1(1-1864) containing an MBP-tag was cloned and purified according to the
protocol described above.
The anti-MBP slurry was preequilibrated in Binding Buffer (100 mM KCl, 25 mM HEPES pH
7.5, 5 % (v/v) glycerol and 0.5 mM DTT). 10 µg of MBP-ctTel1(1-1864) was incubated with
the beads for 1 h under rotation in the cold room. The supernatant was collected for analysis
on SDS-PAGE gel and the beads were washed three times with Binding buffer. The beads were
then incubated with ctMRN(ΔCC) for 1 h and the same procedure was repeated. The final wash
fraction and the beads were analysed on SDS-PAGE gel. The experiment was also performed with
ctMR(ΔCC). As controls, MBP-ctTel1(1-1864) and ctMR(N)(ΔCC) were subjected to the same
procedure separately.
2.2.6.5 Analytical gel filtration
To assess the stability of the interaction between ctTel1(1-1864) and ctMRN(ΔCC), analytical gel
filtration assays were performed using a Superose 6 Increase 5/150 column coupled to an ÄKTA
Micro system (GE Healtcare, Penzberg), with a flow of 0.2 mL/min.
ctMRN(ΔCC) and ctTel1(1-1864) were prediluted in Gel Filtration Buffer (25 mM HEPES-NaOH
pH 7.5, 250 mM NaCl, 1 mM TCEP) to a final concentration typically between 5 µM to 10 µmolar.
The reactions were incubated on ice for 30 min prior to gel filtration analysis. The collected fractions
were analysed on SDS-PAGE gel.
To test the effect of ATP, a gel filtration assay was performed with 200 µM ATP added to the gel
filtration running buffer and 1 mM ATPγS added to the Gel Filtration Buffer.
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2.2.6.6 Kinase activity assays
To monitor the kinase activity of endogenous ctTel1 and its response to potential stimulating
factors, kinase assays were performed. Endogenous ctTel1 were used as purified (25 nM final con-
centration). As a test substrate the histone tail of ctH2AX, in vivo one of the main targets of ATM,
coupled to GST (GST-ctH2AX(120-133)) was used to a final concentration of 1 µM. To determine
the preferred metal ion for ATM activity, MgCl2 or MnCl2 were added to a final concentration of
250 µM. The reactions were started by the addition of ATP, typically in a final concentration of
0.5 to 1 mM. Reactions were incubated at 42 °C for 30 min to 60 min. Reactions were stopped by
the addition of Laemmli buffer and denaturing of the proteins at 95 °C for 5 min. Reactions were
run on an SDS-PAGE gel at 100 V for 60 min for a better separation of the bands.
Phosphorylated proteins were visualised using either of two approaches. The gel was either stained
using a phospho-stain (ProQ Diamond, ThermoScientific), which consists of a fluorescent dye
coupled to a phosphate binding moiety, according to the instructions from the supplier. The other
approach was to use γ-32P-ATP, diluted 1:10 in the ATP solution, and visualisation of the incor-
porated radiolabelled phosphate using autoradiography on a phosphoscreen. For both approaches
bands were visualised using a Typhoon imaging system (GE Healthcare, Penzberg).
To test whether observed kinase activity is specific for ctTel1, different PIKK and ATM-specific
inhibitors were tested. Prior to the addition of ATP to start the reaction, ctTel1 was incubated for
30 min with either the general PIKK inhibitor wortmannin (0.5 µM), KU55933 (10 µM), KU60019
(10 µM), caffeine (2 mM) or Torin-2 (1 mM). The final concentrations are in brackets. All inhibitors
were diluted in reaction buffer.
2.2.7 Cryo-EM
2.2.7.1 Cryo-EM grid preparation
Holey R2/1 copper grids with 2 nm continuous amorphous carbon (Quantifoil, Grosslöbichau))
were glow-discharged (EMS GloQube). Directly before applying the full-length ctTel1 sample to
the grid, TWEEN-20 was added to a final concentration of 0.05 %. Grids were prepared on a Leica
EM GP cryo-plunger by applying 4.5 µL of sample to the grid. The sample was then preincubated
for 45 sec on the grid at 15 °C and 95 % humidity and blotted for 2 sec before vitrification in liquid
ethane. The grids were stored in liquid nitrogen until further use.
2.2.7.2 Cryo-EM data acquisition
Three datasets were collected on an FEI Titan Krios transmission electron microscope operated at
300 kV with a GIF quantum energy filter (slit width 40 eV) and a Gatan K2 Summit direct electron
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detector operated in counting mode. Automated data collection was done using EPU (FEI) with a
defocus ranging from -1.2 µm to -3.5 µm at a calibrated pixel size of 1.059 Å/pixel and a dose rate
of 1.34 e/Å2 frame, 8 sec exposure over 40 frames.
2.2.8 Cryo-EM data analysis
2.2.8.1 Data analysis
All data processing was performed using Relion 3.0 and resolutions reported are based on the
gold standard FSC 0.143 correlation. Motioncor (as implemented within Relion 3) was used for
beam induced motion correction of the movie frames. CTFFind 4.1 was used to determine the
CTF parameters of the motion corrected micrographs. Micrographs that showed abnormal Fourier
patterns, such as ice rings due to contamination, and did not show any information beyond 4.5 Å
were discarded.205–207
Particles were picked within Relion 3 using a 3D reference which was obtained from an earlier, lower
resolution dataset and was filtered to 20 Å to avoid model bias. After particle extraction particles
were sorted according to their figure of merit. Particles that were obvious contaminants, such as
ethane and ice, were removed. 3D classifications were performed using a reference filtered to 60 Å
to clean the dataset. 286,284 particles from dataset 1, 269,295 particles from dataset 2 and 308,368
particles from dataset 3 were selected for initial 3D refinement. As a reference a 3D reference from
an earlier test-dataset that was filtered to 40 Å was used, resulting for each dataset in a 3.9 Å
map, which showed significant flexibility in the N-terminal region. The particles of each dataset
were then subjected to Bayesian polishing, CTF refinement and subsequently another round of
3D refinement, resulting in three maps at 3.5 Å, with still significant flexibility in the N-terminal
region. The datasets were then normalised and merged. The resulting 863,937 particles were used
for another round of 3D refinement, which resulted in a 3.2 Å map.
Further 3D classifications with a mask encompassing the kinase domain and fixed angles yielded a
class of 613,262 particles that led to a 3.0 Å map of the kinase domain after 3D refinement and a
2.8 Å map with C2 symmetry applied, which allowed for de novo modelling.
In order to sort out the conformational heterogeneity of the N-terminal domain, another 3D classi-
fication using fixed angles derived from a previous refinement and a mask for one of the N-terminal
domains was performed. This yielded a class of 111,910 particles of the α-solenoid in an open con-
formation, and a class of 132,127 particles in a closed conformation. Subsequent 3D refinement
yielded a map of 3.6 Å for the open conformation and 3.4 Å for the closed conformation.
Using a mask encompassing the α-solenoid of the other protomer, the 132,127 particles for the closed
conformation were used for another round of masked 3D classification with fixed angles. This way
a class was obtained, containing 51,116 particles, with both protomers in a closed conformation.
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Autorefinement of these particles without applying symmetry led to a 4.0 Å map and with applying
C2 symmetry to 3.8 Å.
The map of the two protomers in a closed conformation still displayed some degree of heterogeneity
in the N-terminal region. In order to improve the density further, a mask was created enclosing
the N-terminal regions of both protomers and another round of masked 3D classification with fixed
angles was performed. This yielded a class consisting of 32,764 particles in which both α-solenoids
were in a better-defined closed conformation. Autorefinement with C2 symmetry applied led to a
more uniform density for the entire particle at an overall resolution of 3.7 Å.
2.2.8.2 Model building
A homology model of the ctTel1 kinase domain was generated using SwissServer based on the
kinase domain of hsATM (5NP0) and was docked into the density of the 2.8 Å ctTel1 FATKIN
domain using USCF Chimera.208–210 Rigid body fitting was performed in PHENIX.211 All residues
beyond the kinase domain itself were built manually in Coot.212 As ctTel1 is predominantly α-
helical, sequence based secondary structure predictions could be used to guide model building. Side
chains were visible throughout the density it was possible to find the sequence register for most of.
The protein and could build an atomic model for 2652 residues out of 2944 residues. For some loops
connecting helices, and for some highly flexible parts of the α-solenoid no density was observed,
preventing modelling for these regions. For the very N-terminus of ctTel1 density for α-helices was
visible, but no side chain information. Based on secondary structure predictions (PsiPred) α-helices
with tentative registers were places in this region.213
The open conformation of ctTel1 was modelled using a rigid body fit in PHENIX of the Spiral
of the α-solenoid as had been built in the closed conformation, as no significant conformational
changes within the α-solenoid were observed at this resolution.
After initial building and fitting of all residues for which density was observed, further rounds of
refinement and model building were performed in PHENIX. The model of the FATKIN domain and
of the closed conformation were refined against their corresponding maps with real space refinement
in PHENIX using Ramachandran and Cβ-restraints and further restraints for secondary structure.
For the modelling of the closed and open conformation of the α-solenoid, self-restraints on the initial
coordinates for the Pincer and the FATKIN were included.
To generate a model of the full dimer in the closed conformation, the other protomer was gen-
erated by applying C2 symmetry and then performed a rigid body fit of both protomers in the
corresponding map encompassing the entire ctTel1 particle at 3.8 Å in PHENIX.
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2.2.9 Bioinformatics and software
All figures containing models were prepared using PyMOL (Schrödinger LLC, 2015) and EM maps
were visualised using Chimera and ChimeraX.210,214 Multiple sequence alignments were performed
using MAFFTS.215 and visualised in JalView.216 Percentages of identity and similarity were cal-







Previous attempts to express full-length ctTel1 in any recombinant system tested were unsuccessful
(work by C. Linke-Winnebeck). The expression tests of different constructs of full-length ctTel1 led
to the identification of a truncated construct comprising the first 35 predicted HEAT repeats,
consisting of the first 1864 residues, which could be expressed in E. coli in large quantities. This
construct, ctTel1(1-1864) enabled biophysical assays and crystallography trials.
The original ctTel1(1-1864) contained a C-terminal TEV-cleavage site before the His6-tag, which
was removed by blunt-end ligation to make the construct shorter, as TEV-cleavage was not used
because it would lead to much lower yields due to inefficient cleavage.
CtTel1(1-1864) was expressed in E. coli Rosetta, yielding soluble overexpressed protein, as is shown
by the band at 210 kDa in the lysate and the supernatant (Figure 3.1). Purification using Ni2+-
NTA and the His6-tag fused to the C-terminus of ctTel1(1-1864) removed many impurities, although
strong contamination bands were still visible in the eluteds fractions. Most of these impurities were
removed by anion exchange chromatography using a HiTrap Q column. The purest fractions were
then applied on a HiLoad Superdex 200 16/60 size exclusion chromatography column, yielding a
sharp peak for CtTel1(1-1864). Minor impurities were still observer after this final purification step.
However, when comparing the intensity of the bands on SDS-PAGE gel, the CtTel1(1-1864) sample
is >95% pure.
The yield for 1 L E. coli culture was 5 mg of pure protein. Due to these high yields, CtTel1(1-1864)
was suitable for further biochemical and biophysical assays.
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Figure 3.1: Purification of ctTel1(1-1864) from E. coli Rosetta. A. Coomassie-stained SDS-
PAGE gel of the His-tag purification step. The upper band corresponds to ctTel1(1-1864). 1: lysate, 2:
supernatant, 3: wash fraction, M: marker. B. Coomassie-stained SDS-PAGE gel of the anion exchange
purification step. C. Coomassie-stained SDS-PAGE gel of the fractions obtained after gel filtration. D.
Gel filtration profile. The first peak corresponds to ctTel1(1-1864).
3.1.2 Purification of endogenous ctTel1 using nanobodies
Endogenous ctTel1 was purified using nanobodies, as we did not succeed in endogenously tagging
ctTel1 or recombinantly expressing full-length ctTel1.
Nanobodies were raised against ctTel1(1-1864) in order to stabilise the protein further for assays and
crystallography (work by C. Linke-Winnebeck in collaboration with ChromoTek GmbH, Martin-
sried). Nanobodies were expressed in E. coli Rosetta from a pMJS187 vector, which was engineered
to enhance the yield of disulphide bond containing proteins, giving high overexpression rates.203,204
Purification using the His6-tag yielded a very pure sample after one step. The subsequent gel filtra-
tion using a HiLoad 75 16/600 column resulted in pure protein without any major contaminants.
The yield was 3 to 5 mg/L culture, depending on the different nanobody constructs.
The nanobodies were used to purify ctTel1 directly from its native source, C. thermophilum. For
one purification, 100g of cryo-milled C. thermophilum was used, which corresponds to 12 L of
liquid culture. CtTel1-nanobody complex was initially eluted using a FLAG-tag. Analysis on SDS-
PAGE gel clearly shows a band that runs higher than 300 kDa, and a band corresponding to the
nanobody at around 20 kDa (Figure 3.2). It was confirmed by liquid chromatography-tandem mass
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spectrometry (LC-MS/MS) finger printing at the Protein Analysis Unit (ZfP, LMU Munich) that
the 320 kDa band corresponds to ctTel1.
As the amounts of ctTel1 were too small for experiments to optimise the buffer, such as Thermo-
Fluor, or further purification steps such as gel filtration, the protein was used as it was eluted from
the anti-FLAG-beads for further kinase assays and cryo-EM analysis. As there was concern that
the negatively charged FLAG-peptide might interfere with biochemical assays and cryo-EM grid
preparation, the nanobodies were recloned to add a PreScission protease cleavage site in between
two G4S linkers to enable efficient proteolytic cleavage.
Using PreScission protease, it was possible to cleave the nanobody-ctTel1 complex of the anti-
FLAG beads. As this form of elution could performed in one step, the sample volume could be
reduced, leading to a more concentration ctTel1. It was still not possible to determine the concen-
tration of ctTel1 accurately with for example using aNanodrop, due to the small amounts and the
presence of the PreScission protease and the nanobody. The concentration of ctTel1 was estimated
by comparing the size of the band to the size of a band of a similarly large protein, of which the
concentration and the dilution factor was known (data not shown). This way, it was estimated that
the ctTel1 concentration after proteolytic cleavage is around 100 nM.
Figure 3.2: Purification of endogenous ctTel1 from C. thermophilum with a nanobody.
A. Coomassie-stained SDS-PAGE gel of a nanobody-based ctTel1 purification. The ctTel1-nanobody
complex was eluted using FLAG-peptide. The upper band corresponds to ctTel1, the lowest band to the
nanobody. B. Coomassie-stained SDS-PAGE gel of a nanobody-based ctTel1 purification. The ctTel1-
nanobody complex was eluted using PreScission protease. The upper band corresponds to ctTel1, the
lowest band to the nanobody. Note the size difference between uncleaved nanobody in the wash fraction
and cleaved nanobody in the eluted fraction.
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3.1.3 Expression trials and purification of recombinant ctTel1
Previous attempts to express full-length ctTel1 were unsuccessful. The small quantities of endogen-
ous ctTel1 were limiting for many experiments, mutants could not be generated and a nanobody
was always bound to the protein, potentially influencing activities or interfering with complex form-
ation. Therefore, it was attempted to express recombinant ctTel1 with an N-terminal FLAG-tag
in insect cells using a codon-optimised gene for the kinase domain. Previous trials (work by C.
Linke-Winnebeck) in insect cells had yielded some protein, albeit insoluble, and therefore insect
cells seemed to be the most promising system to optimise.
Codon-optimisation of genes may improve expression levels and yield more stable protein. As
CtTel1(1-1864) could be expressed in E. coli without problems, it was concluded that the kinase
domain was the problematic region for expression. Therefore a codon-optimised gene for the ctTel1
kinase domains was ordered and fused to the truncated ctTel1(1-1864) construct using Gibson
assembly. A kinase dead (KD) mutant (D2760A and N2765K) was generated using site-directed
mutagenesis. The constructs were then cloned into a pACEbac vector for expression in HighFive
insect cells.
Different virus titres were tested for both the wild-type and the KD mutant to find the optimal
expression level. Expression was analysed using SDS-PAGE gel analysis and Western blot (Figure
3.3). For all titres tested, expression of soluble wild-type ctTel1 was observed. However, on the
SDS-PAGE gel it is already evident there are many impurities in the sample. The Western blot
indeed shows significant degradation of ctTel1. The expression levels for the KD mutant were lower,
and furthermore the mutant suffered from more severe degradation than the wild-type. Therefore,
work on the KD mutant was abandoned.
In order to assess whether the degradation is due to too long expression times, a time course
expression test was performed, and a sample was taken every 24h and analysed as before. After 24
h, no expression is visible yet. The first bands appear after 48 h, but there was initial degradation
is visible, although less severe than observed before. After 72 and 96 h more severe degradation
was observed.
This indicated that the codon optimisation of the kinase domain was insufficient to enable re-
combinant expression in insect cells. As degradation started early on in the expression, no further
attempts at recombinant expression of full-length ctTel1 were undertaken.
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Figure 3.3: Expression tests of FLAG-ctTel1 and FLAG-ctTel1(KD) in HighFive insect
cells A. Coomassie-stained SDS-PAGE gel of the expression levels of FLAG-ctTel1 with different virus
titres. The upper band at 300 kDa corresponds to FLAG-ctTel1. L: lysate, S: supernatant, B: FLAG-
beads, M: marker. CtTel1(1-1864), BSA and nanobody-FLAG were loaded as controls for the Western
blot. B. Western blot the the same gel. An antibody against ctTel1 was used to identify FLAG-ctTel1.
C. Coomassie-stained SDS-PAGE gel of the expression levels of FLAG-ctTel1(KD) with different virus
titres. D. Western blot of the same gel. FLAG-ctTel1(KD) was visualised using an antibody against the
FLAG-tag. E. Coomassie-stained SDS-PAGE gel of the expression levels of FLAG-ctTel1 over 96h with
a virus titre of 1:1000. F. Western blot of the same gel. FLAG-ctTel1 was visualised with an antibody
against ctTel1.
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3.2 Binding assays ctTel1(1-1864)
3.2.1 DNA binding properties
Several studies have demonstrated that ATM has DNA binding properties, and that its kinase
activity is stimulated by DNA. Early work using atomic force microscopy (AFM) showed that
hsATM can bind either to DNA ends or to interior parts of long DNA, and that ATM prefers long
DNA. Kinase assays with hsATM and scTel1 also demonstrated that ATM is stimulated by longer
DNA.111,182
As HEAT repeats often play a role in mediating protein-protein or protein-DNA interactions,
ctTel1(1-1864), which only consists out of HEAT repeats, was considered a suitable construct to
assay the DNA binding properties. Furthermore, assays to establish binding properties are not
possible with the endogenous ctTel1, as they require large amounts of protein.
Previous work by C. Linke-Winnebeck showed that ctTel1(1-1864) also has DNA binding proper-
ties, and displays a preference for blunt ended, double stranded DNA, and has a preference for
longer DNA (data not shown). The fluorescence anisotropy experiments with blunt-ended, double-
stranded DNA of various lengths were repeated with optimised concentrations of protein and DNA
oligonucleotides to determine the KD more accurately. Different lengths of double-stranded blunt
ended were tested (ds20mer, ds25mer, ds30mer and ds60mer) to see whether there is length de-
pendancy. All experiments were performed in triplicates.
CtTel1(1-1864) binds DNA and has a preference for longer DNA. While the ds60mer is bound with
a KD of 58 ± 4 nM, the affinity for the ds30mer, ds25mer and ds20mer is KD = 220 ± 27 nM, KD
= 300 ± 49 nM and KD = 500 ± 230 nM, respectively (Figure 3.4A).
To see if the affinity for longer DNA is higher, it was attempted to perform fluorescence anistropy
with longer DNA. However, when the fluorophore is to far removed from the binding site and still
can ”tumble” independently, it is not possible to measure affinities reliably anymore. Therefore
electrophoretic mobility shift assays (EMSAs), either using agarose gels or native-PAGE gels, were
performed to assay alternative DNA structures and long DNA fragments unsuitable for fluorescence
anisotropy. Furthermore, it would in principle also be possible to observe whether multiple ctTel1(1-
1864) bind to one long oligonucleotide. However, the resolution of the agarose gels was too poor to
see any differences between oligonucleotides of various lengths. While native-PAGE gels typically
allow for a better resolution, ctTel1(1-1864) would not run into native-PAGE gels (data not shown)
and therefore this method also did not allow for assaying DNA binding properties.
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Figure 3.4: Binding properties of ctTel1(1-1864) measured with fluorescence anisotropy.
A. DNA binding properties of ctTel1(1-1864) were assayed using different lengths of 6-FAM, 5′-labelled
double stranded DNA oligonucleotides, ranging from a ds20mer to a ds60mer. The DNA concentration
was kept constant at a final concentration of 5 nM, while the concentration of protein ranged from 0
to 1.25 µM. B. Binding properties of ctTel1(1-1864) towards the C-terminal tail of ctNbs1 was assayed
using a FAM-labelled peptide of ctNbs1(939-954). The peptide concentration was kept constant at a
final concentration of 5 nM. The concentration of protein ranged from 0 to 2.5 µM.
3.2.2 Nbs1 binding properties
Soon after the discovery of the ATM kinase, it was established it interacts with the MRN complex.
MRN recruits ATM to the site of a DSB mainly via the C-terminus of Nbs1.60,88,135 In this process
ATM is activated. Previous work by C. Linke-Winnebeck already established that the C-terminus
of ctNbs1 can be used to pull down ctTel1(1-1864), but it was not known how strong this interaction
was.
To determine the affinity of the C-terminal fragment of ctNbs1 for ctTel1(1-1864), fluorescence
anisotropy was performed using a FAM-labelled Nbs1 peptide (939-954). The experiment was per-
formed essentially the same way as the DNA-binding assays.
Under the conditions tested, the ctNbs1 peptide binds to ctTel1 with a KD of 764 nM ± 219 nM.
This indicates that ctTel1 binds to the ctNbs1 peptide with medium affinity (Figure 3.4B).
In the cell, Nbs1 is part of the MRN complex. It might be the case that the presence of MR and
DNA further enhance the interaction with ATM in vivo.
3.2.3 Pull-down assay with ctMRN(ΔCC) and ctMR(ΔCC)
In the cell, the C-terminus of Nbs1 recruits ATM to the DSB. However, in order to activate ATM,
the complete MRN complex is needed. It has been reported that the ATP-bound state of Rad50
is required for ATM activation. Furthermore, several studies indicated that ATM does not only
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Figure 3.5: Pull-down assay of MBP-ctTel1(1-1864) and ctMR(N)(ΔCC). F1: flow 1, F2:
flow 2, W: wash, B: beads. MBP-ctTel1(1-1864) was immobilised on the beads and incubated with
ctMRN(ΔCC) or ctMR(ΔCC). As controls, MBP-ctTel1(1-1864) and ctMR(N)(ΔCC) were loaded sep-
arately.
directly interact with Nbs1, but also with Mre11 and Rad50.111,112 Therefore, the interactions of
ctTel1(1-1864) with the ctMRN complex were investigated.
To test whether ctTel1 can bind to ctMRN, and whether it can also bind to ctMR, a pull down
assay was performed. As it was not possible to obtain stochiometric and stable full-length ctMRN,
a construct of the ctMRN complex lacking the coiled-coils of Rad50 was used (ctMRN(ΔCC)). This
complex furthermore had a tendency to stick unspecifically to most chromatography resins, making
pull-down experiments problematic. However, ctMRN(ΔCC) was found not to stick to anti-MBP-
nanobody-beads (ChromoTek, Martinsried), which were thus used for pull-down experiments.
As a bait, MBP-ctTel1(1-1864) was used, immobilised to anti-MBP beads. Immobilised MBP-
ctTel1(1-1864) was incubated with ctMRN(ΔCC) or ctMR(ΔCC). It was observed that MBP-
ctTel1(1-1864) can retain ctMRN(ΔCC) but not ctMR(ΔCC), suggesting that binding is mainly
through ctNbs1, which is in accordance with previous studies (Figure 3.5)
However, this does not exclude the possibility that ctTel1 could interact with the coiled-coils of
ctRad50 in an intact complex. Alternatively, MR could also interact with ctTel1 via the FATKIN
domain which is lacking in ctTel1(1-1864).
3.2.4 Analytical gel filtration
As previous experiments showed that ctMRN(ΔCC) and ctTel1(1-1864) interact, gel filtration
assays were performed to assemble a complex of ctMRN(ΔCC) and ctTel1(1-1864) and to assess
the stability of the interaction. CtTel1(1-1864) and ctMRN(ΔCC) were incubated on ice for 30
min prior to injection on a Superose 6 5/150 analytical gel filtration column. CtTel1(1-1864) and
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Figure 3.6: Analytical gel filtration of ctTel1(1-1864) and ctMRN(ΔCC). A. Chromatograms
of the analytical gel filtration of CtTel1(1-1864), ctMRN(ΔCC) and the complex. B. Coomassie-stained
SDS-PAGE gel of the fractions under the peak.
ctMRN(ΔCC) were analysed separately as well. Furthermore, the experiment was also performed
in the presence of ATP, as the ATP-bound form of Rad50 is required for ATM activation.
CtTel1(1-1864) elutes from the column as a sharp peak without any shoulder. ctMRN(ΔCC) how-
ever forms two overlapping peaks. Analysis on SDS-PAGE gel shows that this is due to an under-
representation of ctNbs1, leading to a peak consisting of ctMRN(ΔCC) and a peak consisting of
ctMR(ΔCC)(Figure 3.6).
When ctTel1(1-1864) and ctMRN(ΔCC) are mixed, there is a significant shift in the first peak. Ana-
lysis of the peak fractions shows that ctTel1(1-1864) elutes earlier in the presence of ctMRN(ΔCC),
indicating that ctMRN(ΔCC) and ctTel1 form a stable complex. However, there is also a clear
second peak, consisting of ctTel1(1-1864) and ctMR(ΔCC). It is not possible to say whether there
is any interaction taking place, or whether ctMR(ΔCC) and ctTel1(1-1864) elute at the same time
because their hydrodynamic radius is similar. Addition of ATP gave rise to the same gel filtration
profiles (data not shown), suggesting that ATP does not have an effect on the stability of the
complex tested. However, in the constructs used the coiled-coils were removed, which have been
shown to be essential for Rad50 function, also in its role in activating ATM. It may be that further
interactions or stabilisation of an intact ATM-MRN complex may take place in the presence of
ATP.
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3.3 Kinase activity of ctTel1
3.3.1 Initial characterisation kinase activity
ATM is a highly promiscuous kinase, phosphorylating hundreds of substrates in the cell upon
its activation. ATM targets proteins with an S/TQ motif, including other kinases such as CHK1
and CHK2. Other important targets are histone H2AX and MRN itself. Through this wave of
phosphorylation, ATM orchestrates the DNA damage response by modulating the chromatin, re-
cruitment and stimulation of DNA repair factors and through control of the cell cycle. Studies on
hsATM suggested that MRN and DNA are necessary to stimulate ATM activity. Recently this
has also been demonstrated for scTel1. Furthermore, many other factors have been described that
stimulate or modulate ATM activity, such as BRCA1.89
In order to test basal ATM activity and its response to stimulating factors, an in vitro kinase assay
was established. As a substrate, a GST-tagged ctH2AX histone tail was used, as H2AX is one of
the prime targets of ATM in vivo. The kinase assay was done with FLAG-purified ctTel1.
The reactions were run on an SDS-PAGE gel. In order to visualise the phosphorylation of the
substrate, the experiment was either performed with γ-P32-ATP and the incorporation of the
radioisotope was visualised using autoradiography, or the gel was stained using a phosphostain
(ProQ Diamond phosphoprotein gel stain, Thermo Fischer), in case no radioisotopes were used.
Initially, ATP was titrated to find the optimal concentrations that are needed to observe phos-
phorylation, starting from 1 mM ATP and 0.1 mM γ-P32-ATP. The reactions were run for 60 min.
Interestingly, more substrates were phosphorylated than only GST-ctH2AX(120-133), also ctTel1
itself (upper band), the nanobody and a contaminant that was always observed in ctTel1 elutions
with FLAG-peptide. Furthermore, no activating factors, such as MRN or DNA were added, suggest-
ing that either ATM has some basal kinase activity, or there is a contaminating kinase responsible
for the observed activity (Figure 3.7A).
It was unclear whether ATM prefers Mg2+ or Mn2+ , but it has been reported that described that
hsATM prefers Mg2+ for its role in DNA damage signalling, and Mn2+ for redox signalling (Paull
paper). Therefore, ctTel1 was incubated with either Mg2+, Mn2+ or both. Reactions were analysed
after 30 min and after 60 min. CtTel1 is more active in the presence of Mn2+ than in the presence
of Mg2+. In other PIKKs, such as mTOR, Mg2+ was reported to be the physiological metal ion for
catalysis, suggesting that Mn2+ despite its higher activity is perhaps not physiologically relevant
(Figure 3.7B).
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Figure 3.7: Kinase assays with endogenous ctTel1. A. Titration of different concentrations of
(radiolabelled) ATP. Incorporation of radiolabelled ATP was visualised using autoradiography. B. Metal
dependency of ctTel1. Reactions were run in the presence of Mn2+, Mg2+ or both, for 30 or 60 min.
Incorporation of radiolabelled ATP was visualised bu autoradiography. C. Phospho- and Coomassie-
stained gels of the reactions of a kinase assay run in presence of inhibitors. 1: wortmannin, 2: KU55933,
3: KU60019, 4: Caffeine, 5: Torin-2. The upper band corresponds to ctTel1, the band at 50 kDa is a
contaminant, the first band below 40 kDa is the GST-H2AX(120-133), the lowest band corresponds to
the nanobody used for purification.
3.3.2 Kinase inhibitors
Due to its apical role in DNA damage signalling, ATM is considered to be an interesting drug
target. Inhibition of ATM could lead to the accumulation of DNA damage in cancer cells, thereby
enhancing the effect of other cytostatics that induce DNA damage in fast dividing cells.136 As
the active sites of ATM kinases are extremely conserved, some inhibitors that were specifically
developed to inhibited hsATM could also be tested on ctTel1. As there are nevertheless minor
differences in the active sites, more general PIKK inhibitors were also tested. Furthermore, it was
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also important to establish whether the kinase activity observed in previous assays was specific for
ctTel1 or caused by contaminating kinases.
Therefore, the kinase assay as described above was repeated, but without radiolabelled ATP. Prior
to the addition of ATP to start the reaction, the reaction mixture was incubated with either
wortmannin (a potent PIKK inhibitor), KU55933, KU60019 (specific hsATM inhibitors), caffeine
(a PIKK inhibitor) and Torin-2 (specific for mTOR, ATM and ATR).218–222 After adding ATP, the
reactions were incubated for 60 min and then analysed on SDS-PAGE gel using both phosphostain
and Coomassie.
Weak kinase activity was observed which was not inhibited by the presence of any of the kinase
inhibitors. This suggests that the activities observed previously were due to contaminating kinases.
Most likely, this is because it was not possible to perform more purification steps due to the very
limited amounts of endogenous ctTel1 (Figure 3.7C).
3.4 Cryo-electron microscopy
3.4.1 Structure determination of ctTel1
Despite the fact that ATM has been studied for over two decades, many details of its cellular
function and its activation mechanism remain elusive. This is largely due to the fact that is very
difficult to obtain large quantities of full-length ATM for assays and structural biology. In recent
years, however, developments in cryo-EM, often referred to as the ”resolution revolution”, enabled
the structure determination of proteins and complexes to resolutions that allowed for building
atomic models.223 The advantage of cryo-EM over crystallography is that tiny quantities of protein
are sufficient for grid preparation.
This made the structure determination of full-length endogenous ctTel1 in principle a feasible aim.
Initial attempts at preparing negative stain grids were successful. It was, however, difficult to obtain
reproducible cryo-EM grids of the ctTel1. The protein would not move into free ice, strictly requiring
carbon support. To obtain sufficient particles for cryo-EM data acquisition and data processing,
it was necessary to preincubate the protein sample on the grid for at least 45 sec. Even then, the
ice quality of the grids was very poor. It was possible to obtain an initial dataset yielding a 7.8
Å map of ctTel1, but it was not possible to reproduce or improve this grid. Curiously, changing
from a simple plasma cleaning chamber to a glow discharger yielded reproducible grids with good
ice quality and a uniform particle distribution. Combined with the higher concentrations of ctTel1
obtained using proteolytic cleavage enabled the preparation of grids on which large datasets could
be collected and the elucidation of the ctTel1 structure.
Preliminary test datasets were collected of ctTel1 in complex with different nanobodies to see which
one yielded a more uniform map. For the nanobodies D4 and F7, the overall structure appeared to be
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the same. However, nanobody F7 stabilised the very N-terminus more than nanobody D4. Therefore,
we focussed on the F7-ctTel1 complex for high resolution structure determination. We collected
three different datasets which were merged to enable thorough sorting of different conformations
whilst simultaneously allowing for high resolution structure determination (Figure 3.9).
From 863,937 particles we reconstructed a 3D structure of a ctTel1 dimer in different conformations
(Figure 3.8). The resolution of the FATKIN was overall 2.8 Å. At this resolution, it was possible
to build an atomic model for the entire FATKIN domain, starting from a homology model based
on the polyalanine model of hsATM (PDB: 5NP0).208
The N-terminal Spiral domain displayed a high degree of flexibility, but using masked 3D classifica-
tion and refinement for the α- solenoid of one protomer, two distinct classes were identified showing
a closed conformation and a more open conformation. In the closed conformation, the α-solenoid
touches the FAT domain, whereas in the open conformation this interaction is broken. Using smaller
masks and more rounds of refinement, a resolution of 3.4 Å was obtained for the closed protomer
and a 3.6 Å for the open conformation. The closed conformation was then used to build an atomic
model of the α-solenoid de novo. The open conformation, despite its lower resolution, contained at
the hinge a part that was better resolved than in the closed conformation. Otherwise, the model
for the open conformation was obtained by a rigid body fit of the Spiral into the density.
Due to the higher resolution, the particle subset yielding the closed conformation was subjected to
another round of masked 3D-classification, this time with a mask for the α-solenoid of the other
protomer. This yielded a class in which both α-solenoids were closed. Refinement without symmetry
lead to a map of a closed dimer at 4.0 Å and with C2 symmetry to 3.7 Å. Visual inspection of the
map revealed that the N-terminus still displayed some flexibility, which resulted in some parts of
the maps being patchy and unconnected. Therefore, this particle subset was sorted again using a
masked 3D classification, this time with a mask encompassing both α-solenoids. Refinement with
C2 symmetry of the most prominent class yielded again a 3.7 Å map, in which all parts were equally
well resolved. This map was then used to build an overall dimeric model of ctTel1, in which the
merged structures of the closed α-solenoid and the FATKIN domain we fitted as rigid bodies into
the density.
Overall, we were able to build a side chain model for 90 % of the polypeptide (2652 out of 2944
residues), except for a number of flexible loops and insertions, providing the first near-complete
structure of any ATM kinase (Figure 3.9, Table 3.1). Although at the moment of writing several
ATM structures have been published, atomic models have only been built for the FATKIN domain,
as for all other structures the N-terminal α-solenoid displayed a high degree of flexibility, allowing
maximally for the fitting of a polyalanine chain.
52
Figure 3.8: Data processing overview.
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Figure 3.9: Overview of the resolutions and flexibility within ctTel1. A. Low-resolution maps
of ctTel1 with nanobody F7 and D4 bound, respectively. The presence of the nanobody does not alter
the structure. B. Fourier Shell correlation curves of the different cryo-EM maps. C. Cryo-EM maps
coloured according to local resolutions, calculated in Relion 3.0. Different maps were calculated for
individual domains of ctTel1 due to the high degree of flexibility in the α-solenoid domain. Examples of
local regions show side-chain density.
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Table 3.1: Cryo-EM data collection, 3D reconstruction, model building and refinement
statistics.
FATKIN dimer Closed conf. Open conf. Complete dimer
Data collection and processing
Magnification 130 000 130 000 130 000 130 000
Voltage (kV) 300 300 300 300
Electron exposure (e/Å2) 1.34 1.34 1.34 1.34
Defocus range (µm) -1.2 to -3.5 -1.2 to -3.5 -1.2 to -3.5 -1.2 to -3.5
Pixel size (Å) 1.059 1.059 1.059 1.059
Symmetry imposed C2 C1 C1 C2
Initial particle images (no.) 863937 863937 863937 863937
Final particle images (no.) 613262 132127 111910 32764
Map resolution (Å) 2.82 3.45 3.52 3.65
FSC threshold 0.143 0.143 0.143 0.143
Refinement
Model resolution (Å) 2.83 3.48 3.62 3.80
FSC threshold 0.5 0.5 0.5 0.5
Map sharpening B factor (Å2) -93 -94 -92 -81
Model composition
Non-hydrogen atoms 22348 20930 21041 41860
Protein residues 2824 2638 2652 5276
Ligands
Mg2+ 2 1 1 2
ATPγS 2 1 1 2
B factors (Å2)
Protein 43.8 43.3 52.78
Ligand
ATPγS + Mg2+ 40.1 32.0 40.92
R.m.s. deviations
Bond lengths (Å) 0.009 0.011 0.011 0.011
Bond angles (°) 0.67 0.80 0.82 0.80
Validation
MolProbity score
Clashscore 5.01 8.45 12.43 8.85
Poor rotamers (%) 3.63 5.39 6.46 5.39
Ramachandran plot
Favored (%) 95.77 92.49 91.77 92.45
Allowed (%) 4.23 7.43 8.15 7.47
Disallowed (%) 0.0 0.08 0.08 0.08
3.4.2 Overall architecture of ctTel1
As described for other ATM kinase structures.188,189,208,224–227, also ctTel1 forms a dimer with a
shape reminiscent of a butterfly. At the N-terminus, there is a Spiral domain, which is followed
by a Pincer domain. These two domains combined form an α-solenoid, which is entirely α-helical.
Towards the C-terminus, the α-solenoid is followed by a FAT domain and a canonical bilobal kinase
domain at the C-terminus. The C-terminus contains a number of characteristic insertions, such as
the PRD and the FATC at the very C-terminus (Figure 3.10).
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Figure 3.10: The cryo-EM structure of the ctTel1 dimer in a closed conformation. A. Domain
organisation of ctTel1 indicated in different colours. The C-terminus of tTel1(1-1864) is indicated with
a dashed line. B. Front and top views of the ctTel1 dimer, and a side view of one protomer. The HEAT
repeats are labelled sequentially from N-terminus to the C-terminus. The colours correspond to the
colours used in the domain overview.
The overall arrangement of domains in ctTel1 is the same as in scTel1 and hsATM, showing the
high degree of conservation throughout evolution (see alignment in Appendix). This may not be
so surprising for the FAT and kinase domains, of which the sequence is not only highly conserved
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between ATM kinase orthologs, and also among PIKKs in general. Interestingly, despite the lower
sequence conservation of the N-terminal α-solenoid, the fold is nevertheless highly similar.
CtTel1 forms a dimer, of which most of the interface is formed by the FAT domain, which has
been described for other ATM orthologs too. In total, ctTel1 has 3,500 Å2 buried surface area, as
calculated using PISA.228 For ctTel1 we observe a second, transient dimer interface between the
two α-solenoids of the two protomers. As described in more detail in the next section, the Spiral
moves from a closed conformation to an open conformation relative to the FATKIN, with the hinge
being formed by the Pincer. In the open conformation, the dimer interface is only formed by the
FATKIN domain, whereas in the closed conformation Spiral domains can interact. Interestingly,
the Spirals appear to move independently of each other, giving rise to either symmetric open and
closed conformations, or asymmetric conformations in which one protomer is in a more open or
closed conformation than the other.
Other studies have suggested that conformational changes in the N-terminus are coupled to con-
formation changes in the kinase domain, suggesting a potential mechanism for kinase activation.227
When overlaying the ctTel1 structures of the open and the closed conformation, we do not observe
any significant changes in the kinase domain. ATM has been described to form monomers upon ac-
tivation. We never observed any monomers on the micrographs. Both findings support that ctTel1
is in a stable dimeric and autoinhibited state. More robust conformational transitions induced by,
for example the MRN complex or DNA, are required for potential monomerization and activation.
3.4.3 Structure of the N-terminal α-solenoid
HEAT repeats and similar helix-turn-helix motifs, such as armadillo repeats, typically play a role
in mediating protein-protein interactions or interactions with other macromolecules such as DNA.
As the Spiral and Pincer are also entirely α-helical, this domain of the protein is suggested to be a
hub for interactions. Several studies provided both genetic and biochemical evidence that especially
the Spiral functions as a hub for effector proteins of the DNA repair machinery, such as Nbs1 and
potentially also Mre11 and Rad50, and signalling substrates of the DNA damage response, such as
p53.60,88,144,229
In order to provide detailed structural insight in the N-terminal domain, we determined its structure
to a resolution that allowed de novo model building. The α-solenoid of ctTel1 is flexible, as it can
move around a hinge from an open to a closed conformation relative to the FATKIN. This flexibility
was also observed in other structural studies of ATM kinases and limited the resolution.
In order to solve a structure of the α-solenoid, we made use of 3D classification with a mask for
only the α-solenoid. This resulted in a number of maps showing a closed conformation and multiple
open conformations, which varied from slightly open to wide open. The densities with the highest
resolution information, which was one in the closed state and one in an intermediate open state,
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were refined using focused refinement methods. First, we started with a mask encompassing the
Spiral and the Pincer. Then we restarted the refinement from the last step with a mask for only
the Spiral. This resulted in densities with a resolution of 3.7 Å for the open conformation and 3.4
Å for the closed conformation. At these resolutions, side chain densities can be discerned which
enabled us to build an atomic model de novo for this part of the protein, in both conformations.
In contrast to the kinase domain, no homology model could be used for the α-solenoid. However,
as it is entirely α-helical, model building could be guided by secondary structure predications.
Furthermore, characteristic sequences with very bulky helices, such as multiple aromatic residues
in close proximity, also made it possible to find the correct register of the helices.
The ctTel1 Spiral domain consists out of the HEAT repeats H1 to H22 and a number of helical
and loop insertions of various lengths. For the sake of simplicity, we named all α-helical repeats
HEAT repeats, although some of the repeats are interspersed with longer loops than is typical
and sometimes also contain very short α-helices, which are not representative of canonical HEAT
repeats (Figure 3.11).
The very N-terminus consists of H1 to H4 and forms a flexible but conserved protrusion. Although
α-helical density is visible for H1 and H2, there is no side chain information due to the flexibility.
A tentative side chain model was built in these helices based on secondary structure predictions.
The first two helices and their connecting loop (H1) contain the highly conserved Tel1/ATM N-
terminal motif (TAN motif).230 This motif is present in ATMs from yeast to human and is essential
for telomere maintenance and the DNA damage response. It is conceivable that this motif serves
as one of the interaction sites for other macromolecules, such as other proteins or DNA.
H3 and H4 sit at the bottom of the protrusion and interact with H17 and H18 through hydrophilic
interactions. This interaction stabilises the highly bent conformation of the Spiral. Another site
where the α-solenoid is strongly bent is at H11-H13. In the closed conformation, these helices in
the two protomers interact with each other, and also with the TRD2 domain of the FAT domain
within one protomer. This small interface consists out of a mixture of hydrophobic and hydrophilic
residues. Neither is it highly conserved, which suggests that the interaction is rather unspecific.
In ctTel1, the entire Spiral except for H1 to H4 appears to be in a rigid conformation and also
moves as a rigid body from a closed to more open conformations. It was therefore possible to build
the open conformation, which has a slightly worse resolution than the closed conformation, by rigid
body fitting.
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Figure 3.11: Structures of the N-terminal α-solenoid. A. The Spiral domain can move from a
closed to an open conformation around a hinge formed by the N-terminus of the Pincer domain. In the
closed conformation, there is a small interface between the Spiral and TRD2 of the FAT domain. B.
Details of the fold of the Spiral and the Pincer. The Spiral has several long, unstructured loops, which
are indicated with a dotted line. Their length is shown in numbers. The interior of the Spiral is stabilised
by two Plug loops, which form a structured core via hydrophobic interactions.
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Apart from the interaction between H3-H4 with H17-H18, the Spiral is further stabilised by two
loops in the core of the domain that form together a ”Plug”. The two Plug loops originate from
the HEAT repeats forming the sides of the Spiral and fill the cavity that is formed by the arms of
the α-solenoid. The Plug is highly structured. The first Plug loop is a 40-residue insertion between
helices α16 and α17, which form a HEAT-repeat-like motif. Two patches in this loop, 367-374 and
389-400, are conserved. The insertion is longer in C. thermophilum than in ATM orthologs from
higher eukaryotes. Plug loop 1 interacts tightly through hydrophobic interactions with Plug loop
2, which is a long insertion (650-715) between H12 and H13. The first, hydrophobic part of the
Plug loop 2 interacts with Plug loop 1, forming the core of the Spiral. The loop then reaches across
the Spiral domain and ends in a helix (α28) that sits between the interface of the N-terminal H4
and C-terminal H20-H22 elements of the Spiral. The third and final part of the Plug loop is a long
hydrophilic insert that connects to H13. It spans 60 Å on the interior side the gap underneath the
plug, and is unstructured. Its sequence is poorly conserved.
Apart from the Plug loops, the Spiral contains an additional number of relatively long loop inser-
tions for which we did not observe any density. This reflects the dynamic nature of these loops.
The first 32-residue unstructured loop (417-447) is located on the outside of the Spiral, connecting
alpha helix 17 to H8. Interestingly, this loop contains a highly conserved positively charged patch
(KRRK in C. thermophilum, KRKK in humans), suggesting that this loop may be involved in
interactions with DNA or negatively charged patches on proteins.
The Spiral is connected to the FATKIN via the Pincer. The N-terminal part of the Pincer is forming
the hinge around which the Spiral can move as a rigid body. Due to the inherent flexibility of such
a hinge, this part of the Pincer is less resolved in our structure. It was not possible to see side
chains for a number of α-helices, and for some α-helices it was hard to discern any clear density.
As we observed direct binding of the ctNbs1 C-terminus to the α-solenoid of CtTel1(1-1864), we
also sought to obtain a structure of ctTel1 with an Nbs1 peptide bound. Therefore we added the
synthetic Nbs1 peptide in a 1000-fold excess over ctTel1 before grid preparation. However, when
comparing the dataset with Nbs1 to a dataset without Nbs1, we could not find any additional
density that could reliably account for a peptide bound to ctTel1 (data not shown). This could be
on the one hand because the peptide is too small to give clear density. Alternatively, ctNbs1 could
bind in one of the more flexible parts of the α-solenoid, such as close the hinge.
3.4.4 FATKIN domain
All PIKKs have a FAT domain which wraps around the kinase domain. Both domains are highly
conserved and are often denoted as FATKIN as they form one structural unit. It is likely that
the FAT contains key roles in regulating the kinase activity by transferring conformational changed
induced by allosteric binding to, for example, the α-solenoid (ref). The ATM/Tel1 FATKIN is highly
conserved both in terms of its sequence and architecture. As in other ATM structures described to
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date, the ctTel1 FAT domain is also entirely alpha helical and consists of three tetratricopeptide
domains, denoted as TRD1 (1834-1937), TRD2 (1938-2101), TRD3 (2102-2387) and one HEAT
repeat domain, HRD (2388-2502). TRD3 contains a coiled-coil extension (2285-2387), which is in
close proximity to the kinase domain and therefore also believed to play a direct role in regulating
kinase activity.
The kinase domain has a canonical bilobal kinase architecture, consisting of an N-terminal lobe and
a C-terminal lobe which form a cleft in which the active site is located. The coiled-coil extension
of TRD3 directly interacts with the LBE in the C-lobe via residues 2681-2715. The LBE is a
conserved element, which in mTOR binds to LST8. The C-terminal further contains the PRD
(residues 2848-2910) and FATC domain (2911-2944), elements which are conserved amongst all
PIKKs.
The FAT domain encircles the kinase domain, but only interacts directly with the kinase through
a number of distinct interactions, mainly consisting of hydrogen bonds and salt bridges. These
interactions are astonishingly conserved throughout evolution, and some are identical from yeast
to human. Point mutations in these salt bridges have been associated with A-T and some forms of
cancer. This reflects their importance in the stabilisation of the interface between FAT and kinase
domain (Figure 3.12).208,227
TRD1 and the Pincer interact directly with the C-lobe of the kinase domain via Glu1654 (Pincer)-
Lys1885 (TRD1)-Asp2833 (C-lobe). TRD1 also interacts with the kinase domain via the highly
conserved salt bridge Glu1892-Arg2739, which has been described in other ATM structural studies
as well, and Arg2641-Asp1928-Arg2819.
The coiled-coil within TRD3 and the HRD also interact directly with the kinase domain. A salt
bridge is formed by Glu2638-Arg2176. Additionally, there is a hydrogen bond between Ser2121-
Arg2640.
The HRD connects the TRD domains of the FAT to the N-lobe of the kinase domain. Due to its
proximity, a more extensive surface exists between HRD and the kinase, with highly conserved
salt bridges and other hydrophilic interactions formed by Arg2397-Asp2840, Ans2393-Glu2631 and
Gln2433-Gln2624.
Through this nerwork of interactions, the FATKIN forms one structural unit.
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Figure 3.12: Overview of the interactions between the kinase domain and the Pincer/FAT
domain. Two rotated views of the Pincer and the FATKIN domains of one protomer are shown. The
interacting residues are pictures in boxes, with the interaction sites mapped onto the structures.
3.4.5 Dimer interface
ATM resides in the nucleus as an inactive dimer, and has been reported to monomerise upon
activation, although this monomerisation theory of activation is controversial.46,188 During the
structural analysis of ctTel1, only dimers were observed. This is in accordance with the model that
ATM is a dimer in absence of any activators. To clarify whether monomerisation would in principle
be possible, we analysed the nature of the dimer interface of ctTel1 (Figure 3.13).
CtTel1 has multiple dimer interfaces. Starting from the N-terminus, the Spirals of each protomer
form a transient hydrophilic dimer interface, consisting mainly of ion pairs, when the two protomers
are in a symmetric closed conformation. Interactions such as between Asp576 and Arg615 from the
opposing Spiral domains are in sufficiently close proximity to stabilise the transient interaction.
The major dimer interface is formed by TRD2-TRD2 interactions. The molecular details of this
interface were not described in other structural studies of ATM kinases, presumably due to the
limited resolution, but our high resolution allowed us to resolve this interface to a higher degree of
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detail. The TRD2-TRD2 interface consists mainly out of leucines that form a hydrophobic interface
together with Tyr1963. Additionally, Ser1996 of opposing protomers may form a hydrogen bond to
stabilise the interface further. The overall interface is 870 Å2 (calculated using PISA), suggesting
that a dimer-to-monomer transition would require a substantial amount of free energy.
Other layers of the dimerisation interface are formed by interactions between TRD2 and TRD3 and
by interactions between TRD3 and the kinase domain. The TRD2-TRD3 interface is smaller than
the TRD2-TRD2 interface and consists out of a mixture of hydrophobic and hydrophilic contacts.
Two polar interactions between TRD2 and TRD3 of the opposing protomer, Gln1962 (TRD2)-
Thr 2186 (TRD3) and Ser 1965 (TRD2)-Asp 2190 (TRD3) form a direct connection between these
domains. Another function of the interactions between the TRD2-TRD3 may be to further stabilise
the TRD2-TRD2 interface.
Figure 3.13: Details of the dimer interfaces of ctTel1. The Spiral domains interact in the closed
conformations via polar interactions and salt bridges. The TRD2-TRD2 interface is extensive and con-
sists predominantly out of hydrophobic residues. The coiled-coil of one protomer is in close proximity
to the FATC, PRD and LBE within the kinase domain of the opposing protomer.
Numerous interactions, mainly hydrophilic, exist between the kinase domain and TRD3 of the FAT
domain of the opposing protomer. The coiled-coil within the FAT domain is in close proximity to
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the active site of the other protomer, forming another part of the dimer interface. The coiled-
coil could form direct interacts with the LBE helix bundle (which is the binding site of LST8 in
mTOR). The main interactions are formed by Gln 2354 (coiled-coil)-Thr 2700 (LBE) and Gln 2361
(coiled-coil)-Asn 2702 (LBE).
Furthermore the activation loop within the active site is also in very close proximity to the coiled-
coil, forming another potential interaction site. Another set interactions might be formed between
the flexible loop in the PRD and the coiled-coil. Although the PRD insert is not visible, based on
the locations of the PRD helices it is in close proximity to the coiled-coil. The insert is glycine rich
and contains numerous negatively charged residues, which may interact with a positively charged
region (2342-RNRYQSH-2348) in the coiled-coil of the other protomer (see also Figure 3.16).
The FATC domain of one protomer can also directly interact with TRD3 of the other protomer,
mainly via hydrophilic interactions. TRD3 forms an additional dimer interface with FATC in the
kinase C-lobe, by forming a salt bridge between Arg 2260 (TRD3)-Asp 2922 (FATC).
To summarise, ctTel1 has an extensive dimer interface consisting of multiple layers. The core of
the dimer interface is hydrophobic, wherease the other layers are predominantly hydrophilic. This
suggests that it is unlikely that ctTel1 forms monomers as part of its activation, but there is more
flexibility in the remainder of the molecule. The direct interactions between the TRD3, especially
via its coiled-coil, indicate that conformational changes in one protomer may have a direct effect
on the kinase domain of the other protomer, providing an initial insight in the elements required
for activation.
3.4.6 Kinase domain and active site
In order to stabilise ctTel1 and to identify how a nucleotide is bound in the active site, we solved a
structure of ctTel1 in complex with ATPγS. It was possible to resolve the kinase domain of ctTel1
to a resolution of 2.8 Å, which allowed for the building of a reliable atomic model of the active site
with the ATPγS moiety (Figure 3.14).
As the kinase domain is the most conserved part of ctTel1, it is not only very similar to other
ATM kinases but also to the kinase domains of other PIKKs due to a high degree of sequence and
structural conservation. The active site is formed by a cleft between the N-lobe and the C-lobe. In
contrast to other PIKKs, ctTel1 and other ATM kinases do not have an FRB four-helical bundle
in the N-lobe. In the C-lobe, there is an LBE, which in mTOR binds to LST8.149 As in the other
structures reported to date, the activation loop and the catalytic loop, which are located in the
C-lobe and are required to enable catalysis, are structured. The activation loop wraps around the
catalytic loop and keeps it structured through interactions with the backbone of the catalytic loop,
such as between Asp2794 in the activation loop and the backbone of Asp2760 in the catalytic
loop. The activation loop itself is structured mainly through hydrophobic interactions with the
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FATC domain, which lies buried in the N-lobe. In other known kinase activation mechanisms, the
activation mechanism often entails a change of these loop elements from unstructured to structured
to enable catalysis to take place in the active site.231 Thus, the structured active site of ctTel1 is
indicative of a catalytically proficient, active kinase.149
ATPγS is bound together with a Mg2+ ion in the active site cleft. The adenine moiety lies in a
hydrophobic patch of the active site, which is formed by the side chains of numerous hydrophobic
residues from both lobes of the kinase, including Val2664, Ile2778 and Leu2667 (Figure 3.14B) and
also stacks against the Phe2663 side chain with one side of the purine. Furthermore, the adenine
moiety is coordinated by hydrogen bonds of its NH2 and N6 with the backbone carbonyl of Glu2662
and the backbone nitrogen of Val2664.
The 2-hydroxyl group of the sugar moiety is coordinated by the backbone carbonyl of His2764
through a hydrogen bond. The triphosphates are coordinated by a Mg2++ ion, which is bound either
directly to the side chains of Asn2765 and Asp2779 which are in the activation loop, or indirectly
through a water molecule, for which we do not see any clear density. Lys2610 in the C-lobe, which
is highly conserved, also can make a direct contact to the α-phosphate of ATPγS, which reflects
its role in binding ATP and catalysis. As the catalytic loop is well structured through interactions
with the activation loop and FATC, the key catalytic residue Asp2760 is in the appropriate position
for orienting any bound peptide substrate for nucleophilic attack. His2762 could also interact with
the hydroxyl group of the substrate to stabilise the transition state.
The active site is partially capped by a lid formed by the P-loop (2585-IASGVSAPK-2593), typically
a conserved feature in kinases, but which is not glycine-rich in ctTel1. Another highly conserved
element of the ctTel1 kinase domain is the PRD, which consists of two α-helices connected by a
long flexible loop (2863-2896) of which the sequence is not highly conserved, apart from a number
of negatively charged residues that may interact with the coiled-coil of TRD3.
Due to its flexibility, we could not build this loop, but there was density for the majority of the
helices making up the PRD, except for the residues that connect directly to the flexible loop. The
helices of the PRD directly interact with the activation and catalytic loops, providing a way by
which the PRD can regulate the kinase activity. Tyr2848 and Trp2850 in the PRD contact Phe2784
and Met2786 in the activation loop through hydrophobic interactions. Additionally, a salt bridge
is formed by Glu2785 in the activation loop and Lys2909 in the PRD. The PRD is stabilised by
the insertion of its Arg2856 into a negatively charged pocket consisting of Asp2619, Asp2760 and
Asp2779. The positively charged nature of this interaction is highly conserved in ATM orthologs, as
some possess a lysine instead of an arginine. At the C-terminal end of the first PRD helix, Leu2860
interacts with a hydrophobic pocket in the active site. Gln2861 stacks with Tyr2937 in the FATC
domain and forms a polar interaction with the backbone of Val2792 in the activation loop.
Due to its position, the PRD appears to regulate ctTel1 activity by sterically blocking access
to the active site. Intriguingly, Leu2860-Gln2861 are located closely (less than 10 Å) to the Pγof
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ATPγS. As ATM phosphorylates proteins with an S/TQ motif, Gln2861 might (partially) block the
substrate specificity pocket, while Leu2860 itself cannot be phosphorylated and prohibits catalysis.
The PRD therefore may function as a pseudo-substrate.
Figure 3.14: Overview of the kinase domain and the active site A. Overview of the kinase
domain. The N-lobe is coloured light-grey, the C-lobe dark-grey, the PRD and its flexible loop pink and
the FATC purple. The density for the PRD and FATC domains is displayed in deep blue. The active site
lies in a cleft formed by the N- and C-lobes. Access to the active site is blocked by the N-terminal helix
of the PRD. B. Detailed view of the active site. Density is shown for ATPγS and Mg2+. The catalytic
loop is coloured blue and the activation loop cyan. The residues forming the hydrophobic pocket are
depicted in light teal. All other elements are coloured as in A. C. The active site of ctTel1 modelled
with a peptide substrate of CDK2 (PDB: 3QWH) depicted in navy blue. The active sites of the two
kinases were superimposed. The substrate peptide would clash with the PRD of ctTel1, suggesting that
the PRD inactivates ctTel1 by blocking substrate access through steric hindrance.
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In an earlier structural study done on human ATM, the crystal structure of CDK2 with a peptide
substrate (PDB: 3QWH) was overlayed with apo-hsATM. The PRD clearly clashed with the peptide
substrate, suggesting that the PRD needs to move away as a part of the activation mechanism. We
made an overlay of CDK2 with ctTel1 with ATPγS bound and observed that also in the nucleotide-
bound state the PRD of ctTel1 clashes with the substrate. This indicates that nucleotide binding
alone is not sufficient for ATM activation (Figure 3.14C).
Based on the structure of the active site, ctTel1 displays all the hallmarks of a catalytically proficient
kinase. The loops required for catalysis are structured and the nucleotide is also correctly oriented.
However, the PRD forms a pseudosubstrate blocking the active site. In order to activate ctTel1,
the PRD blockage needs to be lifted, probably due to conformational changes induced by activators
such as MRN or DNA.
3.4.7 Potential DNA binding sites
Several studies have shown that ATM has DNA binding properties and that its kinase activity is
stimulated by DNA. As we confirmed that ctTel1(1-1864) indeed can bind to DNA with a high
affinity, we set out to map the potential DNA binding sites in the α-solenoid. The full-length
structure, including the Spiral-Pincer domains which have DNA binding properties, enabled us to
calculate the electrostatic potential at the solvent-accessible surface using PyMOL and identify the
location of any positively-charged patches that could contribute to DNA binding.
Figure 3.15: Surface map of the electrostatic potential of ctTel1. The electrostatic potential
at the solvent-accessible surface reveals a number of positively charged patches, which may be involved
in DNA binding. Locations of the unstructured loops are indicated with a dotted line. Loop 2 contains
a highly conserved KRRK motif, which may also play a role in DNA binding.
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CtTel1 indeed has a number of positively charged patches. One is located close the the N-terminal
TAN motif, which would due to its role in DNA repair be a logical site for DNA binding. The
inside of the groove formed by the Spiral, Pincer and FAT domain contains two potential patches,
one located halfway the Spiral domain, close to the site where the two protomers touch each other
in the closed conformation. Another patch lies close the hinge formed by the Pincer around which
the Spiral domain pivots.
Several long loops could not be built due to their inherent flexibility. Therefore, we analysed a
multiple sequence alignment for any conserved positively-charged patches in these regions. Inter-
estingly, there is a highly conserved KRRK motif in the large loop insertion between H7 and H8.
Due to the high degree of conservation it is tempting to assume it is playing a role in DNA binding.
Taken together, ctTel1 has several positively-charged patches that could account for its DNA bind-
ing properties. DNA binding could also be mediated by multiple patches simultaneously, e.g. the
TAN motif and the conserved KRRK motif in a flexible loop, which are in close proximity. If mul-
tiple patches across the protein surface are required for DNA binding, this may explain why ctTel1
binds longer dsDNA with higher affinity.
3.4.8 Mapping of disease mutations
Our structure is the first (near-)complete atomic model of any ATM kinase to date. The high
sequence similarity between ctTel1 and hsATM, especially in the FATKIN domain, made it possible
to map somatic cancer mutations from the COSMIC database and germline A-T mutations, as they
are listed in the UniProt database.232,233 Included in the sequence alignment (see appendix) are
cancer mutation sites that were reported at least three times and A-T mutations.
Mutations, both cancer mutations and A-T mutations, occur throughout the entire protein, but
there are higher clusters consisting of more frequent mutations in the kinase domain and the
surrounding FAT domain. Many mutations are found in the active sites and its direct surroundings.
It is evident that any mutations here could have a detrimental effect on the catalysis, hampering
DNA damage signalling. Unsurprisingly, the catalytic residues mention in the previous section are
indeed frequently mutated.
Another cluster of mutations in found in the PRD. Arg3008 is hsATM (Arg2901) has been reported
to be mutated in more than 53 cases. Although this residue does not interact with anything in the
resting state of hsATM/ctTel1, it may be the case that this residue is important in an active
conformation or in binding to substrates. This observation again reflects the importance of the
PRD in the activation of ATM kinases.
Two other domains that contain clusters of cancer mutations are the HRD and the coiled-coils of
TRD3. The interface between HRD and the kinase domain is frequently mutated, indicating that
this domain also plays a role in regulation of kinase activity. The coiled-coils contain two clusters
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of mutations. As it is likely that the coiled-coil directly interacts with the PRD and other parts of
the kinase domain, it is likely that mutations in this area also have a direct effect on ATM activity.
The coiled-coils have been suggested to play a critical role in the transition from an inactive to
an active state (Baretic 2017). As the HRD is also directly interacting with the coiled-coils, it is
possible that further conformational changes in the coiled-coil are mediated through the HRD to
the kinase domain.
Figure 3.16: Mapping of A-T and cancer mutations. A. Overview of germline A-T mutations,
as reported on UniProt, and somatic cancer mutations, as reported in the COSMIC database. The
positions of the mutations are depicted as spheres. A-T mutations are depicted in navy blue. Cancer
mutations that occur three times in the COSMIC database are depicted in yellow, four times in orange
and five times or more in red. B. Two bottom views of the ctTel1 dimer, with and without cancer
mutations. The left panel shows the C-lobe as a surface, with the other domains depicted as cartoons.
The colours scheme is the same as in previous figures. In the right panel, the same colouring as in A. is
used.
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In the Spiral, of which the sequence is less conserved, mutations occur less frequently than in the
FATKIN domain, although it contains a number of relatively frequently mutated residues. In the
very N-terminus, where the TAN motif is located, which plays a role in telomerase maintenance and
DNA damage signalling. Arg23 in hsATM (Arg29 in ctTel1, which is also highly conserved amongst
other orthologs) within this motif is indeed frequently mutated, reflecting its role in the signalling
function of ATM. Further mutations found in the Spiral could also impair stability of the protein.
For example, Arg377 in hsATM (77 times reported), Gln400 in ctTel1) is found at the connection
of one of the plug loops and H7, where it appears to play a stabilising role in the packing of the
HEAT repeats. Any mutation here might destabilise the Spiral. The unstructured loop connecting
H15 to H16 also contains several frequent cancer mutations sites, including Phe858 in hsATM,
which is reported 19 times. As this loop is located on the top of the Spiral, in close proximity to the
N-terminus, which is known to play a role in telomerase maintenance and DNA damage signalling,
it could be that mutations in this loop interfere negatively with regulating proteins or DNA.
The A-T mutation sites follow a similar distribution pattern as the cancer mutations, and frequently
overlap. Interestingly, one cluster A-T of mutations is found, and only one frequent (16 times
reported, Arg2722) cancer mutation in two helices and a loop in the C-lobe of the kinase facing the
FAT domain. As this area surrounds the FATC domain, mutations here might also destabilise the
active site indirectly by destabilising the FATC and the loops that are structured by this element.
In conclusion, most mutations appear to be in places that either destabilise the structure, impair
activation or directly interfere with catalysis. Residues that are directly interacting with the kinase
domain and elements of the active site, such as the coiled-coil of TRD3, presumably play a larger




4.1 The recombinant expression of ctTel1
Soon after the discovery of the ATM gene in the disease A-T, it became clear that ATM is a highly
important protein in our cells, as ATM orchestrates the cellular response towards DNA damage.
This explains why A-T patients are prone to developing tumours and why ATM is also frequently
mutated in many forms of cancer.89,131
Despite its importance, the structure and many aspects of the biochemistry of ATM remained
elusive for many years. One of the main reasons for this knowledge gap is that it is difficult to
obtain ATM in large quantities due to its enormous size. Although systems to express human ATM
have been described, ATM and its yeast homologs such as spTel1 and scTel1 can only be obtained
by tagging or (over)expressing it in its native host, e.g. hsATM can be expressed in HEK cells,
whereas tagged scTel1 can be purified from S. cerevisiae. Still the quantities were not sufficient for
crystallography.112,177,225,226
In recent years C. thermophilum became popular, especially amongst structural biologists, as the
increased thermostability of its proteins makes them more suited for structural analysis. Therefore,
previous work in the lab focussed on obtaining a more stable ATM kinase ortholog from C. thermo-
philum in larger quantities for crystallography. As ATM is highly conserved amongst all eukaryotes,
an ATM ortholog was identified in C. thermophilum based on homology of the FATKIN domain,
which was then named ctTel1 (work by C. Linke-Winnebeck).
Unfortunately, it was not possible to express ctTel1 in any recombinant system tested, including
E. coli, S. cerevisiae, insect cells and mammalian cell lines, usually yielding nothing or at most
insoluble protein. In E. coli, however, ctTel1 was degraded to distinct bands, which were analysed
by LC-MS/MS finger printing. The largest fragment consisted of the first 35 HEAT-repeats of
ctTel1 but lacked the kinase domain. This construct (ctTel1(1-1864)) could be overexpressed in
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E. coli in large quantities. Due to the large amounts this construct could be used for biochemical
assays and crystallisation trials. Crystallography, however, was unsuccessful. In order to stabilise the
flexible HEAT-repeats, antibodies and nanobodies were produced against ctTel1(1-1864). Using the
nanobodies, it was still not possible to obtain crystals, but it enabled purification of the endogenous
full-length ctTel1. However, this required very large amounts of ctTel1 culture for small protein
yields, and furthermore it was not possible to create mutants. Although cloning methods for C.
thermophilum have been described, the cloning is inefficient and the protein yields are low.
It was then attempted to express ctTel1 with a codon-optimised kinase domain, as codon optim-
isation can improve the protein quality and the expression levels. This was again unsuccessful, as
ctTel1 was degraded immediately. This raised again the question why full-length ctTel1 is resistant
to recombinant expression while the entire HEAT repeat domain can be easily expressed in large
quantities.
One explanation is that PIKKs depend on a dedicated chaperone system for proper folding and
maintenance. Cdc37 and Hsp90 are required fo the folding of regular, canonical kinases. PIKKs do
not depend on Cdc37, but instead depend on the chaperone Hsp90 and the Tel2-Tti1-Tti2 (TTT)
complex. TTT and Hsp90 do not interact directly with each other, and details on the interaction
between the TTT complex and PIKKs also remain to be elucidated, although there is evidence that
its Tel2 subunit directly interacts with the HEAT repeat domains of PIKKs.234–236 The interaction
between TTT and Hsp90 depends on another protein complex, R2TP, which in consists of AAA-
ATPase Rvb1 and Rvb2, and the proteins Tah1 and Pih1.234 This complex, together with Hsp90,
interacts with newly synthesized proteins to assemble larger protein complexes, such as for example
RNA polymerase II.237 R2TP does not interact with PIKKs directly, but indirectly via the TTT
complex.234,238 Recently, the R2TP complex was renamed PAQosome (Particle Arrangement of
Quaternary structure), as it has been found that this complex, in combination with other factors
such as prefoldins, plays a a central role in folding and organising the proteome in complexes for
many different clients, including PIKKs.For PIKKs is seems to be the case that there are different
maturation pathways per family member .234,239
It has been proposed that the folding of a large solenoid might depend on chaparones to fold helical
repeats that are distant from each other at the primary sequence.240 The folding of the HEAT
repeats appeared not be the problem, however, as these were overexpressed in large quantities in
E.coli, despite its large size (210 kDa). Furthermore the protein interacts with DNA and MRN,
suggesting it is correctly folded. This suggest that problem rather lies in the intricate fold of the
FATKIN domain.
As is now evident from our structure and the other structures published, the FATKIN domain has a
complex fold. The FAT domain wraps around the kinase domain, interacting via a number of highly
conserved salt bridges. In order to keep the FAT domain open to accommodate the kinase domain,
it is clear that chaperones are required. Furthermore, in ATM there is a large hydrophobic interface
(TRD2), which forms the core of dimer interface. Chaperones might play a role here in avoiding
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aggregation. The kinase domain itself also has a complex fold, consisting out of several structured
loops that are stabilised by the FATC at the very C-terminus, which itself is highly hydrophobic
and folds back into the C-lobe. Furthermore, there is a large unstructured insert in the PRD, and
several elements in the kinase domain interact with the TRD3 of the opposing protomer.
It is likely that the TTT complexes and the PAQosome, despite being conserved elements amongst
eukaryotes, in the recombinant expression systems tested are too different from their orthologs in
Chaetomium that they cannot fold ctTel1 properly. Perhaps ctTel1 too different from the endo-
genous ATM found in these expression systems to be recognised by these folding proteins. Tel2,
for example, indeed has low sequence homology.234,240 Although it would have been interesting
to coexpress these chaperones with ctTel1, it was not possible to find orthologs for all proteins
in C. thermophilum. In the future, further characterisation of such biogenesis pathways may be
interesting for proteins which are difficult to express.
4.2 Binding activities of ctTel1: interaction with DNA and MRN
The large quantities of ctTel1(1-1864) enabled us to perform biochemical and biophysical assays
were are not possible endogenous ctTel1, such as fluorescence anisotropy and gel filtration assays.
As HEAT repeats are frequently implied in protein-protein and protein-DNA interactions, ctTel1(1-
1864) is a suitable construct for these assays. In DNA-PK, for example, where Ku70/80 and DNA
directly interact with the HEAT-repeats of DNA-PKcs.241
Using fluorescence anisotropy, we observed that ctTel1(1-1864) has DNA binding properties and
displays a preference for longer, double stranded, blunt-ended DNA. We also observed that the
truncated protein can directly interact with an Nbs1 peptide, corresponding to the last C-terminal
residues, and with ctMRN(ΔCC), a construct that lacks the coiled-coils of ctRad50. The addition
of ATP did not appear to make a difference for the interaction with ctTel1(1-1864). Furthermore,
we observed that ctMR(ΔCC) does not interact with ctTel1(1-1864)
4.2.1 Interaction with MRN
An early link between ATM and MRN was discovered when it was found that in ATLD Mre11 is
mutated. Patients with ATLD have symptoms that are similar to those observed in A-T patients,
suggesting that Mre11 and ATM are linked. It was later discovered that MRN senses DSBs and
recruits ATM to the lesion, explaining this observation.89,134
Several studies have shown that the final C-terminal residues of Nbs1 (or Xrs2 in yeast) are re-
sponsible for this interactions.60,88 In early work, colocalization of ATM and Nbs1 at DSBs was
observed.242 Subsequent studies further narrowed down the binding domain of Nbs1 to the very
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C-terminal residues. Using a 2-hybrid system in yeast, it was reported again that scTel1 associates
with DSBs via Xrs2, and that this binding is mainly mediated via the Xrs2 C-terminus.137
Two studies in 2005 further confirmed Nbs1-ATM interaction. In a study performed on human ATM
and Nbs1, it was demonstrated that the last 20 C-terminal residues of hsNbs1 directly interact with
hsATM, and that this C-terminus is needed for recruitment of ATM by MRN to the DNA.60 To
map the binding of Nbs1 to ATM, nuclear pull-downs with GST-ATM fragments were performed.
Nbs1 binding mapped to residues 248-522 and 1436-1770 in hsATM, although the GST-fragment
in the latter case seemed very impure. With the structural knowledge we currently have, this either
corresponds to a region at the bottom of the flexible N-terminus, at the top of the Spiral, or to a
region close to the hinge formed by the Pincer.
Another study with S. cerevisiae two-hybrid assays and Xenopus egg extracts defined an FxF/Y
motif, preceded by an acid patch, in the carboxyl tail, which is highly conserved and required for
the interaction. It was found that the interaction with Xrs2 is essential for recruitment of ATM to
sites of DNA damage.137 The last 50 residues are required, both in Xenopus and in yeast. For the
two-hybrid analysis to map the binding site of Nbs1 on ATM, the 49 predicted HEAT repeats were
divided into smaller parts. Repeats 17-18 and 21-22 interacted strongly with Nbs1, which led to
the conclusion that Nbs1 has two ATM binding sites.88 In our structure, these repeats are located
around the flexible hinge of ctTel1, suggesting that Nbs1 binding might modulate the conformation
in this region.
Based on sequence alignment, a homolog of Nbs1, ctNbs1, was identified in C. thermophilum, which
also has the characteristic highly conserved FxF/Y motif and preceding acidic patch (SEEESED-
DELKFRFGRRR), similar to the motifs found in scXrs2 (GDGDDDDDDGPKFTFKRRKG) and
in hsNbs1 (KEESLADDLFRYNPYLKRRR). Pull-down experiments performed with GST-ctNbs1
fragments indeed showed that the C-terminus of ctNbs1 binds to ctTel1(1-1864) (work by C. Linke-
Winnebeck).
To measure the affinity of this interaction, fluorescence anisotropy measurements were performed
using a 6-FAM labelled ctNbs1 peptide. Under the experiment conditions the KD = 764 nM ±
219 nM, suggesting a medium-strength binding. The same peptide, but without a label, was used
to prepare cryo-EM grids in order to map the Nbs1 binding site. Although there appeared to be
some additional density in the HEAT repeats on top of the Spiral, the density was too weak to
unambiguously fit the peptide sequence, or see which residues are exactly involved in the binding.
Neither were any conformational changes observed (data not shown). Alternatively, the peptide
could interact with the hinge region, as earlier studies suggested. Here the resolution is worse due
to the higher degree of flexibility, making it impossible to find a small peptide.
A stable interaction with ATM for recruitment to the DSB may require the entire MRN complex.
Several studies have indeed found that, although the localisation to DSBs seems to be mainly
dependent on Nbs1 interaction.242,243, MR is required for activation, especially with Rad50 in an
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ATP-bound state, even in the absence of Nbs1.112,244 Several studies have suggested that MR
directly interacts with ATM. Using assays in S. pombe it was shown that MR still can bind to
overexpressed Tel1 in absence of Nbs1, suggesting there must be some low-affinity interaction
between MR and Tel1.178 Similar findings were reported for purified human MRN and ATM,
showing that MR also binds ATM directly. It was found that this interaction is dependent on
Rad50, not on Mre11.112 In another recent study, pull-downs were performed with the individual
components of the yeast MRN complex and Tel1. It was found that Tel1 interacts with all subunits,
but in contrast to other studies, the interaction with Mre11 is stronger than with Rad50. In the
same study, MRN and different combinations of heterodimeric complex, such as MR, RN, and
MN were tested in their ability to stimulate Tel1 activity. Surprisingly, MN did not stimulate Tel1
activity while MR and RN did, suggesting not only that the activation might depend on a direct
interaction between Rad50 and Tel1.111
To test the interaction with MRN, we made use of a ctMRN construct in which the coiled-coils of
Rad50 had been truncated (ctMRN(ΔCC)). At the time the experiments were performed, it was
not possible to work with intact, full-length ctTel1, as the complex obtained was not stochiometric,
with ctRad50 binding strongly to chromatographic resins. The sample without coiled-coils was
biochemically better behaved, and therefore it was used for initial studies.
In pull-down experiments performed with MBP-ctTel(1-1864), it was observed that ctTel1(1-1864)
interacts with ctMRN(ΔCC), but not with ctMR(ΔCC) which suggests that the interaction with
MRN mainly depends on Nbs1. In gel filtration assays it was observed that ctTel(1-1864) and
ctMRN(ΔCC) coelute as a complex, as indicated by a significant shift in the peak on the chroma-
togram, suggesting a strong interaction. When ATP was added when mixing the proteins and to
the running buffer, no differences were observed. As in ctMRN(ΔCC) ctNbs1 is underrepresented,
there was a second peak corresponding to ctMR(ΔCC). It was unclear whether this peak coelutes
with ctTel1(1-1864) because also separately they elute at the same volume.
Although the Nbs1-binding is in accordance with earlier work demonstrating that Nbs1 interacts
with ATM, other studies have shown that there are also direct interactions between MR and ATM.
Although it is possible that we did not observe direct interactions between MR and ATM because
of low-affinity binding, another explanation would be the lack of the Rad50 coiled-coils. The coiled-
coils of Rad50 are essential for the proper functioning of the MRN complex, including its role DNA
damage signalling through ATM.129 Mutations and truncations in the coiled-coil domain, and the
Zn2+-hook abolish the functions of the MRN complex.100–102,129,245
Furthermore, several studies have also reported that the ATP-bound state of Rad50, but not ATP
hydrolysis, is required to activate ATM and maintain its binding to the DSB, both in yeast and
in human, suggesting that the structural features of MR are also important for the activation
mechanism.100,111,112,129,244,246 Several structures or MR have been reported showing indeed large
conformation changes based on ATP-binding state.94,116 The ATP-bound state of Rad50 can be
maintained for a relatively long time as the rate of hydrolysis is low.108,246,247 However, it is likely
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that also a proper ATP-bound state depends on the presence of intact coiled-coils. This may explain
why addition of ATP had no effect on the chromatograms obtained by gel filtration.
Furthermore, the entire FATKIN domain was missing in ctTel1(1-1864). Any potential interactions
between MRN and ATM in this region would also be missed when using truncated constructs.
Although the finding that ctTel1 interacts with the C-terminus of ctNbs1 is in accordance with
literature, intact proteins should be used for future biochemical and structural characterisation in
order to find explanations for the observations reported in other studies.
4.2.2 Interaction with DNA
Several studies over the years have reported that ATM has DNA binding properties. This is not
surprising as MRN recruits ATM directly to the lesion. Any DNA binding properties of ATM
may, together with MRN, stabilise its binding to DNA. Therefore, the DNA binding properties
of ctTel1(1-1864) were investigated using fluorescence anisotropy. Work previously done in our lab
and experiments in this thesis indeed show that ctTel1(1-1864) has DNA binding properties, and
displays a preference for double-stranded blunt-ended DNA (work by C. Linke-Winnebeck). In
our fluorescence anisotropy studies, we found a length-dependency, with a ds60mer binding more
strongly (KD = 50 nM) than a ds30mer, a ds25mer or a ds20mer.
DNA binding properties were observed before, and interestingly, most studies also report a length-
dependency, with ATM preferring longer DNA for binding and kinase stimulation.
An early study with purified hsATM showed that ATM activity is stimulated by DNA. ATM also
was shown to prefer to bind to DNA ends using AFM, although a third of the population of ATM
molecules binds internally to the DNA. The binding appeared not to be sequence specific, but was
in accordance what we found highly length dependent.182 In another study on hsATM it was found
that both MRN and DNA are required for ATM activation. Again, the DNA sequence did not seem
to matter, but maximum stimulation was only observed in the presence of 1-2 kb DNA.112
Several studies on the DNA binding properties of ATM were performed using Xenopus extracts.
One report claimed that ATM can be activated by DNA breaks alone in the absence of MRN, in
large excess of DNA.180 In another study in which more physiological amounts of DNA added to
Xenopus extract, a length dependency was observed, with a minimal length required of 200 bp for
ATM activation. Another finding was that full ATM activation requires binding of ATM to the
regions flanking the DNA ends, but not to the ends themselves (You 2007)
More recently, it was demonstrated for purified yeast Tel1 that both MRN and DNA can inde-
pendently stimulate Tel1 activity, and together they have a strong synergistic effect. For minimal
activation, a ds80mer was required, but the optimal DNA substrate is 2 kb linearised, nucleosome-
free plasmid DNA. In line with this finding, there is no requirement for double-stranded ends,
although this is in contrast with the strict requirement for ends of hsATM.111,112 DNA stimulatory
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effect in vitro were also reported for hsATM, also showing more stimulation in the presence of
longer double stranded DNA.189
The length-dependency observed in other studies involves much longer DNAs than we tested.
Partially, the length of DNA we tested limited due to the requirements of fluorescence anistropy (if
the distance between the binding site and the fluorophore is so long that the fluorophore can move
independently, it is not possible to measure anisotropy). Other studies also reported a preference
for double-stranded DNA, which we also observed. Curiously, some studies reported that ATM
prefers to bind to internal regions on the DNA and not to ends.111,182 Depending on the mode in
which ctTel1 binds DNA, a ds60mer might be too short to allow for internal binding.
Based on our atomic model, we calculated a surface charge map (PyMOL), which indeed reveals
a number of positively charged patches that might play a role in DNA binding. Interestingly,
the unstructured loop between H7 and H8 contains a highly conserved RKKR motif, which is a
promising site for potential DNA binding. Another candidate motif for DNA binding is the TAN
motif, which lies exposed at the N-terminus. The TAN motif is also conserved amongst ATMs
in all eukaryotes, and is involved in telomere maintenance and DNA damage signalling.230 Arg29
in ctTel1 is universally conserved and its equivalent in hsATM is frequently mutated in cancer.
Additionally, there are a number of positively charged patches on the α-solenoid, which also may
contribute to DNA binding.
One explanation for the length dependency we observe is that multiple patches might be involved
in stable DNA binding. If this is the case, it is more likely that a longer oligonucleotide binds with
all the patches, than a short oligonucleotide. An interesting future experiment would be to mutate
these patches and test whether these mutations interfere with DNA binding and DNA-dependent
stimulation of kinase activity.
This would however still not fully explain the length dependency on DNA longer than 200bp or
more. Additionally, it was observed that scTel1 requires nucleosome-free DNA for optimal ac-
tivation.111 The physiological meaning of this is unclear, as DSBs and ATM activation leads to
condensation of the chromatin to silence transcription.248, while other studies report a depletion of
nucleosomes in HR.249 The dependance on dsDNA is more explicable, as ATM ”sees” dsDNA when
it recruited. However, during resection, ssDNA is formed, which is coated by RPA. This stimulates
ATR instead of ATM, which might lead to a downregulation of ATM activity and enhance ATR
activity for later steps of HR, providing a way to modulate ATM activity. Alternatively, longer DNA
fragments could allow more ATM molecules to bind, which would lead also lead to an increase in
stimulation of kinase activity.42,89
Taken together, our studies on the interaction with MRN and DNA show that ctTel1 can bind to
both, which is in accordance with literature. For a better understanding of the system, however,
the assays need to be repeated with full-length proteins.
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4.3 Structural biology
Although ATM has been studied for over twenty years now, many aspects of its biochemistry are
not well understood. This is largely due to lack of structural data. The identification of ctTel1(1-
1864) and the generation of nanobodies against this construct enabled the purification of full-length
endogenous ctTel1 from C. thermophilum. Although the yields of these purifications are small, it
was sufficient for structure determination by cryo-EM.
To date, our ctTel1 structural model is the first ATM structure of which an atomic model could be
built for the entire molecule, except for a number of flexible loops.
4.3.1 Comparison to other ATM kinase structures
Over the last years, numerous ATM structures have been solved, to ever increasing resolutions. Ini-
tial low-resolution structures revealed that ATM has a dimeric structures with a striking butterfly-
like architecture, in which the dimerisation is mediated by the FATKIN domain, but not by the
N-terminal α-solenoid.224–226 The higher resolution structures that have been resolved more re-
cently allow us to have a closer look at the molecular details of especially the FATKIN domain and
the active site.188,189,208,227
Overall, the structure described in this thesis is in perfect agreement with other structures, due to
high degree of conservation in especially the FATKIN domain. It is however the first structure to
describe an atomic model for the α-solenoid domain.
4.3.1.1 Comparison α-solenoid
The presence of the nanobodies has been beneficial for stabilisation of the N-terminal Spiral domain.
Different nanobodies were found to stabilise different parts of the N-terminus. Nanobody D4, for
example, stabilises the HEAT repeat on the apical side of the Spiral, whereas nanobody F7 stabilises
the very N-terminus. As the latter nanobody seemed to stabilise a larger part of ctTel1, it was also
used for sample preparation for a large cryo-EM data acquisition. This enabled us, after sorting
out the different conformations of the Spiral domain, to build nearly the entire polypeptide of the
N-terminal Spiral, except for a number of unstructured loops.
Although the FATKIN domain appeared to be rather rigid in our structure and in other structures
reported, the N-terminal α-solenoid displayed more flexibility, with the Spiral moving from an open
to a closed conformation around a hinge formed by the Pincer. Movements within the N-terminal
HEAT-repeats forming an α-solenoid domain have been described in the other ATM/Tel1 struc-
tures.208,227 So far, ctTel1 is the only structure in which interactions between the Spiral domains
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of opposing protomers have been described. In all other structures, the α-solenoid was not resolved
sufficiently to see similar interactions.
In the scTel1 structure, conformational changes are described to be coupled to rearrangements in
the active site, especially in the PRD which blocks access to the active site.227 As is described below
in greater detail, the PRD blocks the access to the active site by functioning as a pseudosubstrate.
Although we also see an open and closed conformation of the α-solenoid, we do not see any coupled
changes in the active site in our structure. Neither were similar motions observed in another recent
scTel1 structure.188
In the first hsATM structure, two types of dimers are reported, one with symmetrical related
FATKINs, which were referred to as closed dimers, and one with an asymmetric conformation,
referred to as a more open conformation. The resolution of the open conformation, however is
rather limited, to 11.5 Å. In this ”open” conformation, however, the α-solenoid seems to be more
closed whereas the kinase domain is more open. In the asymmetric form a ratchet-like movement
is observed between the two FATKINs, twisting one protomer by 30° with respect to the other,
leading to a disordered PRD, suggesting a more active state.208 Similar twisting motions, however
have not been observed in our ctTel1 structure.
In a more recent scTel1 structure with AMP-PNP bound in the active site, motions were observed
as well in the α-solenoid, but these motions were not transferred in the active site, similarly to
what we observe.188 It is not clear whether the active site is more rigid due to the presence of a
nucleotide, and whether the coupled conformational changes observed in the apo-scTel1 structure
reflect a more active state that could be further stabilised by MRN or DNA. Both scTel1 and
hsATM have been demonstrated to have a basal activity. However, it is likely that for robust ATM
activity, activators such as MRN are needed to induce more robust conformational changes. ATM
and Tel1 are indeed more active in the presence of DNA and MRN.111,112,208
4.3.1.2 FATKIN domain
The FAT domain is highly conserved amongst all PIKKS and amongst ATM kinases, they are almost
identical. The salt bridges that connect the FAT domain to the kinase domain are conserved from
yeast to human, and are frequently mutated in cancer, suggesting that these residues are critical
for the stability of ATM.
An important feature of the FAT domain of ATM is that it forms the dimer interface. ATM is
reported to form monomers as part of its activation mechanism.46 However, in all higher resolution
scTel1 structures and our ctTel1 structure the TRD2-TRD2 interface, which forms the core of the
dimerisation interface, is very hydrophobic.188,227 Monomerisation would be highly energetically
unfavourable, suggesting that it is unlikely that this is part of its activation mechanism. The
other interfaces are predominantly hydrophilic, with extensive contacts existing between the kinase
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domain and TRD3, especially between its coiled-coil and the C-lobe. Based on this, it seems more
likely that the activation mechanism of ATM involves motions around a hydrophobic which could
release the hydrophilic interfaces and open the active site. Such a turning motion has been described
for hsATM, where one protomer turns, yielding an asymmetric dimer.
Surprisingly, a 7.8 Å structure of a hsATM monomer has been reported, which was shown to be more
active, as the restraints imposed by the presence of the other protomer have been lifted, opening
up the kinase domain. The monomers were suggested to be induced by the exposure to DNA
during lysis and by leaving out DNase out of the lysis buffer. However, in our ctTel1 preparations,
no DNase was added and no monomers were observed. Thus it is unclear whether the observed
monomers resulted from activation.
4.3.1.3 Kinase domain
The kinase domain of the different ATMs is extremely conserved, both in sequence and in structure.
All elements that are characteristic for PIKKs are present, such as the catalytic and activation loop,
a hydrophobic FATC domain and the PRD, which block substrate access to the active site.
In the active site, there are minor differences between the apo-state and the nucleotide bound
state. In all PIKKs the catalytic elements, such as the catalytic loop and the activation loop,
are structured through interactions with the FATC domain. Therefore, the residues required for
catalysis are also in a correct position. In the nucleotide-bound state, they are oriented such that
they can coordinate the ATP analogs. Similar differences have been observed for mTOR as well
when comparing a nucleotide-bound state to an apo-state (Figure 4.1).
There are conflicting studies on the number of Mg2+ ions in the active site. For ctTel1, density
has only been observed for one Mg2+, whereas for mTOR two Mg2+ have been observed, at rather
different positions in the active. For scTel1 there was faint density for a second Mg2+ at a similar
position as has been described for mTOR, suggesting that ATMs might have a second Mg2+ as well.
Other studies on CDK2 have suggested that the number of Mg2+ ions depends on the stage of the
catalysis, with a second Mg2+ ion binding as an activating Mg2+ together with a substrate.149,188,250
The PRD, which is conserved amongst all PIKKS, functions in ATM as a pseudosubstrate which
blocks the entrance to the active site by sterically hindering peptide binding. The two helices that
make up the PRD (also frequently denoted as Kα9 and Kα10) are highly conserved amongst ATMs,
whereas the linker loop (often denoted as the PRD-insert) connecting the helices is not conserved in
length and amino acid composition. In ctTel1, there is an LQ motif, which reminiscent of the S/TQ
phosphorylation motif, in close proximity to the γ-phosphate. It is tempting to speculate that the
Q binds to a substrate binding pocket, thereby anchoring the PRD. However, the LQ motif is not
conserved among all ATMs, with scTel1 being an exception, suggesting the LQ is not essential for
PRD function.
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Figure 4.1: Comparison of the active sites of ctTel1, scTel1 and hsmTOR. Nucleotide-bound
ctTel1: 6SKY, nucleotide-free scTel1: 6JXC, hsmTOR: 4JSV and nucleotide-free hsmTOR in complex
with Rheb: 6BCU. The active sites ctTel1, scTel1 and hsmTOR are highly conserved. Binding of ATPγS
induces the same orientation of the active site residues to coordinate the nucleotide. The Rheb-bound
mTORCs was reported to active mTORC1 by closing the P-loop covering the active site more. However,
the residues are not oriented accordingly and the P-loop is in the same conformation as in the ATPγS-
bound state.
In several structural studies on ATM kinases, the PRD was reported to becomes more disordered,
either in response to movements in the α-solenoid, ratchet movements giving rise to asymmetric
dimers, or monomerisation. However, many of the maps these structures were based on were at
rather low resolution, in which it is difficult to see whether the helices are disordered or whether
the density in this region is poor due to low resolution.
The PRD has been described to be more ordered in the nucleotide bound state, when compared
to the apo-state.188,227 As has been described before, the PRD makes several contacts with the
activation loop and other parts of the kinase domain. Although it does not appear to make any
direct connections to the ATP analogue, the presence of ATP puts restraints on the active site, and
could thus stabilise the PRD indirectly via the activation loop.
The PRD flexible insert is believed to interact directly with the coiled-coil of TRD3, and other
elements in the active site, such as FATC and the activation loop also interact with TRD3. Any
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shift of TRD3 away from the kinase domain would release the binding to these elements, which
could then become less ordered. While the FATC lies embedded in the C-lobe and the activation
loop, the PRD has fewer interactions with the kinase domain. This could in principle enable it to
become more disordered. The PRD is more ordered in the nucleotide bound state, when compared
to the apo-state.188,227 As has been described before, the PRD makes several contacts with the
activation loop and other parts of the kinase domain. Although it does not appear to make any
direct connections to the ATP analogue, the presence of ATP restrains the active site, and could
stabilise the PRD indirectly via the activation loop.251
4.3.2 Comparison to other PIKKs
To date, no structures have been reported of ATM kinases in complex with activators such as MRN
or DNA. Comparing ATM to other PIKKs might shed more light on the activation mechanism and
binding mode of modulators. Structures of all PIKKs have been reported now, most of which have
been solved by cryo-EM. In addition, of several PIKKs higher order complexes have been reported.
Although the α-solenoids are highly divergent in sequence and structure, all have a similar function
as a integration hub for activators and modulators. The large variation in these HEAT-repeat
domains also reflects the diverse roles that PIKKs play in the cell. In contrast, the FATKIN domain
and especially the kinase domain are highly conserved. Any differences in these domains also reflect
diverging substrate specificities. In this section some structures of PIKKs that have recently been
solved are compared to the ctTel1 structure in order to gain more insight in common themes (Figure
4.2 and 4.3).
4.3.2.1 Comparison to ATR
ATR/Mec1 is also involved in DNA damage signalling. It is the PIKK which is most similar to
ATM in terms of sequence similarity and architecture. ATR also forms a dimer, and the α-solenoid
folds in a comparable manner. Together with ATRIP (Ddc2 in yeast) it forms one structural unit,
that dimerises in a similar fashion as ATM. Structures have been solved for both ATR-ATRIP and
Mec1-Ddc2 at 4.7 Å and 3.9 Å respectively.252,253
Whereas in ATM the dimer interface is dominated by interactions between the FATKIN domains of
neighbouring protomers, the dimer interface of ATR/Mec1 is more distributed along the structure,
and ATRIP/Ddc2 also plays a role in dimerisation at the α-solenoid close to the N-terminus.
However, the exact nature of the ATRIP/Ddc2 dimer is unclear as the different structures reported
are contradictory. A crystal structure has been reported that suggests that ATRIP forms a coiled-
coil, but such a coiled-coil is not observed in the ATR-ATRIP structure. The limited resolution of
the ATRIP/Ddc2 densities did not allow for modelling the entire ATRIP molecule.
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Figure 4.2: Overview of the structures of all PIKKs. hsATR:ATRIP: 5YZ0, hsDNA-PK+DNA:
5Y3R, hsmTORC1: 6BCX, hsSMG1 + SMG8/9: 6SYT, scTra1: 5OJS. The domains are coloured ac-
cording to the same scheme in the introduction. The HEAT repeat domain is navy blue, the FAT domain
green, the kinase domain yellow and the FATC domain magenta. Any additional binding proteins are
depicted in grey. The α-solenoid domains are both in terms of structure and sequence the most divergent
domain, whereas the FAT and especially the kinase domains show more similarities.
The protomers are reported to have distinct conformations due to inherent flexibility. Similar asym-
metry we observe for ctTel1 too in the α-solenoid domain. The residues involved in dimerisation are
highly conserved. Interestingly, the TRD2-TRD2 interface of ATR is also hydrophobic, comparable
to ATM, although in contrast to ATM, ATR has not been reported to monomerise, despite having
a similar architecture.252,253
The kinase domain of ATR is highly similar to the kinase domain of ATM. Both ATM and ATR
lack the FRB four-helix bundle located close the entrance to the active site in all other PIKKs. The
FRB is suggested to play a role in the regulation of mTOR in which is was discovered as the binding
site of the mTOR inhibitor rapamycin.149 It might have a similar regulatory role in other PIKKs in
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Figure 4.3: Overview of the kinase domains of all PIKKs. hsATR: 5YZ0, hsDNA-PKcs: 5Y3R,
hsmTORC1: 6BCX, hsSMG1: 6SYT, scTra1: 5OJS. The domains are coloured according to the same
scheme as in results section xyz. The kinase domains are highly conserved in terms of architecture,
although there are a number of striking differences. ATM does not have the FRB four helix bundle.
Furthermore, the PRD, which functions as a pseudosubstrate in ATM, and perhaps also in DNA-PKcs,
does not block the active site cleft in all PIKKs, as is evident in hsATR. In hsmTOR and hsSMG1 the
unstructured insert in the PRD may play a larger role in regulation the activity than the helices. The
activation loop of scTra1, which is longer than in other PIKKs, lies on the PRD, which is not blocking
an active site. Instead, it is blocked by the FRB and LBE, reflecting its loss of kinase activity.
limiting their activity. It is therefore also tempting to speculate that the substrate promiscuity of
ATM and ATR might in part be due to the lack of this domain. The active sites of ATM and ATR
are also highly conserved, showing the same architecture and orientation of the catalytic residues.
In the structure of Mec1, however, part of the activation loop is not visible due to a lack of density.
The catalytic residues are also positioned in a way that is not optimal for catalysis. Whether this
reflects an inactive state is not clear, however, it was suggested that an in/out transition of the
catalytic DFG motif could form an alternative activation mechanism.251
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The PRD in ATR is shorter than the PRD in ctTel1, with a loop just long enough to connect
the α-helices. When comparing the kinase domains, it is obvious that the PRD of ATR does not
block the active site access as it does in ATM, and the activation loop is exposed. In ATM, on
the other hand, the activation loop is encircled by the PRD. There is however no steric hindrance
when modelling a Chk1 peptide onto ATR. While the PRD of ATR does not regulate activity by
blocking the active site, it has been shown to be the interaction site of TopBP1, which has been
proposed to activate ATR directly via the activation loop.147,252,253
4.3.2.2 Comparison to DNA-PKcs
DNA-PKcs is the other PIKK involved DNA damage signalling and mainly plays a role in respond-
ing to DSBs that are repaired by NHEJ. Together with the Ku70/80 dimer it forms DNA-PK. Of
DNA-PKcs and DNA-PK several structures have been reported in the last decade. Astonishingly,
two crystal structures have been solved, an apo-crystal structure of 6.6 Å, and a structure with
the C-terminal tail of Ku80 bound at 4.3 Å. Furthermore, cryo-EM structures have been reported
of DNA-PKcs and C-terminal tail of Ku80 and a structure of a DNA-PK complex including the
Ku70/Ku80 dimer and DNA.153,241,254,255
DNA-PKcs folds into an enormous, concave ring-like structure, with the FATKIN domain forming
a head that sits on top of the circular α-solenoid domain. The fold of the HEAT repeats is rather
different than when comparing it to ATM kinases, but the FAT and kinase domain are highly
conserved.
Comparable to ATM, of which the Nbs1 C-terminus has been mapped to the HEAT repeats, the C-
terminus of Ku80 was also mapped to bind in an equivalent region in DNA-PKcs.60 Two structures
have been reported with only the C-terminal tail of Ku80 present. Curiously, these structures are
contradictory, as the crystal structure shows segments of the C-terminal tail spread over the HEAT
repeat domain.254, whereas an EM structure does not show these segments, but a rather weak
density (9 Å) sitting on the α-solenoid in a flexible region close the FATKIN. The latter study fits
better with existing NMR data, according to which the Ku80 C-terminus form globular core of
six helices. Interestingly, for ATM the Nbs1 binding sites have been mapped as well to the flexible
hinge region which is relatively close the FATKIN domain.255
A later study resolved the structure of complete DNA-PK, with Ku70, Ku80 and DNA. The binding
between DNA-PKcs and Ku70/80 is weak in the absence of DNA, and vice versa the affinity for
DNA is also weak in the absence of Ku70/80. Similar as has been described for ATM and MRN,
binding of Ku70/80 stimulates the kinase more strongly in presence of DNA. The actual DNA
interaction site, which is located in the α-solenoid, is very limited and unspecific, allowing for a
wide range of different DNA sequences as substrates. This is another example of how PIKKs are
allosterically regulated and activated. It is conceivable that there is a similar mode of binding
for ATM, with DNA interaction mediated by MRN, but also involving direct binding to ATM.
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For ATM, the location of the DNA binding site is not known, but DNA binding properties have
been demonstrated. On our ctTel1 map, there are multiple patches that could be involved in DNA
binding, but as in DNA-PKcs, they do not involve many residues.241
The DNA duplex in DNA-PK lies in flexible ridge between two HEAT repeat segments. ATM also
has such ridges where the α-solenoid takes a sharp turn, such as the hinge which Nbs1 binding
has been mapped. It could be that such interactions, whether with DNA or regulatory proteins,
stabilise a conformation in the HEAT repeats which are subsequently allosterically transferred to
the kinase domain.
The FATKIN and active site are highly conserved. In DNA-PKcs a conserved metal is observed
in the active site. Comparable to mTOR there is an FRB like domain, which is not present in
ATM. Where in ATM the PRD consists of two helices connected by a flexible loop, the PRD in
DNA-PKcs forms a helical hairpin of about 30 residues occluding direct access to the active site
as it stacks between the catalytic loop and the FRB. Allosteric binding of Ku70/80 and DNA has
been described to induces an inward motion of the HEAT repeats, which in the kinase domain leads
to a slightly larger entry groove for the substrate. The PRD does not appear to move, however,
leaving unclear what changes DNA-PK is requires to become activated instead.241,254
4.3.2.3 Comparison to mTOR
In terms of structural insight into the activation mechanisms of PIKKs, the different structures
that have been solved of (m)TOR and the different complexes in which it exists provide the most
complete picture. In 2013, a crystal structure was reported of the FATKIN domain of human mTOR
in complex with LST8, and also in complex with ATP analogs and inhibitors. This was the first
high resolution structure of any PIKK. A few years later structures were reported that included
the α-solenoid, also in complex with its regulators Raptor, Rictor and the activator Rheb.149,256–260
In contrast to ATM, mTOR does not dimerise via its FATKIN domain, but via its α-solenoid,
forming a symmetric dimer, with the FATKIN domains and LST8 at opposing ends of the structure.
In the middle of the structure is a large cavity. The α-solenoid forms a large spiral-like structure,
where regulating proteins such as Raptor, Rictor and Rheb bind.256,259–261
The FATKIN of mTOR is so highly conserved that it fits into low resolution ATM maps, reflecting
the degree of structural conservation among PIKKs. The main differences are the absence of a
comparable coiled-coil in TRD3, while mTOR has a prominent FRB domain, which forms a four-
helix bundle in the N-lobe. The FRB of mTOR is the rapamycin-binding location, which inhibits its
activity. On the other side of the substrate access cleft LST8 is bound to the LBE (LST8 Binding
Element) in the C-lobe. All PIKKs including ATM have an LBE domain, but they do not bind
to LST8, and neither is the role of LBE in the regulation of kinase activity clear. In the ctTel1
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structure however, the LBE interacts directly with the coiled-coils of TRD3 of the other protomer,
suggesting that the LBE could play a role in the activation of ATM.149
Between the FRB and the LBE with LST8 lies the mTOR PRD, which has a long insertion of 56
residues. As for ATM, the mTOR PRD also plays an important role in regulating the activity of
mTOR, potentially by blocking access to the active site. Mutations in the PRD have indeed been
identified to make mTOR more active. Although the α-helix of mTOR is not in exactly the same
position as the α-helix of ctTel1, it might be that the insert blocks substrate access.149
The active site is highly conserved, which is particularly striking when comparing the ATPγS bound
state to our ctTel1 structure. The mTOR active site contains two Mg2+ ions. While in the ctTel1
structure the Mg2+ ion is in a different position, we did not observe convincing density for second
Mg2+ ion (Figure 4.1).
A cryo-EM structure of mTOR in complex with its activator Rheb provides the most complete
picture so far of PIKK activation. Binding of Rheb to the mTOR α-solenoid induces conformational
changes that cause the α-solenoid to move inwards to form new interactions between the N-terminal
part of the α-solenoid and the FAT domain. These new interactions then lead to conformational
changes in the FAT domain, which occur mainly at the flexible hinges. A large, 30 ° angle, twist
between TRD1 and TRD2 in FAT domain was described to lead to further closure of the active site
by the N-lobe and a rearrangement of catalytic residues to optimal position the ATP. The PRD
helices do not appear to move significantly, however, but they also do not form a pseudosubstrate
as in ctTel1 or other ATM kinases.261
Conformational changes induced by MRN and DNA in the ATM α-solenoid could have comparable
effects on the FAT domain and the kinase domain. Especially the turn of the FAT domain at
the TRD2 residue in mTOR is intriguing, as a similar ratchet movement has been suggested for
hsATM, which would leave the hydrophobic TRD2-TRD2 interface intact. Such movements would
break the contacts between TRD3 and the kinase domain, opening the active site without requiring
energetically unfavourable monomerisation.251,261
4.3.2.4 Comparison to SMG1
Whereas ATM and ATR are involved in many phosphorylation events, SMG1 only phosphorylates
UPF1, which is a key event in NMD. It forms a complex with SMG8 and SMG9 which regulate
its kinase activity. Very recently several structures have been reported of human SMG1 in complex
with SMG8 and 9, and a structure of apo-SMG1, of which the coordinates have not been released
at the moment of writing this thesis.262,263
As seen in all other PIKKs, the α-solenoid of SMG1 forms also a Spiral like structure which functions
as a hub for interactions with its regulators SMG8 and 9 and also the FATKIN is highly conserved.
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Interestingly, SMG1 has a longer α-helical bundle in the TRD3 at the same location as ATM kinases
have their coiled-coil insertion, although its function within a SMG1 monomer is not clear.
Like mTOR there is an FRB-like domain in the N-lobe of the kinase. The active site is also similar
due to its high level of conservation. Unexpectedly, the PRD of SMG1 contains an extremely large,
unstructured insert, spanning over a thousand residues, and end in the FATC domain, which is
structured as in all other PIKKs. The function of this insert is not clear but presumably also plays
a regulatory function, comparable to the other PRDs.
From the comparison of the apo-SMG1 structures and the SMG1-complex the main differences
in the α-solenoid are in the N-terminal HEAT repeats, which adopt a more curved conformation
upon SMG8/9 binding. SMG8/9 inhibits SMG1 kinase activity, which seems to be via an allosteric
mechanism, but it is from the available structures not clear how.
Another unusual feature of SMG1 is the presence of InsP6 (inositol hexaphosphate) in a conserved
positively charged pocket, where it seems to have a role in stabilising a cavity between the FAT
domain and the kinase domain. It was suggested that an unaccounted density in mTOR might
also correspond to InsP6, suggesting this is common for more PIKKs. In ctTel1, however, there
is a positively charged cavity present as well, but no density for InsP6 was observed, even at the
high resolutions we obtained. The positively charged residues lining the cavity also do not point
inwards, suggesting furthermore nothing is bound. Whether the presence of InsP6 is only a feature
of some PIKKS, or whether it depends on the organism, the purification method or the activation
state remains to be investigated.262
4.3.2.5 Comparison to Tra1
Tra1/TRAPP is an interesting member of the PIKK family as it is the only pseudokinase. Tra1
functions as a scaffold in numerous complexes, such as SAGA and NuA4, which are involved in the
regulation of transcription.156,157
In terms of its general architecture, yeast Tra1 is strikingly similar to DNA-PKcs. This is even more
curious, as DNA-PKcs, an active kinase, only exist in higher eukaryotes. Several structures have
been described of Tra1, both of the apo-protein and of the protein within higher order complexes.
Tra1 functions entirely as a scaffold for different proteins. From mapping mutations and structural
studies of higher order complexes, Tra1 has multiple non-competing binding sites for different
proteins contributing to its role as an integration hub. This may be true for the α-solenoids of
other PIKKs as well. Of mTOR it has been well established it functions in the context of different
complexes.146,156,157 This is comparable to the many modulators of ATM activity that have been
described, some of which might bind simultaneously to ATM to fine-tune its kinase activity.89
Despite being a pseudokinase, Tra1 still retains all of the characteristics of PIKKs, albeit it with
modifications that reflect its inactivity. The active site within the kinase domain is conserved,
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but the catalytic DFG motif is not present anymore. The activation loop contains an 18-residue
insertion not present in other PIKKs, which lies on the PRD on the outside of the kinase domain.
Furthermore, the FRB four helix bundle contacts the LBE in the C-lobe, occluding the substrate
binding site completely. Tra1 also contains a conserved FATC domain, in which mutations are often
found to interfere with Tra1 functioning. As Tra1 is not an active kinase, it is likely that the FATC
is not important for kinase activity or substrate recognition per se, but mainly fulfils a role in
maintaining structural integrity of the kinase domain.156,157
4.3.3 Summary
In recent years, the improvements in cryo-EM have allowed for the unravelling of structures of
all PIKKs. Although their α-solenoid domains are highly divergent in architecture, their FATKIN
domains are conserved. For all PIKKs, the α-solenoid functions as a hub for regulating proteins.
Allosteric binding of these regulators can induce changes in the α-solenoid, which are mediated
through the FAT domain toward the kinase domain, as has been described for mTORC1 in complex
with Rheb. Motions in the FAT domain enable further closing of the N-lobe a rearrangement of
the catalytic residues for optimal ATP binding.261
The kinase domains of all PIKKs are highly conserved, with only Tra1 diverging more due to the
fact it is catalytically dead.156 ATM and ATR do not contain the FRB insertion in the N-lobe,
which might enable them to bind to an enormous variety of potential substrates. ATM contains
an LBE, which in mTOR interacts with the regulatory protein LST8, and in ATM interacts with
the coiled-coil of TRD3, suggesting that the LBE in ATM also a regulatory function. The PRD,
an element which is present in all PIKKs, differs significantly in structure and position. In ATM
it functions as a pseudosubstrate, while in other kinases its regulatory role is less clearly defined.
All these differences are likely to be a reflection of the different roles and corresponding substrate
specificities the PIKKs have in the cell.
4.4 A model for ATM activation
The comparison between the different ATM kinase structures and other PIKK structures published
to date allow us to speculate on the activation mechanism of ctTel1. Furthermore, the mapping of
the somatic cancer and germline A-T mutations also sheds light on which elements are critical for
ATM/Tel1 activity.
In earlier work on human ATM it was reported that its activation mechanism involves phosphoryla-
tion of Ser1981 and subsequent monomerization, which releases the autoinhibited state.46 Both
concepts are controversial, as the autophosphorylation site is not conserved and not required in
mouse ATM.186,187 Furthermore, this serine appears to be located in a flexible loop on the outside
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of the molecule, and is not located closely to the dimerisation interface.188,208 Monomerization is
unlikely due to the large hydrophobic dimer interface, as is observed in our ctTel1 structure and in
a recent scTel1 structure.188
Our structure reveals the autoinhibitory circuitry of ctTel1, which shows that the active site is in
an optimal conformation for catalysis, but is rendered inactive by the PRD, which blocks the active
site as a pseudosubstrate. The PRD directly interacts with the activation loop, and also potentially
interacts with the coiled coil in the FAT domain of the other protomer via its unstructured insertion.
Any conformational changes within the FAT domain, especially in TRD3, could directly lead to
movements in the kinase domain that would open the active site.
As was described for mTORC1, the binding of Rheb to the α-solenoid induces a conformational
change which is translated through large twists in the FAT domain to multiple rearrangements in
the active site. The N-lobe and P-loop close and catalytic residues are positioned more optimally
to bind the ATP. It is conceivable that similar motions are induced by the binding of MRN and
DNA. Although we and others observed motions in the α-solenoid, these were not unambiguously
coupled to changes in the active site. This suggests that the movements that are induced by MRN
and DNA must be larger. However, in apo-scTel1, motions in the α-solenoid were coupled to a
more disordered PRD. In a study on human ATM a ratchet movement within the FAT domain was
observed, which also led to a more disordered PRD. Such findings suggest that MRN and ATM
could alternatively stabilise or induce such motions as part of the activation mechanism.227,261
The ratchet movement described for human ATM is reminiscent of the twisting motion the mT-
ORC1 FAT induced by Rheb. Any conformational changes in the FAT domain have a direct effect
on the coiled coil, which is directly connected to the PRD. Indeed, most disease mutations are also
clustered in the active site, the coiled coil and the region between the coiled coil and the active
site. Where the mutations in the active site are detrimental for catalysis, mutations in the other
regions potentially interfere with the activation process.208,261
When a double strand breaks occurs, more factors that are associated with the break modulate
ATM activity. One of the first steps in the activation of ATM is the acetylation of Lys3016 in
hsATM (which is Lys2909) by Tip60/Kat50. This lysine is located in the PRD, where it forms a
salt bridge with Glu2785 in the activation loop (in C. thermophilum). This salt bridge would be
broken upon acetylation, thereby contributing to the release of the PRD and increasing the levels
of ATM activity.89,264,265
To summarise, ATM activation depends on MRN and DNA, which are likely induce conformational
changes via the FAT domain through allosteric binding to the α-solenoid, which positions the active
site residues in an optimal conformation for catalysis and releases the PRD pseudosubstrate to
enable phosphorylation of a broad range of substrates.
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4.5 Conclusion and outlook
In this thesis a structure of ctTel1, a fungal ATM ortholog, is presented, providing the first complete
atomic model of any ATM kinase to date, with only a small number of flexible loops missing.
The kinase domain was solved to a resolution of 2.8 Å and an overall structure including the HEAT
repeat domain to 3.7 Å. The structure reveals the architecture of the α-solenoid, which is involved
in binding to MRN and DNA. Using a truncated ctTel1 construct, we could demonstrated that this
domain interacts with MRN, and particularly via Nbs1, and with DNA.
Interestingly, ctTel1 displays a preference for longer DNA, binding a ds60mer with a higher affin-
ity than shorter oligonucleotides. By calculating the electrostatic surface of ctTel1 and multiple
sequence alignment we could indeed identify a number of conserved positively charged patches,
which may be involved in DNA binding.
The high resolution of our structure allowed for analysis of the dimer interfaces. Interestingly, this
revealed a hydrophobic dimer interface, suggesting monomerisation is unlikely to be an aspect of
the activation mechanism, as this would be highly energetically unfavourable.
The kinase domain is extremely conserved when compared to other PIKKs. In the active site of
the kinase the loops required for catalysis are structured, coordinating an ATPγS molecule and a
Mg2+ ion. This finding suggested that ATM is in a catalytic proficient state. However, access to
the active site is physically blocked by the PRD, which appears to function as a pseudosubstrate.
This also suggests that part of the activation mechanism entails its removal in response to allosteric
binding of activators.
By mapping cancer mutations and A-T mutations, certain clusters of mutations appeared, suggest-
ing that these are found in elements which are important for the activation. Apart from mutations
in the kinase domain itself, where any mutations has a detrimental effect on catalysis, many muta-
tions were also found in interface between the kinase domain and the FAT domain, especially in its
coiled-coil, which directly interacts with conserved elements lining the active site of the opposing
protomer.
The ctTel1 structure thus reveals the autoinhibitory circuitry and provides the first step towards
understanding the activation mechanism of this important kinase. However, important questions
remain: what conformational changes take place in ATM upon activation? How is the PRD released
from the active site? Does it form a monomer, or would the FAT domain undergo a twist, thereby
releasing the constraints on the kinase domain?
In order to understand the activation mechanism, it will be necessary to obtain structures of ctTel1,
or another ATM ortholog, in complex with activators, such as DNA and MRN. The reconstitution
of higher order complexes will require careful analysis of the biochemical requirements, such as the
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ATP-state of Rad50, the presence of DNA and the nature of the oligonucleotide, and possibly even
post-translational modifications, such as phosphorylation.
Another way to approach the question would be to generate mutants and test the activity of ATM.
It would, for example, be highly interesting to mutate the positively charged patches, such as
the TAN motif and the conserved KRRK motif, to confirm whether these are involved in DNA
binding, and whether ATM would still be stimulated when these are mutated. Similarly, analysis of
the residues in the coiled-coil and along the kinase interface could yield insight in which elements
play a role in ATM activation.
To summarise, this work provides a structural framework for future studies on the activation
mechanism. As ATM is one of the apical kinases in the DNA damage response, and also is frequently
mutated in cancer, it will continue to be a highly important protein to be studied, both out of
scientific interest as from a therapeutic perspective.
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Appendix: Multiple sequence alignment of ATM kinases
Alignment of ATMs from different species, created using MAFFT-E-INS-I and visualized using
JalView.215,216 Secondary structure elements displayed for ctTel1 are based on the ctTel1 structure
and for hsATM on secondary structure predictions using PsiPred. For ctTel1, the domains are
indicated with the same colour scheme as in Figure 3.10. On the hsATM sequence, cancer mutations
from the COSMIC database are mapped by the numbers. These also indicate the frequency in which
they occur in the database. A-T mutations, as listed in the UniProt database, are indicated by black









First of all, I would like to thank my PhD supervisor Prof. Dr. Karl-Peter Hopfner for giving me
the opportunity to do a PhD in his lab and for allowing me to work on such a challenging and
exciting project.
I would also like to thank Prof. Dr. Roland Beckmann and Dr. Boris Pfander for being part of my
thesis advisory committee and sharing their valuable support and advice.
Furthermore, many thanks go to Christian Linke-Winnebeck for introducing me to the project. You
did an amazing job during you postdoc and without all the groundwork you provided, there would
not be a structure of ctTel1 now. Also many thanks for helping with the paper, despite having left
the lab years before and having many other obligations. Although we only overlapped for a few
months, it was a great pleasure to work with you.
Many thanks also go to Sebastian Eustermann. Thank you for sharing your expertise on cryo-EM
data processing, your enthusiasm for science, and especially for having faith that the project would
work out.
I also would like to thank Katja Lammens for all the indispensable help with the microscopy and
the structure building. Many thanks as well for smuggling a ctTel1 grid into the newly-built Titan
to collect one of the first (non-ribosomal) datasets.
I also thank Joe Bartho for help with microscopy (even at the most impossible times of the day) and
Dirk Kostrewa for help with building and refining the structure when there was a lot of pressure
on the project.
Of course, many thanks also go to all members of the DNA repair subgroup, past and present, but
I would like to mention a number of people in particular. Rob Byrne: thank you for introducing me
to cryo-EM data processing, and your endless patience with me when I once again had forgotten
my linux password. Hinnerk Saathoff: thank you for helping me with setting up the biochemical
assays. Thanks also for all the Schoki and introducing me to FM4. Claudia Litz: thanks for helping
me find my way in the lab and in the project. Lisa Käshammer: thank you for all the conversations,
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